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My doctoral studies have concentrated on the use of C2-symmetic catalysts to 
control the three-dimensional construction of molecules.  The first half of my thesis 
focuses on asymmetric addition of phenols into Pd π-allyl complexes.  This work was 
inspired by the natural product, sch202596, an antagonist for the galinin receptor that 
contains a highly stereogenic and compact carbasurgar structure appended onto a 
phenol by an allylic aryl-ether bond. A transformation was developed in which 
racemic allylic oxides underwent a Tsuji-Trost reaction to give diastereomeric π-allyl 
complexes.  Addition of a nucleophile resulted in enantioenriched regioisomers in 
good yields.  We termed this approach allylic oxide regio resolution (AORR). Using 
this approach, four different carbasurgar natural products were synthesized: streptol, 
MK7607, cyathiformine B and polyporapyranone G.  Additionally, this method was 
extended to append carbasugar-like molecules onto complex natural products. 
 
 Furthermore, C2-symmetic catalysts were used to synthesize polymers with 
stereoregularity, which will be the focus of the second half of my thesis.  Utilizing 
advances in chain walking polymerization, 1-butene was polymerized resulting in a 
novel isotactic semi-crystalline polymer.  The ligand framework and reaction 
  iv 
conditions were probed in order to optimized the system, which gave an active catalyst 
that produced a polymer with few stereo and regioerros.  Specifically, it was found 
that ortho-cumyl groups were necessary to maintain the stereochemical information 
through the chain walking steps.  Additionally reaction conditions were explored and 
discovered that a reaction temperature of −40 °C and a concentration of approximately 
8 M were the optimal conditions. Finally, the use of non-aromatic, high polarity, 
aprotic solvents proved beneficial. !  
  v 
BIOGRAPHICAL SKETCH 
 
David Vaccarello was born on March 8th, 1990 to parents Anthony and Jean 
Vaccarello.  He grew up in a suburb of Pittsburgh, Pennsylvania where he attended 
Pine-Richland school district.  It was there that he discovered both his passion for 
science and running.  While there, Dave took numerous elective science courses, 
specifically in chemistry, which he excelled at.  Additionally, he completed eight  
seasons of cross-country and track as a Ram, setting several marks on the schools all-
time performance list. 
 In 2008, Dave began his college career, as both a scientist and athlete, at 
Duquesne University in Pittsburgh, Pennsylvania.  He competed as a Duke for the 
duration of his time as a distance runner on the cross country, indoor, and outdoor 
track teams.  Beginning college, he enrolled as a chemistry major because it combined 
a subject he was passionate about with the strong scientific foundation he had already 
begun to build.  As his coursework continued to deepen his understanding of 
chemistry, he was eager to begin research in an academic chemistry lab.  He soon met 
Dr. Partha Basu and began research under his supervision, which changed the course 
of his life.  In Basu’s lab, Dave worked on synthetic routes for the de novo synthesis of 
the Molybdenum Cofactor.  The combination of skill, art, and perseverance necessary 
for success in total synthesis was irresistible to Dave who wanted to make a career in 
it.  Although graduate school was never an option in Dave’s eyes, Dr. Basu saw early 
talent and a strong drive in his undergrad.  With encouragement, Dave applied to 
graduate school in chemistry to enhance his training in organic synthesis. 
  vi 
 In August 2012, Dave began his graduate studies at Cornell University in 
Ithaca, New York.  There he joined the group of Dr. Chad Lewis where he worked on 
total synthesis and synthetic methodology.   After spending three years in the group 
and completing the total synthesis of several carbasugar natural products, his time 
came to an abrupt end when Dr. Lewis left to join the research laboratories at Pfizer.  
Dave was quickly offered a position in the laboratories of Dr. Geoffrey Coates where 
he began his training in polymer chemistry.  There, Dave was able to utilize the 
synthetic skills he had developed and apply them towards the development of new 
polymer catalysts. 
 While at Cornell, Dave received several awards including the Bayer Teaching 
Excellence Award in 2015 and the Simon Bauer Scholarship Award in 2016.  He also 
participated in several outreach events hosted by the university such as Expanding 
Your Horizons and Kids Science Day.  Dave continued to run, but at a recreational 
level, and completed his first half marathon in 1:15:09 in 2014.  After graduating, 
Dave plans to move to Washington, DC and begin his postdoctoral appointment at the 
National Institute of Standards and Technology (NIST) in a collaborative project 
between Kathryn Beers and John Marino. 
  
  vii 
 
 
 
 
 
 
 
 
 
 
This dissertation is dedicated to my mother, Jean Biermeyer. Only with her constant 
love and support was this possible. 
  viii 
ACKNOWLEDGMENTS 
 
 It would have been impossible for me to make it through graduate school 
without the help and support of numerous people.  Without them, I would not have 
made it.  I would first like to thank both of my graduate advisors.  Chad Lewis taught 
me more about synthetic chemistry and laboratory techniques than anyone else could 
have.  He was always available for his students and was willing to stop what he was 
doing to help us whenever we needed it.  He gave me the tools in synthetic chemistry 
that will allow me to be successful in any of my future endeavors.  I would next like to 
thank Geoff Coates.  He offered me a position and help without hesitation in a time 
that I needed it most.  He was then exceptionally patient with me while I began 
learning a new subject late in my graduate career.  Finally, he always kept my best 
interest in his mind.  He sculpted projects that would suit my skills best and set me up 
for success.  He also kept me on track to ensure that I would land on my feet and 
graduate on time.  Without him, I would not have finished the program. 
 Next, I would like to acknowledge all my numerous coworkers.  Meagan 
Hinze, Jess Daughtry, Anirudra Paul, Tony Tierno, and Matt Moschitto.  Times were 
tough, but it helped to work with such a fun group of people who all shared the 
struggle together. Moreover, I would like to acknowledge Tony for always being 
available, regardless of which research group I may have been in.  It was truly a 
pleasure having him around as a mentor and friend.  I wish him the best of luck in his 
future.   Additionally, I owe a lot to Matt.  The projects we worked on together would 
not have gone as far without him.  He gave me significant portions of his time in both 
  ix 
hands on training and helping to progress the projects. Without him, I certainly would 
not be where I am now.  Both in and out of lab we made a good team.  I’m sure he will 
continue to be successful.  
I also need to acknowledge the Coates Group.  I could not have asked for a 
better place to end up.  They welcomed me with open arms and all did a part in 
helping me learn my way around the lab and steering me in the right direction.  
Specifically I would like to thank Kyle O’Connor, James Eagan, and Maria Sanford.  I 
don’t think an hour went by where I wasn’t pestering one of them with a question.  
With their help and reassurance I was able to successfully navigate the field of 
polymer chemistry without going down to many dead ends or rabbit holes. 
Furthermore, I would also like to thank those in the Department of Chemistry 
and Chemical Biology who have helped me including my committee members, Dave 
Collum and Kyle Lancaster.  There was a lot going on behind the scenes that I will 
probably never know about, but they ensured I did not fall between any cracks and 
finished the program. I also need to thank my friends for giving me an outlet to vent 
and for fun times that gave me the energy to forge ahead.   I had a solid support 
system that was always there for me when I needed it.  Whether it was my friends 
from home, who made annual trips to visit me and tear up the town, or my coworkers 
who accompanied me to the Big Red Barn on Friday nights for $1 beers.  I always had 
a group of people I could have fun with that served as an outlet for the frustrations of 
grad school. 
Finally I would like to thank those closest to me.  Jess is amazing.  She is 
always at home waiting for me after the tough days of grad school.  Although she may 
  x 
claim that we are an equal team, she has helped me far more than I’ve helped her.  I 
hope someday I can find a way to repay her.  Additionally, she has allowed me to 
follow my dreams and adopt our crazy horse sized puppy, Toast.  It requires 
approximately 100 people to keep him under control, but with Jess’s help, the two of 
us seem to manage.  To my parents, Lee has always been very supportive and kind.  
He made sure I always had a place to call home and always felt welcomed.  I don’t 
think I could ever thank my mother, Jean, enough.  She has always been then for me.  
After my father died, she kept our family going.  She miraculously found a way to pay 
for my undergraduate education, without which I would have never discovered my 
passion for chemistry.  She also talked me down during countless late night phone 
calls during my undergraduate and graduate studies.  I owe her everything. 
 
  
  xi 
TABLE OF CONTENTS 
 
Chapter 1: Introduction to Carbasugars and Carbasugar Containing Natural Products, 
Tsuji-Trost Allylation, and Resolutions in Synthesis .................................................. 1 
1.1. Natural Products and Carbasugars ............................................................ 2 
1.2. Tsuji-Trost Allylations  .......................................................................... 11 
1.3. Resolutions in Synthesis  ........................................................................ 15 
References and Notes  ................................................................................... 21 
Chapter 2: Allylic Oxide Regio Resolution as a Tool for the Total Synthesis of 
Carbasugars  .............................................................................................................. 25 
2.1. Introduction  ........................................................................................... 26 
2.2. Discovery and Optimization of AORR  ................................................. 28 
2.3. AORR Application to Carbasugar Total Synthesis  ............................... 36 
2.4 Experimental  ........................................................................................... 41 
 References and Notes  ................................................................................... 97 
Chapter 3: A Brief Introduction to the History of Polyolefins and Chain walking 
Polymerizations  ...................................................................................................... 102 
3.1. Introduction to Polymer Structures and Properties  ............................. 103 
3.2. Brief History of Polyolefins and Chain walking  ................................. 109 
References and Notes  ................................................................................. 122 
Chapter 4: Synthesis of Semi-Crystalline Polyolefin Materials: Precision Methyl 
Branching Using Chiral Isoselective α-Diimine Nickel Catalysts  ......................... 129 
4.1. Introduction  ......................................................................................... 130 
  xii 
4.2. Polymerization of 1-Butene  ................................................................. 133 
4.3. Experimental  ........................................................................................ 143 
References and Notes  ................................................................................. 170 
Appendix ................................................................................................................ 174 
 A.1. Spectra for Chapter 2 ........................................................................... 175 
 A.2. Spectra for Chapter 4 ........................................................................... 232 
 
 
 
 
 
   
 
 
 
 
 
  
 
  
  xiii 
LIST OF SCHEMES, FIGURES, AND TABLES 
 
Figure 1.1. All FDA approved drugs from 1981–2010 2 
Figure 1.2. Examples of glycosylated phenolic natural products 4 
Figure 1.3. Different classes of glycomimetics 5 
Figure 1.4. Examples of natural carbasurgars and carbasugar containing 
compounds 
7 
Scheme 1.1 Proposed synthetic pathway for the synthesis of carbasugars by 
Nature 
8 
Scheme 1.2. Strategies towards the synthesis of carbasugars 9 
Scheme 1.3. a) Boyd's synthesis of pericosine A. b) Koizumi's synthesis of 
carba-mannopyranose. 
10 
Scheme 1.4. a) Generic Tsuji-Trost reaction. b) Catalytic cycle of Tsuji-Trost 
reaction. 
11 
Scheme 1.5 Mechanism for allyl-inversion and anti-addition to linear 
substrates. 
13 
Scheme 1.6 Mechanism of palladium-palladium allyl inversion in cyclic 
substrates 
13 
Figure 1.5. a) Examples of TMLs. b) Lloyd-Jones model for selectivity. c) 
Trost wall-and-flap model. 
14 
Scheme 1.7. Example of a classical resolution using stoichiometric reagent 16 
Scheme 1.8. Sharpless asymmetric epoxidation using chiral tartrates 16 
Scheme 1.9. a) Noyori dynamic kinetic resolution. b) Trost DKYAT of an 
allylic epoxide. 
18 
Scheme 1.10. Fu’s parallel kinetic resolution of alkynes 19 
Scheme 1.11. Pfaltz and co-workers’ regio-divergent parallel kinetic resolution 20 
Scheme 2.1. Strategic allylic oxide regio-resolution (AORR) to access targeted 
carbasugar motifs 
27 
Table 2.1. Regiochemical control of enantioinduction 28 
  xiv 
 
Scheme 2.2 
 
Proposed transition states for stereoinduction with observed 
product ratios 
 
30 
Table 2.2. Predicted and observed er values for AORR in Scheme 2.2. 30 
Table 2.3. Phenolic scope of regiodivergence 33 
Scheme 2.3. Applying AORR to estradiol, tyrosine, and giseofulvin.  35 
Scheme 2.4. Kinetic and thermodynamic palladium allyl distribution and 
resulting diastereomers. 
37 
Scheme 2.5. Applying AORR for the total synthesis of streptol, cyathiformine 
B, MK7607, and a new cyclitol. a) Results with a racemic oxide. b) 
Results with chiral pool 
40 
Table 2.4 Observed versus predicted enantiomeric ratios for AORR 69 
Scheme 2.6. Allylic oxide regio-resolution predictive model 70 
Scheme 2.7. Synthesis of dioxolane epoxide (2.19) 72 
Scheme 2.8. Thermodynamic AAOR pathway 81 
Scheme 2.9. Total synthesis of streptol and MK7607 84 
Scheme 2.10. Total synthesis of cyathiformine B type 89 
Scheme 2.11. Synthesis of new cyclitol 2.42 92 
Table 2.5. Comparison of natural and synthetic samples 96 
Figure 3.1. a) Different types of tacticity of polymer side chains. b) Types of 
dyads and triads in polymer sequences 
104 
Figure 3.2. Types of polymer architecture and branching 105 
Figure 3.3. Different structures for PE 106 
Figure 3.4. Stress-strain curves for different types of plastics 108 
Scheme 3.1. Monomer insertion into a propagating polymer chain 111 
Scheme 3.2. The Cossee-Arlman mechanism, or back-skip mechanism, for iso-
selectivity  
111 
   
  xv 
Scheme 3.3. Ligand isomerization of phenoxy-imine catalyst during 
polymerization 
113 
Figure 3.5. Original Brookhart α-diimine catalysts 114 
Scheme 3.4. Proposed chain walking mechanism 114 
Scheme 3.5. Associative displacement of propagating polymer chain through 
coordination of new olefin at axial site 
116 
Scheme 3.6. Different modes of monomer insertion leading to different 
structures  
117 
Scheme 3.7. a) Brookhart’s stereoselective polymerization of cyclopentene. b) 
Taceuchi’s stereoselective polymerization of non-conjugated 
dienes.  
118 
Scheme 3.8. Coates's iso-selective polymerization of trans-2-butene 119 
Scheme 3.9. a) Coates’s strategy for the production of elastomers by changing 
temperature. b) Iso-selective polymerization of PP at low 
temperatures to yield iPP  
121 
Scheme 4.1. Nickel (II) catalyzed 4,2-enchainment polymerization of 1-butene 131 
Figure 4.1. α-Diimine nickel complexes used in this study 133 
Table 4.1. Catalyst screen for the polymerization of 1-butene 134 
Scheme 4.2. Proposed source of stereoselectivity in chain walking 
polymerization of 1-butene 
135 
Figure 4.2. 13C NMR spectrum of 4,2-poly(1-butene) produced by complex 
4.7/MAO (Table 4.1, entry 7).  
136 
Table 4.2. Effects of varying reaction conditions on the polymerization of 1-
butene.  
138 
Table 4.3. Solvent effects on the polymerization of 1-butene 140 
Scheme 4.3. Deuterated propylene study 141 
Figure 4.3. Representative tensile strength curve for 4,2-poly(1-butene) 142 
Table 4.4. 13C NMR signal assignments for 4,2-poly(1-butene) produced by 
nickel catalysts in this study 
152 
Figure 4.4. Equations used to calculate enchainment pathways 153 
  xvi 
 
  !!  
Figure 4.5. Representative 13C NMR spectrum of 4,2-poly(1-butene)  154 
Table 4.5. Effect of reaction conditions on the polymerization of 1-butene 
using complex 4.5 
155 
Table 4.6. Effect of solvent on the polymerization of 1-butene using complex 
4.5 
155 
Figure 4.6. 4,2-poly(1-butene) produced by 4.1 (Table 4.1, entry 1) 156 
Figure 4.7. 4,2-poly(1-butene) produced by 4.2 (Table 4.1, entry 2) 156 
Table 4.7. Crystal data and structure refinement for Rdv1 157 
Table 4.8. Atomic coordinates for 4.5 159 
Table 4.9. Bond lengths [Å] and angles [°] for 4.5 162 
Figure 4.8. X-ray crystal structure of 4.5 169 
  xvii 
LIST OF ABBREVIATIONS AND SYMBOLS 
 
Ac: acetyl 
AIBN: azobisisobutyronitrile 
AORR: allylic oxide regio resolution 
Ar: Aryl 
BINAP: (2,2'-bis(diphenylphosphino)-1,1'-binaphthyl) 
Bn: benzyl 
Boc: tert-butoxycarbonyl 
Bu: butyl 
CAN: ceric ammonium  nitrate 
conc: concentration  
COSY: correlated spectroscopy 
Đ: (Mw/Mn) or dispersity of polymer sample 
DART: direct analysis in real time 
dba: dibenzylideneacetone 
DBU: 1,8-diazabicyclo[5.4.0]undec-7-ene 
DCM: dichloromethane 
DEA: diethylamine 
DFT: density function theory 
DMAP: 4-dimethylaminopyridine 
DMF: dimethylformamide 
DMP: Dess-Martin periodinane 
DMSO: dimethylsulfoxide 
dr: diastereomeric ratio 
DSC: differential scanning calorimetry  
DYKAT: dynamic kinetic asymmetric transformation 
ee: enantiomeric excess 
EI: electron impact 
er: enantiomeric ratio 
ESI: electrospray ionization 
Et: ethyl 
FDA: Food and drug administration  
GALR: galinin receptor 
GPC: gel-permeation chromatography  
DIBAl-H: diisoproylaluminium hydride 
HDPE: high density polyethylene 
HMBC: heteronuclear multiple bond correlation 
HMDS: hexamethyldisilazide 
HPLC: high-pressure liquid chromatography 
HSQC: heteronuclear single quantum coherence 
IC50: half maximal inhibitory concentration 
iPP: isotactic polypropylene 
  xviii 
iPr: isopropyl 
IR: infrared spectroscopy 
Ki: inhibition constant, binding constant 
LCMS: liquid chromatography mass spectrometer 
LDA: lithium diisopropylamide 
LDPE: low density polyethylene 
LLDPE: linear low density polyethylene 
m: meso dyad 
MAO: methylaluminoxane 
m-CPBA: meta-chloroperoxybenzoic acid 
Me: methyl 
Mn: number-average  molecular weight 
MOM: methoxymethyl 
M.p.: melting point 
Mw: weight-average molecular weight  
NADH: nicotinamide adenosine dinucleotide 
nap: naphthyl 
NBS: N-bromosuccinimide 
NMR: nuclear magnetic resonance 
nOe: nuclear Overhauser effect 
NOESY: nuclear Overhauser effect spectroscopy 
NP: natural product 
Nu: nucleophile 
PE: polyethylene 
Ph: phenyl 
PIFA: bis(trifluoroacetoxy)iodobenzene 
PMP: paramethoxyphenyl 
PP: polypropylene 
ppm: parts per million 
PVC: polyvinyl chloride 
py: pyridine 
r: racemic dyad 
rac: racemic 
Rf: retention factor 
ROSEY: rotating frame nuclear Overhauser effect spectroscopy 
SGLT: sodium-glucose co-transporter 
SM: starting material 
sPP: syndiotactic polypropylene  
TBAF: tetrabutylammonium fluoride 
TBS: tert-butyldimethylsilyl 
tBu: tert-butyl 
TEMPO: (2,2,6,6-tetramethyl-piperidin-1-yl)oxyl 
TES: triethylsilyl 
Tf: trifluoromethylsulfonyl 
TFA: trifluoroacetic acid 
  xix 
 
TFAA: trifluoroacetic anhydride 
Tg: glass transition temperature 
THF: tetrahydrofuran 
TLC: thin layer chromatography 
Tm: melting transition temperature 
TML: Trost modular ligand 
TOF: turnover frequency 
Trxn: temperature of reaction 
trxn : length time of reaction 
Ts: toluenesulfonyl 
Tyr: tyrosine  
UHMWPE: ultra-high molecular weight polyethylene 
ω: terminal carbon of monomer that is not the olefin 
Xantphos: 4,5-bis(diphenylphosphino)-9,9-dimethylxanthene 
 
 
1 
CHAPTER 1 
 
 
 
 
 
 
 
 
 
 
 
Introduction to Carbasugars and Carbasugar Containing Natural Products, 
Tsuji-Trost Allylation, and Resolutions in Synthesis 
 
  
2 
1.1 Natural Products and Carbasugars 
Total synthesis refers to the complete chemical synthesis of a complex 
molecule from simple, commercially available precursors. Since the beginnings of 
organic synthesis, total synthesis has always been the flagship of the science. The 
ability to recreate naturally occurring molecules in a laboratory setting has had a 
profound impact on human history and continues to play a critical role in modern 
society. Beginning in 1828 with Friedrich Wöhler’s synthesis of urea and continuing 
to today, total synthesis has been transformed into an elegant combination of art and 
science whose development has been the result of painstaking efforts of countless 
scientists,1 several of which were recognized with the Nobel prize.2   
 
Arguably, one of the largest impacts of chemical synthesis is on the 
pharmaceutical industry, as Figure 1.1 demonstrates. From 1980 to 2014, 
 
Figure 1.1. All FDA approved drugs from 1981–2010.3 
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approximately 46% of all FDA-approved pharmaceutical compounds were classified 
as, or coming from, natural products.3 Semi-synthesis allows for the subsequent 
diversification of these complex scaffolds, yielding novel therapeutic agents. 
However, due to difficulties associated with isolating natural products, which typically 
requires tremendous amounts of biological starting material and tedious purifications 
resulting in low yields, we seek new routes to access these important compounds via 
total synthesis. Considering the percentage of drugs that rely on synthetic methods for 
their development is approximately 77%,3 improving synthetic methods to render 
these materials remains a critical challenge at the forefront of organic synthesis.  
One example that exemplifies these challenges and is of particular interest is 
sch202596. A spirocoumaranone, sch202596 was isolated from fungal culture of 
Asperillus sp. found in an abandoned uranium mine in Tuolemene, California. The 
novel compound was found to be an antagonist of the Galanin receptor,4 which is 
considered an important target for the treatment of eating disorders. Synthetically, 
sch202596 has never been prepared, although attempts by Inoue5 resulted in the total 
synthesis of (±) geodin, a related natural product that contains an identical core to 
sch202596 but lacks the carbasugar functionality. To complete the total synthesis of 
sch202596, we require a method for the synthesis of the carbasugar fragment as well 
as a process to append it onto its natural product core, geodin. 
To understand carbasugars and their functionality, we must first review 
carbohydrates and glycoconjugates, which play an unprecedented role in biology and 
are ubiquitous throughout nature.6 Due to their enormous structural diversity, 
glycoconjugates far exceed proteins or nucleic acids in their ability to encode for 
4 
cellular information. Their biological activities can range from simple energy sources 
to intercellular communication by activating complex signaling cascades through the 
binding of specific receptors.7 When bound to natural products, carbohydrates enhance 
biological activity by increasing solubility, changing the mechanism of action, 
increasing potency, enhancing target-specific binding, or protecting against oxidative 
damage.8 As a result, numerous natural products are found to contain this structural 
motif, as seen in Figure 1.2.  
 
 
Figure 1.2. Examples of glycosylated phenolic natural products. 
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5 
resulting in a free alcohol or phenol on the molecule. The phenol-containing molecules 
are particularly susceptible to this kind of deglycosylation because of the inherent 
stability and, therefore, lability of the phenoxide. Because of this inherent instability, 
half lives for phenolic charbohydrates are short, typically on the order of minutes to 
hours in vivo.9 Natural products containing these types of phenol-bound carbohydrates 
are common and found in many forms, including quinones, flavonoids, tyrosine or 
phenylglycinol-bound polypeptides, and polyphenolic or highly substituted methoxy 
phenols. Once deglycosylation occurs, the agylcone species can suffer a variety of 
complications, ranging from a decrease in uptake or increase in excretion to decreased 
binding affinity or complete loss in specificity.10 Preventing the degradation of these 
compounds and thus broaden their applicability has become an important field of 
study.  
 
 
One possible way to prevent deglycosylation is by using a non-degradable 
sugar or glycomimetic. While several strategies exist for increasing the stability of the 
glycoside, most approaches attempt to stabilize the glycosidic bond by removing the 
anomeric effect shown in Figure 1.3 by introducing a glycomimetic. This can be 
accomplished in two ways: C-glycosylation, where the oxygen leaving group moiety 
 
Figure 1.3. Different classes of glycomimetics. 
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6 
is replaced with a carbon, or replacement of the endocylic oxygen in the 
tetrahydropyran with a methylene. Synthetic C-glycosylation has been particularly 
effective in the synthesis of dapagliflozin, a Bristol-Meyers Squibb marketed 
pharmaceutical that treats type II diabetes (Figure 1.3, left). The parent phenolic 
glycoside, sergliflozin, possesses a half life of only 15 minutes (presumably due to 
rapid deglycosylation), while the modified dapagliflozin has a half life of 17 hours.10  
The second form of glycomimetic, where the endocyclic oxygen of 
carbohydrate has been replaced with a carbon linker, is commonly referred to as a 
carbasugar or carbocycle (Figure 1.4). Carbasugars possess a wide range of biological 
activity and are naturally occurring in several forms. Monomeric carba-pyranoses are 
rarest, with carba-galactopyranose being the only carba-pyranose found in Nature. 
Isolated from a Streptomyces broth, its bioactivity is still unknown.11   Other, more 
prominent, forms of natural monomeric carbasugars are polyhydroxylcyclohexene 
derivatives, including MK7606, streptol, and the pericosine family members. More 
complex examples include polyporapyranone G and cyanthiformine B, which contain 
additional functionality appended to the polyhydroxylcyclohexene core. Like 
carbohydrates, natural carbasugars can also be found appended to the core of natural 
products (Figure 1.4, blue). Interesting examples include sch202596 and maximiscin, 
both of which possess attractive anti-cancer activity. Finally, a third class of natural 
carbasugars consists of polysaccharide polymers. Some examples include validamycin 
A (Figure 1.4, bottom), acarviosine, and acarbose, an important molecule used in the 
treatment of type II diabetes.11  
7 
 
Figure 1.4. Examples of natural carbasugars and carbasugar containing compounds. 
 
The biosynthesis of carbapyranoses occurs in several different ways, but the 
pentose phosphate pathway is the most predominate route.11 This multi-step synthesis 
is believed to begin with sedo-heptalose-7-phosphate (1.1), which is then converted to 
a 6-membered carbocyclic intermediate (1.7), catalyzed by dehydroquinate synthase 
enzymes containing cobalt (Scheme 1.1).12 From here, minor alterations such as 
epimerizations can occur to give the vast structural diversity seen in carbasugars. 
Alternatively, most shikimate-bound natural products, such as sch202596, are 
synthesized via the shikimic acid pathway.  
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Scheme 1.1. Proposed synthetic pathway for the synthesis of carbasugars by Nature. 
 
  
Besides their natural sources, carbasugars are also produced synthetically. The 
importance of synthetic carbasugars has been demonstrated by Shing and co-workers 
when testing compounds for use in treating type II diabetes, mentioned above (Figure 
1.3, right).10 The carbasugar variant showed a dramatic increase in selectivity and 
binding of the target of interest over the original carbohydrate-containing molecule 
(Figure 1.3, center). It is believed that the remarkable activity results from the 
metabolic stability imparted by the carbasugar, which maintains a structure nearly 
identical to the original molecule. Currently, over 140 carbasugars have been 
synthesized. When considering only carbasugars of the polyhydroxylcyclohexene 
form, there exist over 40 separate syntheses. To match the vast structural diversity of 
carbasugars, there are an equally diverse number of strategies and routes towards 
overcoming the synthetic obstacles to produce these compounds (Scheme 1.2). 
The majority of carbasugar syntheses begin with compounds from the chiral 
pool, such as carbohydrates, tartrates, or natural cyclitols such as shikimic and quinic 
acid (Scheme 1.2, blue).13 Syntheses starting from carbohydrates, similar to Nature, 
elongate an open chain hexose to a heptose, followed by a ring closure. Unlike Nature, 
though, which typically performs ring closure through an intramolecular aldol 
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reaction, these syntheses involve intramolecular Wittig olefinations or ring closing 
metathesis.11 However, overall the chiral pool approach has several limitations. First, 
only a single enantiomer of the carbasugar is accessible from this route. This is 
problematic because the opposite enantiomer could have far superior biological 
activity. Second, each synthesis is unique to its target molecule; therefore, completely 
novel routes are required for new targets of interest.  
 
Scheme 1.2. Strategies towards the synthesis of carbasugars. 
 
 
Another synthetic route towards carbasugars involves enzymatic 
dihydroxylation of arenes (Scheme 1.2, green).14  This strategy has been employed by 
Boyd, Donahue, and Hüdlicky to synthesize a variety of carbasugars, including 
Pericosines A-C. Using Donahue’s procedure, Boyd’s efficient synthesis of pericosine 
A begins with the dihydroxylation of methyl benzoate to yield 1.17 using mutant 
strains of the soil bacterium Pseudomonas putida and Escherichia coli recombinant 
strains (Scheme 1.3a). This sets the stereochemistry for the remainder of the synthesis. 
Further oxidation OsO4 to installs an additional set of diols (1.18). This is followed by 
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a few minor tailoring steps, including the introduction of a chloride and deprotection.15 
Overall, the approach suffers the same limitation as previous strategies in that it allows 
access to only a single enantiomer of the carbasugar. 
 
Scheme 1.3. a) Boyd's synthsis of pericosine A. b) Koizumi's synthesis of carba-
mannopyranose. 
 
 
A third method for the synthesis of carbasugars is accomplished through Diels-
Alder cycloadditions.16 Many of these syntheses result in racemic products (Scheme 
1.2, purple), but asymmetric routes that provide access to both enantiomers exist 
(Scheme 1.2, red). For example, Koizumi and coworkers synthesized a chiral sulfonate 
that undergoes a Diels-Alder cycloaddition to yield a bicyclic compound (scheme 
1.3b). Subsequently, endo and exo isomers must be separated, followed by 
desulphenylation to give carba-mannopyranose in ten steps. It is important to note that 
in an enantiopure case, the enantiodetermining step occurs early in the synthesis, 
typically as the first step. The precious chiral material must then be carried through 
numerous steps to the final product. If the opposite enantiomer of final product is 
desired, the synthetic sequence must be restarted from the very beginning (1.20). 
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Furthermore, the initial source of chirality, typically a chiral auxiliary, must be 
removed, which adds additional steps to already lengthy sequences. 
 
1.2 Tsuji-Trost allylations  
Carbasugar skeletons commonly exhibit syn- or anti-1,2 and 1,4-
cyclohexenediol structural motifs. Given the similarities of these structures, our goal 
was to develop a catalytic asymmetric reaction capable of generating both of these 
structural motifs from a single common precursor.  Therefore, the reaction needs to be 
both stereoselective and regioselective when installing the desired hydroxyl moieties. 
There exist very few reactions that are capable of stereo as well as regiocontrol. One 
such reaction is the Tsuji-Trost allylation, which involves a palladium catalyzed 
substitution of allylic leaving groups (1.22) by a nucleophile (Scheme 1.4).17 A wide 
variety of leaving groups are tolerated, including halides, carboxylates, and 
carbonates. This method can also be extended to allylic epoxides (1.25), where relief 
of epoxide ring strain (26-28 kcal/mol) is the driving force. An equally diverse number 
of nucleophiles are allowed, provided they are soft nucleophiles such as phthalimides, 
malonates, enolates, enamines, carboxylic acids, and phenols.  
 
Scheme 1.4. a) Generic Tsuji-Trost reaction. b) Catalytic cycle of Tsuji-Trost reaction. 
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The Tsuji-Trost allylation proceeds by the addition of palladium(0) to an allylic 
leaving group (Scheme 1.4a, 1.22). The displacement of the leaving group in an SN2-
type process results in a η3 π-allyl complex (1.23). Subsequent nucleophile addition to 
the opposite face of the substrate forges the product (1.24) and displaces the palladium 
catalyst, which re-enters the catalytic cycle. Overall, this two-step mechanism 
proceeds through double inversion so that the product exhibits identical 
stereochemistry as the starting material (overall retention). When applied to linear 
substrates, η3-η1 isomerization (1.30–1.33) of the π-allyl complex can occur if it is 
significantly destabilized through factors such as A1,3 or A1,2 strain (Scheme 1.5, 1.30). 
Bond rotation results in a new π-allyl complex (1.33), with subsequent nucleophilic 
addition giving products with inverted stereochemistry (1.34) compared to the starting 
material (1.29). In cyclic systems where bond rotation is impossible, the inversion of 
stereochemistry via this η3-η1-η3 pathway is not observed. The regioselectivity of this 
reaction is controlled by electronic and steric factors with nucleophilic addition 
typically occurring at the less hindered terminus. When employing precursors such as 
allylic epoxides (Scheme 1.4b, 1.25) or aziridines, the formation of the π-allyl 
generates an alkoxide (1.26) or amide. In most cases the incoming nucleophile 
protonates the anion, which results in a directed attack at the two position of the allyl 
complex (1.28).18 Similar directed attacks are observed with nucleophiles capable of 
binding the anionic intermediate, such as TMSN319 or B(OPh)3.20 
 
13 
Scheme 1.5. Mechanism for allyl-inversion and anti-addition to linear substrates. 
 
 
In addition to the routes described above, there exists another avenue for the 
formation of inverted, rather than retained, stereochemistry in the final product. As 
first described by Backväll using a system that employed an allylic acetate (Scheme 
1.6, 1.36), he observed inverted products (1.39).  He speculated that this was the result 
of a destabilized π-allyl complex (1.37) being attacked by exogenous palladium(0) to 
yield a new, more stable π-allyl intermediate (1.38) with palladium(II) on the opposite 
face as before.21 Using a high catalyst loading, he observed by 31P NMR that two 
distinct π-allyl species were formed and were capable of interconverting. The ratio of 
retention/inversion products could be influenced by reaction conditions, and the 
inversion mechanism could be significantly reduced when using reactive allylic 
substrates, low palladium concentrations, and bidentate ligands.  
 
Scheme 1.6. Mechanism of palladium-palladium allyl inversion in cyclic substrates.21 
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With the advent of asymmetric variants of the Tsuji-Trost allyation, a series of 
Trost Modular Ligands (TML) were concurrently developed.22 TMLs are typically C2-
symmetric and comprised of chiral diamine backbones that are amide bound to 
triarylphosphines. The most common TMLs are shown in Figure 1.5a and differ 
mainly in their bite angles. To help explain the outcome of reactions using these 
ligands, Trost originally developed a wall-and-flap model (Figure 1.5c) based on DFT 
studies.23 In this model, the palladium-π-allyl sits in a pocket beneath the diammine 
backbone of the ligand. The phenyl groups of the ligand orient themselves to either 
serve as “walls” that block access to the substrate or “flaps” that allow access to the 
pocket.  
 
 
Figure 1.5. a) Examples of TMLs. b) Lloyd-Jones model for selectivity. c) Trost wall-
and-flap model. 
 
More recently, Guy Lloyd-Jones provided an alternative model to explain 
TML selectivity using a combination of fully deuterated TMLs and computational 
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(Scheme 1.5b, 1.43). Lloyd-Jones coined the term “torqueselectivity” to describe the 
twisted conformation the ligand adopts in order to convey high levels of 
stereoinduction. This twisted profile results in one position of the allyl being slightly 
more exposed to the amide which is directing the attack of the incoming nucleophile. 
Although helpful, the model has not been used for allylic expoxides and Trost’s “wall 
and flap” model still provides a useful explanation for almost all Tsuji-Trost 
asymmetric allylations. 
 
1.3 Resolutions in Synthesis 
Asymmetric catalysis is a useful method for producing stereocenters. 
Typically, a chiral catalyst imparts chirality onto a previously achiral material. 
Through this method, chiral TMLs allow many Tsuji-Trost reactions to proceed 
asymmetrically and install chiral centers with high levels of selectivity. An alternative 
approach for the generation of enantioenriched compounds is the resolution of racemic 
material, and chiral TMLs are also capable of this task. Resolutions can be broadly 
categorized into three major classes. The first are classical resolutions, which require 
stoichiometric amounts of chiral resolving agent (Scheme 1.7).25 The chiral agent 
(1.46) associates to the substrate (1.45), either covalently or non-covalently, to 
generate diasteriomers (1.47) that are subsequently separated through other chemical 
means, such as crystallization. This technique is one of the oldest and most common, 
but its drawbacks include multistep procedures and the need for large sources of pre-
existing chiral resolving agents. The second class is chiral chromatography, which 
relies on a chiral stationary phase to resolve pairs of enantiomers. Although effective, 
16 
the use of large volumes of solvent, long separation times, and cost of chiral 
chromatography supports make this method impractical for anything above analytical 
scale. The third class, catalysis, can be divided into multiple unique sub-classes, 
including kinetic, dynamic kinetic, and parrallel kinetic resolutions.  
 
Scheme 1.7. Example of a classical resolution using stoichiometric reagent.25 
 
Kinetic resolutions were first pioneered by Jacobsen, Kagan, and 
Sharpless.26,27 Notably, Sharpless’s work focused on the use of chiral tartrates and 
Ti(OiPr)4 for the asymmetric epoxidation of allyl-alcohols, for which he was awarded 
the Nobel prize in 2001 (Scheme 1.8). In a kinetic resolution, a pair of enantiomers 
reacts with the chiral catalyst but at different rates, with one reacting much faster than 
the other. The result is a single enantioenriched product and enantioenriched starting 
material.28 In order to obtain high levels of enantioinduction, a catalyst must have a 
high selectivity factor for one of the starting enantiomers. Another significant 
drawback to kinetic resolutions is their maximum theoretical yield of 50%.  
Scheme 1.8. Sharpless asymmetric epoxidation using chiral tartrates.27 
 
1.45 1.46
H2N NH2 HO2C
OHHO
CO2H
H2O
 HOAc
(±)
+ H3N NH3
CO2
HO OH
O2C
2 eq K2CO3
H2O/EtOH H2N NH2
> 98 % ee
1.47
1.48
1.49
1.50
1.51
R2
R3R1
OH
R2
R1 R3
O
OH
R2 R3R1
O OH
(S,S)-diethyltartrate
(-)-DET
Ti(OiPr)4
tBuOOH
(R,R)-diethyltartrate
(+)-DET
Ti(OiPr)4
tBuOOH
17 
 
In contrast, dynamic and parallel kinetic resolutions achieve maximum 
theoretical yields of 100%. A dynamic kinetic resolution represents a unique case 
where enantiomers of starting material, or their respective intermediates before 
forming the final product, are interchangeable. In these situations, one enantiomer 
reacts readily with a chiral catalyst while the other does not. As the reactive material is 
consumed, the unreactive enantiomer is converted into the reactive form by some 
chemical means, such as base-mediated epimerization, in order to maintain 
equilibrium, and is then converted to product. An example of this was demonstrated 
by Noyori and co-workers29 (Scheme 1.09a). Additionally, there exist numerous 
examples of Tsuji-Trost reactions that undergo this unique reactivity, which Trost 
coined the term dynamic kinetic asymmetric transformation (DYKAT) (Scheme 
1.9b).30  DYKAT’s success relies on the ability of π-allyls to proceed through η3-η1-η3 
isomerization (1.59–1.62). This allows enantiomeric π-allyls, generated from a 
racemic starting material, to be converted into a single π-allyl that yields a sole 
enantioenriched product using a chiral ligand (1.63). Trost has exploited this strategy 
many times, such as in his total synthesis of furaquinocin E.31 The critical stereocenter 
for the molecule is installed through a DKYAT, whose product is obtained in a 92:8 er 
before being further functionalized into the natural product. 
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Scheme 1.9. a) Noyori dynamic kinetic resolution.29 b) Trost DKYAT of an allylic 
epoxide.32 
 
 
Although parallel kinetic resolutions are similar to dynamic kinetic resolutions 
in that both enantiomers of starting material are consumed to form product, parallel 
kinetic resolutions do not form a single product. Instead, each enantiomer of starting 
material reacts at a similar rate to produce two unique products where at least one of 
the products is enantioenriched.33,11 As in kinetic resolutions, each product formed has 
a maximum potential of 50% yield, since each is derived from a single enantiomer of 
starting material. An excellent example of a parallel kinetic resolution of 4-alkynals is 
provided in Scheme 1.10, where Fu and co-workers use chiral rhodium-BINAP 
complexes to resolve racemic starting compound 1.64 into two different 
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enantioenriched products, 1.65 and 1.66, in high ee at nearly the maximum theoretical 
yield of 50% for both.34 The products result from two different insertions of the chiral 
catalyst across the alkyne. If enantiopure starting material (+)-1.64 is subjected to the 
reaction conditions instead of a racemic mixture, a single product, 1.66, is generated. 
Switching the enantiomer of the catalyst switches the product distribution to give 
compound 1.65 instead. 
 
Scheme 1.10. Fu’s parallel kinetic resolution of alkynes.34 
 
 
If the two products obtained from a parallel kinetic resolution install the same 
functional group but at different locations in the product, the procedure is called a 
regiodivergent parallel kinetic resolution. In the remainder of this thesis, we refer to 
this process as a regio-resolution. Regio-resolution is a subset of parallel kinetic 
resolution, where each enantiomer of a starting material reacts at a similar rate with a 
chiral catalyst to yield two regioisomeric enantioenriched compounds, which are 
separable. Few examples of regiodivergent parallel kinetic resolutions, or regio-
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chiral palladium(0), to give two enantioenriched products with addition at the 1 and 3 
position of the allyl (Scheme 1.11).35 When employing a single starting enantiomer of 
1.67, they observe mostly one product, 1.68, in high yield. If the enantiomer of ligand 
is switched, so is the product distribution, giving 1.69 as the major compound. 
 
Scheme 1.11. Pfaltz and co-workers’ regio-divergent parallel kinetic resolution.35 
 
  
As we have seen, resolutions offer efficient and practical ways of generating 
enantiopure compounds. Particularly useful are parallel kinetic resolutions, which can 
diverge a single racemic synthon into multiple products. The ability to obtain multiple 
different products from a single intermediate is highly advantageous, especially if they 
are regio-isomers. Using this technique, a late stage common synthon could be 
efficiently transformed into multiple carbasugar products. Such an approach would 
offer significant improvement over current carbasugar syntheses, which mostly rely on 
linear routes from chiral starting materials to produce a single enantiomer and product. 
Further, the diverse array of stereogenic hydroxyls observed on carbasugars could be 
introduced through Tsuji-Trost allylation of an allylic epoxide. In the next chapter, we 
use these concepts to develop a new, more efficient method for synthesizing 
carbasugars. 
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2.1. Introduction 
Carbasugars,1 owing to their biomimicry of carbohydrates, possess a wide 
range of biological activity from antitumor to antibiotic to antifungal, and therefore are 
attractive targets for synthesis. Several classes of carbasugars, including MK7607, 
streptol, and cyathiformines, have been isolated as enantiopure products or racemates 
(Scheme 2.1). As described in Chapter 1, the contiguous array of stereogenic 
hydroxyls is typically derived from the chiral pool, enzymatic dihyroxylation of 
arenes, or asymmetric Diels-Alder reactions that have been used to synthesize the 
complex stereoarrays of natural and unnatural carbasugars. Each approach suffers its 
own limitation, but in all cases, the syntheses target a specific compound and single 
enantiomer with no intent to access the other enantiomer. Currently, there exists no 
single method for the synthesis of various carbasurgar stereoarrays, and their 
enantiomers, from a shared intermediate. A strategy that allows for enantio-, diastereo-
, and regioselectivity from a common synthon could afford access to the gamut of 
biologically active carbasugars. 
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Scheme 2.1. Strategic allylic oxide regio-resolution (AORR) to access targeted 
carbasugar motifs. 
!
 
The majority of the carbasugars have syn- or anti-1,2- and 1,4-cyclohexendiol 
motifs. The four possible regioisomers (syn-1,2; syn-1,4; anti-1,2; anti-1,4) are notable 
for their relationship to a single precursor, an allylic oxide (Scheme 2.1). Ideally, a 
single synthon would provide all possible stereoisomers and streamline the preparation 
of several carbasugars. We propose the term allylic oxide regio-resolution (AORR) for 
this process of resolving a racemic allylic oxide to regioisomeric products using the 
Tsuji-Trost reaction.2–3 Regioselective substitution4 of enantioenriched allylic acetates 
with malonates has been investigated with chiral molybdenum5 and palladium6 
complexes, resulting in regioisomeric products of 1,2- and 1,4-additions. Our efforts 
resulted in a catalyst-controlled AORR that delivers asymmetric 1,2- and 1,4-addition 
products that can be relayed to carbasugar natural products (see Scheme 2.1). 
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Table 2.1. Regiochemical control of enantioinduction.a 
 
 
 
2.2. Discovery and Optimization of AORR 
We began our study using allylic oxide 2.1 as a model compound. It contains 
several critical moieties that could be subsequently transformed into carbasurgar 
framework, but has less complexity than a full carbasurgar making it an ideal 
candidate for probing reaction conditions. Oxide 2.1 was synthesized efficiently from 
benzoic acid according to literature procedures in four steps.  Exposing a racemic 
mixture of oxide 2.1 to Pd2(dba)3, TML L2,7 and p-cresol resulted in the isolation of 
1
2
3
−−
−−−
10:9022:7840:60
32:6898:292:8
96:424:7610:90
5
6
20:15:50
n. d.e
35:29:24
31:34:4
28:8:37
(R)-BINAP
(R,R)-L1
(S,S)-L2
(S,S)-L2
(±)
(±)
(±)
(+)f
(−)g
aEnantiomers shown are the major enantiomers derived from the S,S-ligand (entries 4−6). 
bEnantiomeric ratio of recovered epoxides was determined with GC analysis. cEnantiomeric 
ratios were determined with liquid chromatography analyses against prepared racemic 
standards. dYield refers to isolated yields following silica gel chromatography. eDecomposition 
of epoxide. fEnantiomeric ratio of 92:8 favoring the (+)-2.1 isomer. gEnantiomeric ratio of 10:90 
favoring the (−)-2.1 isomer. dba = dibenzylideneacetone, BINAP = 2,2'-bis(diphenylphosphino)-
1,1'-binaphthyl.
4 93:796:457:43 2:39:34(S,S)-L2(±)
PPh3
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two products that were identified by 1H NMR spectroscopy analysis of coupling 
constants and confirmed by COSY, to be the 1,2- and 1,4-nucleophilic addition 
products, 2.2 and 2.3, respectively. 2.2, the 1,2-product, was isolated in a 39% yield in 
96:4 enantiomeric ratio (er), while 2.3, the 1,4-product, was obtained in 34% yield 
with a 93:7 er (Table 2.1, entry 5). The relative stereochemistry of the two chiral 
centers were confirmed by X-ray crystal structure and 1H NMR spectroscopy and 
found to be syn to one another, as expected. Small amounts of the starting oxide was 
recovered and found to be racemic providing the first signs that a regio-resolution was 
occurring. The cyclohexyl TML variant (L1) also yielded identical 1,2 and 1,4 
products, albeit with reduced yields and observed enantioenrichment. Using Pd(PPh3)4 
favored syn-1,4-addition (50% yield; Table 2.1, entry 1) over syn-1,2 addition (15%). 
The use of BINAP, a common chiral ligand, proved to be ineffectual. The high- 
conversion and enantioinduction of 2.2 and 2.3 and the absence of kinetic resolution of 
2.1 (57:43 er after reaction) suggested that each epoxide enantiomer proceeds to a 
different regioisomer.  
To test this hypothesis, we examined each enantioenriched epoxide of 2.1 
under optimized conditions to gauge the “match”8 to a single enantiomer of L2 and 
confirm the anticipated selectivity toward either syn-1,2- or 1,4-addition (Table 2.1, 
entries 5 and 6). As predicted, the enantioenriched oxides smoothly converted to the 
syn products in an improved er. Notably, the (+)-oxide matched the S,S ligand to 
provide 1,2:1,4-addition products in an 8.5:1 ratio (entry 5), and the (−)-oxide 
switched the selectivity for a 1:4.6 ratio (entry 6). The recovered oxide showed no 
changes in enantiopurity for either entry (5 or 6).  
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Similar to Trost’s stereoinduction of allylic acetates and carbonates,2 the C2-
symmetric ligand blocks one of the two sites of the π-allyl, diverting each oxide to a 
different constitutional isomer of 1,2- or 1,4-addition. The proposed model fits the 
observed enantioenriched oxide data and provides a predictive basis for new studies of 
complex allylic oxides in total synthesis.9 
Scheme 2.2. Proposed transition states for stereoinduction with observed product 
ratios. 
!
 
Table 2.2. Predicted and observed er values for AORR in Scheme 2.2. 
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When oxide (+)-2.1 is used, the π-allyl of the ester is generated within the 
complex, resulting in attack at the pro-(R) carbon for 1,2-addition (2.2; equation 1 in 
Scheme 2.2). The 1,4-addition is accessible using the (–)-2.1 oxide (2.3; equation 2) 
via attack at the pro-(S) carbon. The selectivity of this addition is consistent with 
Lloyd-Jones and co-workers’ studies10 of the proposed transition states of the 
asymmetric allylic alkylation of cycloalkenyl esters. 
The predicted enantiomeric ratios can be calculated using the observed ratio of 
1,2:1,4- addition products and the enantiopurity of the oxide (Table 2.2). Beginning 
with the (+)-2.1 (92:8 er), the S,S ligand predicts a 1,2-addition with an increase to 
99:1 er and a decrease of the 1,4-addition product to 67:33. The observed 1,2-addition 
product matches a 98:2 er, with a 1,4-addition product er of 68:32. The (−)-2.1 (90:10 
er) with the S,S ligand predicts a 1:99 er of 1,4-addition products and a 40:60 er for the 
1,2-addition. The observed 1,4-addition is within error at 4:96, and the 24:76 of the 
1,2-addition is reasonable. 
The utility of the AORR approach was then advanced with numerous phenols. 
Native phenol provided useful enantioinduction (Table 2.3, entry 1, 98:2 er for 1,2-
addition, 91:9 for 1,4-addition) in a combined yield of 58%. Allylic oxide 2.1 was not 
recovered and the mass balance is suspected to be due to competitive beta-hydride 
elimination. Alkyl substitution (entries 2, 3) proved similar in stereoinduction and the 
recovered allylic oxide was weakly enantiomerically enriched. Other phenol donors 
such as electron releasing substituents were similarly well tolerated (entries 4 and 5) 
with the Boc-protected aniline providing lower conversion. 4-Hydroxy anisole11 (entry 
4) provided high levels of regiocontrol, enantioinduction, and conversion. 
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Furthermore, the absolute stereochemistry of addition could be determined using 4-
hydroxy anisole under oxidative cleavage conditions to liberate a stereogenic hydroxyl 
and converge onto a known molecule. This strategy is critical to carbasurgar 
preparation via AORR. 4-Nitrophenol provided the highest enantioinduction (97:3 and 
98:2 for 1,2- and 1,4-addition respectively, entry 6) albeit with low yield and 
degradation upon standing. Sterically larger arenes, including ortho- and meta-
substitution (entry 7 and 8 respectively) behaved similarly, and both 1- and 2-naphthol 
offered less selectivity overall (entries 9 and 10). Interestingly, sesamol provided high 
enantioinduction for both addition modes (entry 11). In all cases, the absence of 
palladium resulted in no conversion. 
With these data in hand, the application of the AORR method upon chiral 
phenolic scaffolds was examined. The substrates were chosen for their biological 
activity and for the emergence of diastereomers by competitive 1,2- or 1,4-addition to 
the palladium-allyl. Estradiol, tyrosine, and griseofulvin were selected and 
regiodiverged into four distinct diastereomers under catalyst control. 
Silyl protected estradiol (2.4)12 was first examined to gauge the suitability of 
larger phenol substrates with remote stereochemical elements for the regiodivergence 
(Scheme 2.3a). Interestingly, the regiodivergence provided high stereoselectivity for 
the 1,2- and 1,4-addition products with no detectable diastereomers. Using (R,R)-L2, 
the 1,2-adduct was obtained in 60% yield and the 1,4-adduct in 27%. The enhanced 
yield of the 1,2-product was surprising considering the achiral phenols were roughly 
equal in reactivity to produce 1,2- and 1,4-products. Switching to the (S,S)-L2 ligand, 
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Table 2.3. Phenolic scope of regiodivergence. 
 
the 1,2-adduct was obtained in 44% with an increase to 41% for the 1,4-addition 
product as compared to the (R,R)-L2 ligand. 
A more challenging regiodivergence was examined using tyrosine (2.9) 
(Scheme 2.3b). The protected amino-acid, as compared to estradiol, was predicted to 
be prone to mixtures of diastereomers from carbamate chelation to palladium12 and/or 
populations of rotamers. Applying the AORR conditions resulted in the isolation of 
the 1,2- and 1,4-addition products in similar yield for each enantiomer of applied 
ligand. The additional constraints of the tyrosine moiety were reflected in the 
appearance of diastereomers for the 1,2-addition products: 4.37:1 for 2.10 and 4.20:1 
PhPh
NH HN
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23:31:34
91:998:2- 0:31:27
84:1690:1051:49 29:21:235
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84:1684:16- 0:33:33
88:1280:20- 0:35:38
95:590:10- 0:29:23
OHO
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95:585:1556:44 1:48:35
98:297:350:50 64:4:46
entry phenol
(±)-2.1
2.2 erb 2.3 erb
2.2 2.3
% yieldc
(2.1 : 2.2 : 2.3)
phenol (1.1 equiv.)
1.0 mol% Pd2(dba)3
3.0 mol% (S,S)-L2
PhMe, −40 °C, 18 hrs
OMeO
O
OMeO
O
HO
OMeO
O
OH
2.1 era
aEnantiomeric ratio of recovered epoxide was determined by GC analysis. 
bEnantiomeric ratios were determined by LC analysis against prepared racemic 
 standards. cYield refers to isolated yields following silica gel chromatography.
R  = H
R  = 4-Me
R  = 4-tBu
R = 4-OMe
R  = 4-NHBoc
R  = 4-NO2
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R R
Product Product
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2.2h 2.3h
2.2i 2.3i
2.2j 2.3j
2.2k 2.3k
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for 2.12 in 45% and 51% yield respectively. The 1,4-adducts were isolated as single 
diastereomers in 40% yield for 2.11, and 36% yield for 2.13. The similarity in 
structure required the isolation of the 1,2- and 1,4-adducts as a co-mixture with 1H 
NMR spectroscopy integration to determine yield of each isomer. The estradiol and 
tyrosine phenol substrates provided high-regiodivergence to the desired stereoisomers. 
Moving forward, the application of this method toward a multiply substituted hindered 
chiral phenol would demonstrate the robustness of the method with diverse phenolic 
substrates. 
Polyketides continue to provide diverse functionality including 
spirocoumaranones such as griseofulvin,14 geodin,15 and Sch202596.16 The interesting 
biological properties of these phenolic spirocycles make them ideal substrates for 
analog generation using AORR. The native structure of griseofulvin has recently been 
advanced as a cancer treatment17 and is readily available in large quantities. Cleavage 
of the C-4 methyl18 provided a chiral phenol donor (2.14) that was then studied for the 
AORR (Scheme 2.3c). In parallel with the estradiol and tyrosine studies, applying the 
(R,R)-L2 ligand resulted in two products. The 1,2-adduct 2.15 (60%) was dominant as 
compared to the 1,4-adduct 2.16 (31%) with the remaining mass balance attributed to 
recovered griseofulvin (2.14). Similar to the tyrosine studies, the complexity of the 
1,2- and 1,4-adducts required isolation as a co-mixture and determination of yield by 
1H NMR spectroscopy integration. Crude reaction mixture analysis showed no starting 
material remained, with griseofulvin being regenerated from degradation of the 1,2- 
and 1,4-adducts 
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during isolation.19 The (S,S)-L2 ligand proved similar in reactivity to provide 1,2-
adduct 2.17 (54%) and 1,4-adduct 2.18 (25%) and recovered griseofulvin. The 1,2-
addition products for both reactions was approximately double in yield as compared to 
the 1,4-products, a result we had observed previously with estradiol  (Scheme 2.3a, 
2.5, (R,R)-L2 ligand), and appears to substrate dependent. The presence of 
diastereomers associated with off-catalyst addition modes was less than 2% when 
examining the 1H-NMR spectrum of the product mixture for both ligands. 
 
2.3. AORR Application to Carbasugar Total Synthesis 
The predictive model was then applied to carbasugar frameworks that 
incorporate additional functionality within the cyclohexenoate. Applying the AORR 
method to common synthon 2.1920 was anticipated to provide syn-1,2-addition (2.22) 
and syn-1,4-addition (2.23) products originating from the kinetic palladium π-allyl 
complex 2.21 (Scheme 2.4). 
The steric demands of the substituted dioxolane may destabilize kinetic π-allyl 
complex 2.20, resulting in conversion to the thermodynamic π-allyl complex 2.24 via 
an exogenous palladium(0) complex, as observed by Bäckvall.21 Addition of the 
nucleophile to complex 2.25 results in two forms: anti-1,2 (2.26) and anti-1,4 (2.27). 
Previous efforts by Hudlicky and co-workers22 have established that anti-1,2-addition 
of malonates to acetonide allylic oxides is possible but occurs in low yields or as 
mixtures of diastereomers. Common synthon 2.19 would be demonstrative of the 
kinetic to thermodynamic isomerization and would provide access to four classes of 
carbasugars. 
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Scheme 2.4. Kinetic and thermodynamic palladium allyl distribution and resulting 
diastereomers. 
!
 
We discovered that all four possible regioisomers were formed from synthon 
2.19 with the reaction proceeding to full conversion (Scheme 3a). Anti-1,2-addition 
product 2.30 was isolated in 14% yield23 (90:10 er) and syn-1,4 product 2.31 in 16% 
yield (90:10 er). The high stereoselectivity, albeit with low yield, for each isomer 
reflects the additional constraints the dioxolane imposes on the palladium π-allyl 
system. The syn-1,2-addition product (2.32) was isolated in 25% yield (92:8 er) with 
the anti-1,4-addition product (2.33) detected in less than 1-2% by 1H-NMR 
spectroscopy. The enhanced yield of the syn-1,2 product (2.32) was expected given the 
sterically encumbered anti-1,4-addition mode under these conditions. The three 
isolated regioisomeric products were then carried forward to three natural products.  
The anti-1,2 product (2.30) comprises the stereoarray of streptol (2.34), a 
PdII
O
OO
H H
OH
OO
H H
PdII
OH
OO
H H
Nu-
Nu- OH
OO
H H
Nu-
Nu-
PdII
PdII
MeO2C
MeO2C
MeO2CMeO2C
Kinetic
Anti Pd0
Addition
2.20 2.24
2.21 2.25
Common synthon (2.19)
Thermodynamic
Syn PdII via Pd0
Pd0Pd0
(syn-1,2) (syn-1,4) (anti-1,2) (anti-1,4)
O
O
O
MeO
O
MeO
O
OH
O
O
MeO
O
OH
O
O
2.26 2.272.22 2.23
MeO
O
OH
O
O
MeO
O
OH
O
O
Nu
Nu
Nu
Nu
OH
OO
H H
MeO2C
 38 
potent plant growth inhibitor.24 The conversion to streptol 2.34 was achieved by 
reducing the ester and protecting the transient acyl followed by cerium ammonium 
nitrate (CAN) oxidative cleavage of the anisole. The removal of the dioxolane using 
acetyl chloride and catalytic zinc chloride followed by global acyl cleavage proved 
uneventful. The syn-1,4 product (2.31) matches the unusual fungal metabolite 
cyathiformine B, a chorismic acid derivative.25 The cyathiformine structure poses 
potential problems due to its sensitive enol pyruvate that could complicate the 
oxidative cleavage of the anisole and Lewis-acid mediated dioxolane removal. 
Proceeding forward, the installation of the diazophosphonate using rhodium acetate 
was followed by CAN oxidation with surprisingly little degradation. Horner– 
Wadsworth–Emmons olefination using gaseous formaldehyde provided cyathiformine 
B type 2.35. The dioxolane proved difficult to remove with varying levels of success 
(not shown). The syn-1,2 product (2.32) mapped to MK760726 (2.36) and was targeted 
next. Following a similar approach to streptol, we prepared MK7607 in five steps. 
The minor isomer, anti-1,4, 2.33, was unisolable in the regio-resolution of 
oxide 2.19. To carry out all possible additions to the allylic oxide, we determined that 
two criteria must be met to remove the other three regioisomers (syn-1,2; syn-1,4; anti-
1,2): (1) the thermodynamic palladium complex must be formed to eliminate syn-1,2 
and syn-1,4, and (2) the ligand must match the enantiopure oxide to eliminate anti-1,2 
addition. The first criterion was satisfied via removal of the kinetic π-allyl isomer by 
increasing the steric crowding proximal to the palladium center. We hypothesized that 
a switch from a dioxolane to an acetonide would facilitate this population inversion, 
which was observed when applying racemic 2.3827 to the reaction conditions (see 
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experimental). The second criterion was fulfilled by evaluating the predicted model 
(Scheme 2.2) and observed modes of addition for streptol, cyathiformine B type, and 
MK7607, which revealed the (S,S)-L2 to be optimal. Enantiopure acetonide oxide 
2.3828
 
provided the previously unobtainable anti-1,4-product 2.41 in 44% yield via a 
predicted interconversion of 2.39 to 2.40 and ligand directed addition to the anti-1,4 
site (Scheme 2.5b). Acylation, oxidative cleavage of the anisole and saponification of 
the acetate followed by acid-mediated hydrolysis of the acetonide gave the new 
cyclitol 2.42.29 
In conclusion, we developed a regiodivergent, catalyst-controlled, asymmetric 
addition of phenols to allylic oxides that leads to the synthesis of streptol, MK7607, 
cyathiformine B type, and a novel cyclitol. The AORR method tolerates complex, 
fully substituted cyclohexenoates to provide access to the enantiomers of carbasugar 
natural products. The mechanistic dichotomy of the syn versus anti chiral palladium 
complexes and the study of complex nucleophiles and allylic oxides will be reported 
in due course. 
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2.4 Experimental  
Methyl 1,3-cyclohexadiene-2-carboxylate was prepared according to literature 
procedures.30 The diene carboxylate (2.01 g, 14.5 mmols, 1.0 equiv) was exposed to 
m-CPBA (3.38 g, 19.6 mmols, 1.3 equiv) in DCM (140.0 mL) at 0 °C for 6 h. The 
reaction was then poured into 100.0 mL of a cooled 1 M solution of NaOH, extracted 
with DCM (3 x 50.0 mL) and dried over Na2SO4. Flash column chromatography of the 
crude oil (9:1 hexanes/EtOAc, v/v) resulted in 1.36 g (61% yield) of a volatile 
colorless oil (2.1).  
Enantioenriched epoxide (+)-2.1 was prepared using the corresponding [N,N'-
bis(3,5-di-tertbutylsalicylidene)-1,2cyclohexane-diaminato]manganese(III) chloride 
complex according to literature procedure.31 To a buffered solution of 0.05 M 
Na2HPO4 and bleach (10.0 mL, 0.55 M in NaOCl) was added methyl 1,3-
cyclohexadiene-2-carboxylate (400.0 mg, 2.89 mmol, 1.0 equiv)  and R,R [N,N'-
bis(3,5-di-tertbutylsalicylidene)-1,2cyclohexane-diaminato] manganese(III) chloride 
(185.0 mg, 0.289 mmol, 0.1 equiv)  in DCM (4.0 mL). The reaction was stirred for 18 
hours under air after which the layers were separated. The aqueous layer was extracted 
with DCM (10.0 mL), and the combined organic layers were washed with brine (10.0 
mL), dried over Na2SO4 and concentrated in vacuo. Flash column chromatography 
(9.5:1 hexanes/EtOAc) yielded (80.3 mg, 0.519 mmol) enantioenriched (+)-2.1 as a 
yellow oil. Analysis by chiral GC indicated (+)-2.1 ([α]
0.20
D  +31.9 (c 1.00, CHCl3) was 
obtained in a 90:10 enantiomeric ratio. 
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Methyl 7-oxabicyclo[4.1.0]hept-2-ene-2-carboxylate (2.1) 
1H NMR (400 MHz, CDCl3) δ 7.11 (m, 1H), 3.92 (m, 1H), 3.79 (s, 3H), 3.59 (m, 1H), 
2.31 (m, 1H), 2.20 (m, 1H), 1.61 (m, 1H), 1.27 (m, 1H); 13C NMR (101 MHz, CDCl3) 
δ 165.9, 143.0, 127.6, 54.2, 51.5, 45.8, 20.5, 19.7; IR (neat) ν = 2932, 2857, 1715, 
1641, 1268 cm-1; TLC Rf = 0.60 (9:1 hexanes/EtOAc v/v); HRMS (ES+) calc’d for 
C8H10O3 154.0630; found 154.0625.  
 
General Procedure A: Racemic epoxide 2.1 (43.0 mg, 0.279 mmol, 1.0 equiv.) was 
dissolved in 2.0 mL of toluene in a flame-dried vial outfitted with a septum followed 
by the addition of phenol (15.8 mg, 0.149 mmol, 0.6 equiv.). The resulting solution 
was degassed with argon and cooled to −40 °C. In a separate vial, Pd2(dba)3 (2.4 mg, 
1.0 mol%) and (S,S)-L27 (6.6 mg, 3.0 mol%) were dissolved in 1.0 mL of toluene. The 
resulting purple solution was degassed and stirred at room temperature until it became 
yellow (approx. 10 min.). The solution was then cooled to −40 °C and added to the 
epoxide solution via syringe. The reaction was allowed to stir for 6 hours before 
additional phenol (16.4 mg (0.174 mmol, 0.6 equiv.) was added and the solution 
purged with argon. The reaction was stirred for an additional 12 hours at −40 °C 
before the reaction was quenched with an aqueous NH4Cl solution, extracted with 
ether (2 x 1.5 mL), dried with MgSO4, and concentrated under reduced pressure. The 
crude oil was purified by column chromatography (9:1 hexanes:EtOAc v/v) to give 
1,2-product 2.2a (21.5 mg, 31% yield, 98:2 e.r.) and 1,4-product 2.3a (18.7 mg, 27% 
yield, 91:9 e.r.) as white solids.  
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Analytical standards used for the characterization of 2.2a and 2.3a were prepared from 
a separate trial giving enantiomeric ratios of 97:3 and 95:5 respectively. 
Methyl (5S, 6R)-5-hydroxy-6-O-(phenoxy)-cyclohex-1-enecarboxylate (2.2a) 
[α] 020D
.  −127.7 (c 1.00, CHCl3); M.p. 63 – 66 °C; 1H NMR (400 MHz, CDCl3) δ 7.32 
– 7.25 (m, 2H), 7.20 – 7.15 (m, 2H), 7.15 – 7.12 (m, 1H), 7.02 – 6.91 (m, 1H), 5.28 (d, 
J = 3.7 Hz, 1H), 3.92 (dt, J = 11.5, 3.8 Hz, 1H), 3.61 (s, 3H), 2.54 (m, 1H), 2.39 – 2.26 
(m, 1H), 2.10 – 1.93 (m, 1H), 1.93 – 1.82 (m, 1H); 13C NMR (75 MHz, CDCl3) δ 
166.5, 159.6, 144.0, 129.5, 122.0, 117.3, 115.9, 73.2, 69.5, 51.8, 25.3, 25.3; IR (film, 
cm-1) 3435, 2950, 2360, 1710, 1595, 1490, 1250, 1227, 750; TLC Rf = 0.37 (7:3 
hexanes:EtOAc v/v); HPLC 97:3 e.r., Chiral HPLC eluting at 1.0 mL/min with 95% 
hexanes:methanol. Retention times:  RT= 8.0 min, 10.7 min; HRMS (EI+) m/z Calc’d 
for C14H16O4 248.1049, found 248.1047.  
Methyl (3R, 6S)-3-hydroxy-6-O-(phenoxy)-cyclohex-1-enecarboxylate (2.3a) 
[α] 020D
.  −20.8 (c 0.50, CHCl3); M.p. 36 – 39 °C; 1H NMR (400 MHz, CDCl3) δ 7.32 – 
7.25 (m, 2H), 7.12 (t, J = 1.8, 1.8 Hz, 1H), 7.04 – 6.95 (m, 3H), 5.14 (br s, 1H), 4.34 
(d, J = 8.5 Hz, 1H), 3.75 (s, 3H), 2.24 – 2.14 (m, 1H), 2.05 – 1.96 (m, 1H), 1.91 – 1.77 
(m, 1H), 1.61 (tt, J = 14.2, 3.2 Hz, 1H); 13C NMR (75 MHz, CDCl3) δ 166.3, 158.0, 
145.8, 130.5, 129.6, 121.6, 116.9, 68.1, 67.8, 52.1, 26.5, 25.3; IR (film, cm-1) 3403, 
2950, 2358, 1718, 1490, 1250, 1226, 751; TLC Rf = 0.25 (7:3 hexanes:EtOAc v/v); 
HPLC 95:5 e.r., Chiral HPLC eluting at 1.0 mL/min with 90% hexanes:isopropanol. 
Retention times: RT= 5.9 min, 6.6 min; HRMS (EI+) m/z Calc’d for C14H16O4 
248.1049, found 248.1055.  
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1,2-product 2.2b (32% yield) and 25.0 mg (47% yield) of 1,4-product 2.3b as white 
solids. The recovered epoxide 2.1 (2%) was recovered in 57:43 enantiomeric ratio. 
Methyl (5S,6R)-5-hydroxy-6-(p-tolyloxy)cyclohex-1-ene-1-carboxylate (2.2b) 
[α] 020D
.  −112.4 (c 1.00, CHCl3); M.p. 88 – 90 °C 1H NMR (CDCl3, 400 MHz) δ 7.14 
(dd, J = 4.8, 3.0 Hz, 1H), 7.09 – 7.01 (m, 4H), 5.20 (d, J = 3.8 Hz, 1H), 3.88 (ddt, J = 
11.4, 9.2, 3.7 Hz, 1H), 3.61 (s, 3H), 2.59 – 2.46 (m, 1H), 2.35 – 2.25 (m, 1H), 2.28 (s, 
3H), 2.14 (d, J = 9.2 Hz, 1H), 2.02 – 1.92 (m, 1H), 1.90 – 1.80 (m, 1H); 13C NMR 
(CDCl3, 100 MHz) δ 166.5, 157.5, 143.9, 131.3, 129.9, 129.4, 117.2, 73.4, 69.4, 
51.8*, 51.8*, 25.2, 20.6; IR (film, cm-1) 3450, 3312, 2219, 1698, 506, 1221, 983, 796, 
734; TLC Rf = 0.32 (7:3 hexanes/EtOAc v/v);  HPLC 96:4 e.r., Chiral HPLC eluting 
at 1.0 mL/min with 95% hexanes/isopropanol. Retention times:  RT= 7.6 min, 9.6 min; 
HRMS (EI+) m/z Calc’d for C15H18O4 262.1205, found 262.1200. * denotes presumed 
rotamers in a 1:1 ratio. 
Methyl (3R,6S)-3-hydroxy-6-(p-tolyloxy)cyclohex-1-ene-1-carboxylate (2.3b) 
[α] 020D
.  −12.1 (c 1.00, CHCl3); M.p. 94 – 98 °C; 1H NMR (CDCl3, 400 MHz) δ 7.14 – 
7.06 (m, 3H), 6.95 – 6.88 (m, 2H), 5.07 (br s, 1H), 4.36 – 4.28 (m, 1H), 3.76 (s, 3H), 
2.29 (s, 3H), 2.21 – 2.14 (m, 1H), 2.04 – 1.96 (m, 1H), 1.92 – 1.77 (m, 1H), 1.57 (dt, J 
= 3.5 Hz, 14.2 Hz 1H); 13C NMR (CDCl3, 75 MHz) δ 166.4, 155.9, 145.8, 131.0, 
130.6, 130.1, 117.1, 68.6, 67.8, 52.1, 26.4, 25.3, 20.7; IR (film, cm-1) 3175, 2954, 
1713, 1508, 1251, 1226, 1025, 960, 812; TLC Rf = 0.21 (7:3 hexanes/EtOAc v/v); 
HPLC 93:7 e.r., Chiral HPLC eluting at 1.0 mL/min with 90% hexanes/isopropanol. 
Retention times: RT= 5.7 min, 8.4 min; HRMS (EI+) m/z Calc’d for C15H18O4 
262.1205, found 262.1202.  
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1,2-product 2.2c (21.9 mg, 28%, 96:4 e.r.) and 1,4-product 2.3c (26.9 mg, 34%, 91:9 
e.r.). Recovered epoxide 2.1 (9.5 mg, 24%, 52:48 e.r.). 
Analytical standards used for the characterization of 2.2c and 2.3c were prepared from 
a separate trial giving enantiomeric ratios of 96:4 and 91:9 respectively. 
Methyl (5S, 6R)-5-hydroxy-6-O-(4-tert-butylphenoxy)-cyclohex-1-enecarboxylate 
(2.2c) 
[α] 020D
.  −92.4 (c 1.00, CHCl3); M.p. 53 – 56 °C; 1H NMR (CDCl3, 300 MHz) δ 7.35 – 
7.24 (m, 2H), 7.15 (dd, J = 4.7, 3.0 Hz, 1H), 7.11 – 7.03 (m, 2H), 5.26 (d, J = 3.8 Hz, 
1H), 3.90 (dt, J = 11.2, 3.7 Hz, 1H), 3.61 (s, 3H), 2.61 – 2.46 (m, 1H), 2.39 – 2.23 (m, 
1H), 2.15 – 1.90 (m, 1H), 1.91 – 1.79 (m, 1H), 1.29 (s, 9H); 13C NMR (CDCl3, 75 
MHz) δ 166.6, 157.2, 144.6, 143.9, 134.7, 129.4, 126.3, 116.7, 73.1, 69.5, 51.8, 34.2, 
31.6, 25.4, 25.2; IR (film, cm-1) 3435, 2953, 2358, 1716, 1509, 1220, 1043; TLC Rf = 
0.42 (7:3 hexanes:EtOAc v/v);  HPLC 96:4 e.r, Chiral HPLC eluting at 1.0 mL/min 
with 95% hexanes:isopropanol. Retention times:  RT= 6.7 min, 7.2 min; HRMS (EI+) 
m/z Calc’d for C18H24O4 304.1675, found 304.1661. 
Methyl (3R, 6S)-3-hydroxy-6-O-(4-tert-butylphenoxy)-cyclohex-1-enecarboxylate 
(2.3c) 
[α] 020D
. −10.1 (c 0.75, CHCl3); 1H NMR (CDCl3, 400 MHz) δ 7.33 – 7.27 (m, 2H), 
7.11 (br s, 1H), 6.96 – 6.91 (m, 2H), 5.11 (br s, 1H), 4.37 – 4.28 (m, 1H), 3.75 (s, 3H), 
2.24 – 2.15 (m, 1H), 2.03 – 1.95 (m, 1H), 1.88 – 1.77 (m, 1H), 1.58 (tt, J = 14.2, 3.4 
Hz, 1H), 1.29 (s, 9H); 13C NMR (CDCl3, 100 MHz) δ 166.4, 155.6, 145.7, 144.2, 
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130.6, 126.4, 116.3, 68.0, 67.8, 52.1*, 52.1*, 34.2, 31.6, 26.5, 25.3; IR (film, cm-1) 
3399, 2952, 2867, 2359, 1718, 1508, 1250, 1225, 1030, 757; TLC Rf = 0.29 (7:3 
hexanes:EtOAc v/v);  HPLC 91:9 e.r., Chiral HPLC eluting at 1.0 mL/min with 90% 
hexanes:isopropanol. Retention times:  RT= 4.6 min, 6.0 min; HRMS (EI+) m/z Calc’d 
for C18H24O4 304.1675, found 304.1673. * denotes presumed rotamers in a 1:1 ratio. 
 
1,2-product 2.2d (48% yield) as a pale yellow oil and 443.0 mg (35% yield) of 1,4-
product 2.3d as waxy white solid. The epoxide (2.1, >1%) was recovered in 56:44 
enantiomeric ratio. 
Methyl (5S,6R)-5-hydroxy-6-(4-methoxyphenoxy)cyclohex-1-ene-1-carboxylate 
(2.2d) 
[α] 020D
.  −114.9 (c 1.00, CHCl3); 1H NMR (CDCl3, 300 MHz) δ 7.14 (dd, J = 4.6, 3.1 
Hz, 1H), 7.12 – 7.04 (m, 2H), 6.84 – 6.78 (m, 2H), 5.11 (d, J = 3.7 Hz, 1H), 3.89 (dt, J 
= 11.3, 3.8 Hz, 1H), 3.77 (s, 3H), 3.61 (s, 3H), 2.61 – 2.46 (m, 1H), 2.39 – 2.22 (m, 
1H), 2.06 – 1.95 (m, 1H), 1.91 – 1.81 (m, 1H); 13C NMR (CDCl3, 75 MHz) δ 166.6, 
154.8, 153.6, 143.9, 129.4, 118.9, 117.6, 114.5, 74.4, 69.4, 55.7, 51.8, 25.3; IR (film, 
cm-1) 3481, 3004, 2950, 2834, 2359, 1709, 1500, 1211, 748; TLC Rf = 0.21 (7:3 
hexanes/EtOAc v/v);  HPLC 92:8 e.r., Chiral HPLC eluting at 1.25 mL/min with 99% 
hexanes/isopropanol for 20.00 minutes then a gradient from 1% to 30% isopropanol in 
hexanes from 20.01 to 40.00 minutes. Retention times:  RT= 29.2 min, 31.7 min; 
HRMS (EI+) m/z Calc’d for C15H18O5 278.1154, found 278.1152. 
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Methyl (3R,6S)-3-hydroxy-6-(4-methoxyphenoxy)cyclohex-1-ene-1-carboxylate 
(2.3d) 
[α] 020D
.  +15.5 (c 1.00, CHCl3)†; M.p. 49 – 54 °C; 1H NMR (CDCl3, 400 MHz) δ 7.09 
(dd, J = 1.8 Hz, 1H), 7.01 – 6.96 (m, 2H), 6.86 – 6.81 (m, 2H), 4.97 (br s, 1H), 4.36 – 
4.28 (m, 1H), 3.77 (s, 3H), 3.77 (s, 3H), 2.20 – 2.11 (m, 1H), 2.02 (d, J = 18.7 Hz, 
1H), 1.90 – 1.80 (m, 1H), 1.55 (tt, J = 14.2, 3.2 Hz, 1H); 13C NMR (CDCl3, 126 MHz) 
δ 166.4, 154.7, 152.1, 145.8, 130.6, 118.9, 114.7, 69.9, 67.8, 55.7, 52.1, 26.3, 25.2; IR 
(film, cm-1) 3285, 2953, 2869, 1713, 1505, 1252, 1218, 1032, 826, 724; TLC Rf = 
0.15 (7:3 hexanes/EtOAc v/v);  HPLC 94:6 e.r., Chiral HPLC eluting at 1.00 mL/min 
with 90% hexanes/isopropanol. Retention times:  RT= 8.7 min, 14.4 min; HRMS (EI+) 
m/z Calc’d for C15H18O5 278.1154, found 278.1167. †Analytical standard was obtained 
as the enantiomer of 2.3d from the (R,R)-L2 ligand. 
 
1,2-product 2.2e (20.7 mg, 21%, 90:10 e.r.) and 1,4-product 2.3e (22.3 mg, 23%, 
84:16 e.r.). Recovered epoxide 2.1 (12.1 mg, 29%, 51:49 e.r.). 
Analytical standards used for the characterization of 2.2e and 2.3e were prepared from 
a separate trial giving enantiomeric ratios of 94:6 and 89:11 respectively. 
Methyl (5S, 6R)-5-hydroxy-6-O-(4-N-Bocphenoxy)-cyclohex-1-enecarboxylate 
(2.2e) 
[α] 020D
.  −92.4 (c 0.50, CHCl3); M.p. 134 – 136 °C; 1H NMR (CDCl3, 400 MHz) δ 
7.27 – 7.23 (m, 2H), 7.15 (dd, J = 4.7, 3.0 Hz, 1H), 7.10 – 7.04 (m, 2H), 6.35 (s, 1H), 
5.15 (d, J = 3.6 Hz, 1H), 3.88 (ddt, J = 12.2, 8.5, 3.8 Hz, 1H), 3.61 (s, 3H), 2.58 – 2.47 
(m, 1H), 2.37 – 2.24 (m, 1H), 2.03 – 1.91 (m, 1H), 1.90 – 1.81 (m, 1H), 1.50 (s, 9H); 
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13C NMR (CDCl3, 75 MHz) δ 166.5, 155.5, 153.1, 144.0, 132.7, 129.3, 120.3, 118.0, 
80.4, 73.9, 69.5, 51.9, 28.5, 25.3, 25.3; IR (film, cm-1) 3481, 3358, 2974, 2921, 1720, 
1695, 1511, 1210, 1150; TLC Rf = 0.13 (7:3 hexanes:EtOAc v/v);  HPLC 94:6 e.r., 
Chiral HPLC eluting at 1.00 mL/min with 95% hexanes:isopropanol for 20.00 minutes 
then a gradient from 5% to 30% isopropanol in hexanes from 20.01 to 40.00 minutes. 
Retention times:  RT= 33.1 min, 35.5 min; HRMS (EI+) m/z Calc’d for C19H25O6N 
363.1682, found 363.1686.  
Methyl (3R, 6S)-3-hydroxy-6-O-(4-N-Bocphenoxy)-cyclohex-1-enecarboxylate 
(2.3e) 
[α] 020D
.  −19.8 (c 0.50, CHCl3); M.p. 61 – 65 °C; 1H NMR (CDCl3, 400 MHz) δ 7.28 – 
7.23 (m, 2H), 7.10 (dd, J = 1.9, 1.6 Hz, 1H), 6.97 – 6.92 (m, 2H), 6.37 (s, 1H), 5.01 (t, 
J = 3.0 Hz, 1H), 4.36 – 4.29 (m, 1H), 3.74 (s, 3H), 2.18 – 2.09 (m, 1H), 2.02 – 1.94 
(m, 1H), 1.81 (tdd, J = 13.0, 10.4, 2.9 Hz, 1H), 1.58 (tt, J = 14.5, 3.0 Hz, 1H), 1.49 (s, 
9H); 13C NMR (CDCl3, 100 MHz) δ 166.3, 154.0, 153.2, 145.8, 132.4, 130.6, 120.6, 
117.9, 80.4, 69.1*, 69.1*, 67.8, 52.2*, 52.1*, 28.5, 26.4, 25.3; IR (film, cm-1) 3342, 
2950, 1702, 1509, 1254, 1220, 1160; TLC Rf = 0.12 (7:3 hexanes:EtOAc v/v);  
HPLC 89:11 e.r., Chiral HPLC eluting at 1.0 mL/min with 95% hexanes:isopropanol 
for 20.00 minutes then a gradient from 5% to 30% isopropanol in hexanes from 20.01 
to 40.00 minutes. Retention times:  RT= 31.9 min, 34.0 min; HRMS (EI+) m/z Calc’d 
for C19H25O6N 363.1682, found 363.1688. * denotes presumed rotamers in a 1:1 ratio. 
 
 
 49 
1,2-product 2.2f (3.2 mg, 4%, 97:3 e.r.) and 1,4-product 2.3f (2.9 mg, 4%, 98:2 e.r.). 
Recovered epoxide 2.1 (27.6 mg, 64%, 50:50 e.r.). 
Analytical standards used for the characterization of 2.2f and 2.3f were prepared from 
a separate trial giving enantiomeric ratios of 98:2 and 98:2 respectively. 
Methyl (5S, 6R)-5-hydroxy-6-O-(4-nitrophenoxy)-cyclohex-1-enecarboxylate 
(2.2f) 
[α] 020D
.  −108.2 (c 0.50, CHCl3); 1H NMR (CDCl3, 400 MHz) 8.22 – 8.17 (m, 2H), 
7.26 – 7.21 (m, 3H), 5.44 (d, J = 3.7 Hz, 1H), 3.96 (ddt, J = 12.0, 8.0, 3.8 Hz, 1H), 
3.66 (s, 3H), 2.58 (dtd, J = 20.3, 5.4, 2.3 Hz, 1H), 2.45 – 2.32 (m, 1H), 2.05 – 1.87 (m, 
2H); 13C NMR (CDCl3, 100 MHz) δ 166.1, 164.9, 145.1, 141.9, 128.2, 125.9, 116.6, 
73.0, 69.8, 52.1*, 52.1*, 25.7, 25.2; IR (film, cm-1) 3458, 2952, 1710, 1590, 1509, 
1493, 1330, 1250; TLC Rf = 0.12 (7:3 hexanes:EtOAc v/v);  HPLC 98:2 e.r., Chiral 
HPLC eluting at 1.0 mL/min with 95% hexanes:isopropanol for 20.00 minutes then a 
gradient from 5% to 30% isopropanol in hexanes from 20.01 to 40.00 minutes. 
Retention times:  RT= 35.9 min, 38.4 min; HRMS (EI+) m/z Calc’d for C14H15NO6 
239.0899, found 239.0898. * denotes presumed rotamers in a 1:1 ratio 
Methyl (3R, 6S)-3-hydroxy-6-O-(4-nitrophenoxy)-cyclohex-1-enecarboxylate 
(2.3f) 
[α] 020D
.  +37.5 (c 0.50, CHCl3) †; 1H NMR (CDCl3, 400 MHz) δ 8.24 – 8.17 (m, 2H), 
7.18 (dd, J = 2.2, 1.4 Hz, 1H), 7.06 – 7.00 (m, 2H), 5.28 (s, 1H), 4.38 (s, 1H), 3.74 (s, 
3H), 2.21 – 2.13 (m, 1H), 2.10 – 2.02 (m, 1H), 1.88 – 1.69 (m, 2H); 13C NMR 
(CDCl3, 75 MHz) δ 165.9, 163.1, 146.6, 141.7, 129.4, 126.1, 115.8, 68.4, 67.5, 52.3, 
26.4, 25.5; IR (film, cm-1) 3391, 2950, 1708, 1438, 1255, 1041, 756; TLC Rf = 0.09 
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(7:3 hexanes:EtOAc v/v); HPLC 98:2 e.r., Chiral HPLC eluting at 1.0 mL/min with 
95% hexanes:isopropanol for 20.00 minutes then a gradient from 5% to 30% 
isopropanol in hexanes from 20.01 to 40.00 minutes. Retention times:  RT= 31.9 min, 
34.0 min; HRMS (EI+) m/z Calc’d for C14H15NO6 239.0899, found 239.0895. 
†Analytical standard was obtained as the enantiomer of 2.3f from the (R,R)-L2. 
 
1,2-product 2.2g (23.4 mg, 31%, 96:4 e.r.) and 1,4-product 2.3g (25.8 mg, 34%, 84:16 
e.r.). Recovered epoxide 2.1 (0.4 mg, 1%, 68:32 e.r.). 
Analytical standards used for the characterization of 2.2g and 2.3g were prepared from 
a separate trial giving enantiomeric ratios of 85:15 and 90:10 respectively. 
Methyl (5S, 6R)-5-hydroxy-6-O-(2,4-dimethylphenoxy)-cyclohex-1-
enecarboxylate (2.2g)  
[α] 020D
.  −106.6 (c 0.75, CHCl3);  1H NMR (CDCl3, 300 MHz) δ 7.19 – 7.11 (m, 2H), 
7.00 – 6.89 (m, 2H), 5.20 (d, J = 3.7 Hz, 1H), 3.89 (ddt, J = 12.0, 8.0, 3.7 Hz, 1H), 
3.57 (s, 3H), 2.62 – 2.47 (m, 1H), 2.41 – 2.31 (m, 1H), 2.25 (s, 3H), 2.14 (s, 3H), 2.07 
– 1.96 (m, 1H), 1.93 – 1.83 (m, 1H); 13C NMR (CDCl3, 75 MHz) δ 166.6, 155.5, 
143.7, 131.5, 131.0, 129.8, 127.7, 127.3, 115.7, 73.5, 69.6, 51.8, 25.4, 25.4, 20.6, 16.5; 
IR (film, cm-1) 3434, 2949, 1716, 1489, 1250, 1217, 1042; TLC Rf = 0.50 (7:3 
hexanes:EtOAc v/v);  HPLC 85:15 e.r., Chiral HPLC eluting at 1.0 mL/min with 90% 
hexanes:isopropanol. Retention times:  RT= 3.7 min, 4.2 min; HRMS (EI+) m/z Calc’d 
for C16H20O4 276.1362, found 276.1357. 
Methyl (3R, 6S)-3-hydroxy-6-O-(2,4-dimethylphenoxy)-cyclohex-1-
enecarboxylate (2.3g)  
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[α] 020D
.  −19.4 (c 0.50, CHCl3); 1H NMR (CDCl3, 300 MHz) δ 7.10 (dd, J = 2.2, 1.3 
Hz, 1H), 7.03 – 6.92 (m, 3H), 5.09 (br s, 1H), 4.39 – 4.27 (m, 1H), 3.74 (s, 3H), 2.26 
(s, 3H), 2.15 (s, 3H), 2.13 – 2.06 (m, 1H), 2.05 – 1.96 (m, 1H), 1.93 – 1.78 (m, 1H), 
1.65 – 1.58 (dt, J = 13.9, 3.3 Hz, 1H); 13C NMR (CDCl3, 75 MHz) δ 166.4, 154.1, 
145.3, 131.5, 130.8, 130.4, 128.0, 127.1, 114.3, 68.7, 67.7, 51.9, 26.6, 25.5, 20.5, 16.4; 
IR (film, cm-1) 3415, 2949, 1719, 1499, 1250, 1219, 1032; TLC Rf = 0.40 (7:3 
hexanes:EtOAc v/v);  HPLC 90:10 e.r., Chiral HPLC eluting at 1.0 mL/min with 90% 
hexanes:methanol. Retention times:  RT= 4.2 min, 5.0 min; HRMS (EI+) m/z Calc’d 
for C16H20O4 276.1362, found 276.1367.  
 
1,2-product 2.2h (21.5 mg, 31%, 90:10 e.r.) and 1,4-product 2.3h (24.5 mg, 34%, 91:9 
e.r.). Recovered epoxide 2.1 (9.2 mg, 23%, 52:48 e.r.). 
Analytical standards used for the characterization of 2.2h and 2.3h were prepared 
from a separate trial giving enantiomeric ratios of 90:10 and 92:8 respectively. 
Methyl (5S, 6R)-5-hydroxy-6-O-(3,5-dimethylphenoxy)-cyclohex-1-
enecarboxylate (2.2h)  
[α] 020D
.  −93.3 (c 1.00, CHCl3); 1H NMR (CDCl3, 400 MHz) δ 7.15 (dd, J = 4.7, 3.0 
Hz, 1H), 6.77 (s, 2H), 6.63 (s, 1H), 5.26 (d, J = 3.7 Hz, 1H), 3.90 (ddt, J = 12.3, 8.2, 
3.7 Hz, 1H), 3.64 (s, 3H), 2.53 (dtd, J = 20.0, 5.2, 3.0 Hz, 1H), 2.33 (dddd, J = 9.7, 
6.4, 3.1, 1.1 Hz, 1H), 2.28 (s, 6H), 2.02 – 1.92 (m, 1H), 1.90 – 1.82 (m, 1H); 13C 
NMR (CDCl3, 100 MHz) δ 166.5, 159.5, 143.9, 139.2, 129.4, 123.8, 114.8, 72.7, 69.5, 
51.8*, 51.8*, 25.4, 25.2, 21.5; IR (film, cm-1) 3434, 2949, 1714, 1590, 1293, 1246, 
1150, 1039, 755; TLC Rf = 0.53 (7:3 hexanes:EtOAc v/v);  HPLC 90:10 e.r., Chiral 
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HPLC eluting at 1.25 mL/min with 97% hexanes:methanol. Retention times:  RT= 6.0 
min, 6.4 min; HRMS (EI+) m/z Calc’d for C16H20O4 276.1362, found 276.1352. * 
denotes presumed rotamers in a 1:1 ratio. 
Methyl (3R, 6S)-3-hydroxy-6-O-(3,5-dimethylphenoxy)-cyclohex-1-
enecarboxylate (2.3h)  
[α] 020D
.  −14.0 (c 0.75, CHCl3); M.p. 93 – 95 °C; 1H NMR (CDCl3, 400 MHz) δ 7.10 
(dd, J = 2.2, 1.4 Hz, 1H), 6.63 (s, 3H), 5.11 (br s, 1H), 4.37 – 4.28 (m, 1H), 3.76 (s, 
3H), 2.28 (s, 6H), 2.18 (ddt, J = 14.5, 4.0, 2.6 Hz, 1H), 2.04 – 1.95 (m, 1H), 1.86 – 
1.78 (m, 1H), 1.58 (dt, J = 14.0, 3.3 Hz, 1H); 13C NMR (CDCl3, 75 MHz) δ 166.4, 
157.9, 145.7, 139.3, 130.7, 123.4, 114.5, 67.9, 67.7, 52.1, 26.5, 25.3, 21.5; IR (film, 
cm-1) 3408, 2949, 1717, 1590, 1292, 1252, 1150, 1031; TLC Rf = 0.29 (7:3 
hexanes:EtOAc v/v); HPLC 92:8 e.r., Chiral HPLC eluting at 1.25 mL/min with 90% 
hexanes:isopropanol. Retention times:  RT= 3.6 min, 4.2 min; HRMS (EI+) m/z Calc’d 
for C16H20O4 276.1362, found 276.1370. 
 
1,2-product 2.2i (25.8, 33%, 84:16 e.r.) and 1,4-product 2.3i (25.7 mg, 33%, 84:16 
e.r.). No recovered epoxide 2.1. 
Analytical standards used for the characterization of 2i and 3i were prepared from a 
separate trial giving enantiomeric ratios of 89:11 and 97:3 respectively. 
Methyl (5S, 6R)-5-hydroxy-6-O-(2-naphthoxy)-cyclohex-1-enecarboxylate (2.2i) 
[α] 020D
.  −124.3 (c 2.00, CHCl3); M.p. 82 – 86 °C; 1H NMR (CDCl3, 400 MHz) δ 7.78 
– 7.74 (m, J = 8.4, 6.9 Hz, 3H), 7.57 (d, J = 2.5 Hz, 1H), 7.43 (ddd, J = 8.1, 6.8, 1.3, 
1H), 7.34 (ddd, J = 8.2, 6.8, 1.2, 1H), 7.30 (dd, J = 8.9, 2.5 Hz, 1H), 7.19 (dd, J = 4.8, 
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3.0 Hz, 1H), 5.44 (d, J = 3.6 Hz, 1H), 4.02 – 3.92 (m, 1H), 3.58 (s, 3H), 2.62 – 2.50 
(m, 1H), 2.40 – 2.27 (m, 1H), 2.07 – 1.97 (m, 1H), 1.94 – 1.85 (m, 1H); 13C NMR 
(CDCl3, 100 MHz) δ 166.5, 157.4, 144.2, 134.5, 129.6, 129.4, 129.2, 127.6, 127.1, 
126.3, 124.0, 119.6, 111.3, 73.2, 69.6, 51.8, 25.3, 25.3; IR (film, cm-1) 3431, 3055, 
2949, 1709, 1250, 1212, 1041, 747; TLC Rf = 0.29 (7:3 hexanes:EtOAc v/v);  HPLC 
89:11 e.r., Chiral HPLC eluting at 1.25 mL/min with 99% hexanes:isopropanol then a 
gradient of 1% to 30% isopropanol in hexanes from 20.01 to 40.00 minutes. Retention 
times:  RT= 26.2 min, 29.9 min; HRMS (EI+) m/z Calc’d for C18H18O4 298.1205, 
found 298.1215. 
Methyl (3R, 6S)-3-hydroxy-6-O-(2-naphthoxy)-cyclohex-1-enecarboxylate (2.3i) 
[α] 020D
.  −5.7 (c 0.50, CHCl3); M.p. 63 – 66 °C; 1H NMR (CDCl3, 400 MHz) δ 7.79 – 
7.71 (m, 3H), 7.44 (ddd, J = 8.2, 6.8, 1.3 Hz, 1H), 7.34 (ddd, J = 8.1, 6.9, 1.2 Hz, 1H), 
7.31 (d, J = 2.5 Hz, 1H), 7.20 (dd, J = 8.9, 2.5 Hz, 1H), 7.16 (dd, J = 2.2, 1.4 Hz, 1H), 
5.30 (t, J = 2.9 Hz, 1H), 4.36 (dddd, J = 10.5, 6.1, 2.2, 1.1 Hz, 1H), 3.75 (s, 3H), 2.32 
– 2.25 (m, 1H), 2.07 – 1.98 (m, 1H), 1.94 – 1.81 (m, 1H), 1.67 (tt, J = 14.2, 3.2 Hz, 
1H); 13C NMR (CDCl3, 100 MHz) δ 166.4, 155.8, 146.0, 134.6, 130.4, 129.6, 129.4, 
127.7, 126.9, 126.4, 123.9, 120.0, 109.9, 68.0*, 68.0*, 67.8, 52.2*, 52.2*, 26.6, 25.2; 
IR (film, cm-1) 3420, 2949, 2359, 1717, 1250, 1214, 1031, 748; TLC Rf = 0.18 (7:3 
hexanes:EtOAc v/v);  HPLC 97:3 e.r., Chiral HPLC eluting at 1.25 mL/min with 99% 
hexanes:isopropanol then a gradient from 1% to 30% isopropanol in hexanes from 
20.01 to 40.00 minutes. Retention times:  RT= 31.0 min, 31.5 min; HRMS (EI+) m/z 
Calc’d for C18H18O4 298.1205, found 298.1194. * denotes presumed rotamers in a 1:1 
ratio. 
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1,2-product 2.2j (27.3 mg, 35%, 80:20 e.r.) and 1,4-product 2.3j (29.8 mg, 38%, 88:12 
e.r.). No recovered epoxide 2.1. 
Analytical standards used for the characterization of 2.2j and 2.3j were prepared from 
a separate trial giving enantiomeric ratios of 80:20 and 90:10 respectively. 
Methyl (5S, 6R)-5-hydroxy-6-O-(1-naphthoxy)-cyclohex-1-enecarboxylate (2.2j) 
[α] 020D
.  −123.2 (c 0.50, CHCl3); 1H NMR (CDCl3, 400 MHz) δ 8.19 – 8.13 (m, 1H), 
7.83 – 7.77 (m, 1H), 7.49 – 7.39 (m, 5H), 7.24 (dd, J = 4.9, 2.9 Hz, 1H), 5.52 (d, J = 
3.7 Hz, 1H), 3.99 (ddt, J = 11.7, 9.8, 3.7 Hz, 1H), 3.44 (s, 3H), 2.69 – 2.58 (m, 1H), 
2.47 – 2.33 (m, 1H), 2.21 – 2.09 (m, 1H), 2.01 – 1.93 (m, 1H); 13C NMR (CDCl3, 100 
MHz) δ 166.5, 155.5, 144.2*, 144.2*, 134.7, 129.4, 127.8*, 127.7*, 126.6, 126.3*, 
126.2*, 126.1*, 126.1*, 126.1*, 126.1*, 125.5*, 125.4*, 121.9*, 121.9*, 121.5*, 
121.5*, 109.4, 73.9, 73.8, 69.7, 51.8*, 51.7*, 25.6, 25.5; IR (film, cm-1) 3390, 2951, 
1709, 1395, 1246, 1235, 1091, 1042, 770; TLC Rf = 0.28 (7:3 hexanes:EtOAc v/v);  
HPLC 80:20 e.r., Chiral HPLC eluting at 1.0 mL/min with 95% hexanes:methanol. 
Retention times:  RT= 10.7 min, 15.4 min; HRMS (EI+) m/z Calc’d for C18H18O4 
298.1205, found 298.1201. * denotes presumed rotamers in a 1:1 ratio. 
Methyl (3R, 6S)-3-hydroxy-6-O-(1-naphthoxy)-cyclohex-1-enecarboxylate (2.3j) 
[α] 020D
.  +67.0 (c 1.00, CHCl3); M.p. 132 – 135 °C; 1H NMR (CDCl3, 400 MHz) δ 
8.25 – 8.18 (m, 1H), 7.82 – 7.77 (m, 1H), 7.50 – 7.35 (m, 4H), 7.20 (dd, J = 2.2, 1.3 
Hz, 1H), 7.08 (d, J = 7.4, 1H), 5.41 (t, J = 3.0 Hz, 1H), 4.42 – 4.35 (m, 1H), 3.70 (s, 
3H), 2.30 – 2.22 (m, 1H), 2.07 – 1.87 (m, 2H), 1.68 (dt, J = 14.0, 3.4 Hz, 1H); 13C 
NMR (CDCl3, 100 MHz) δ 166.4, 153.8, 145.9, 134.7, 130.6, 127.5, 126.7, 126.4, 
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126.0, 125.3, 122.3, 120.9, 107.2, 68.2, 67.8, 52.2*, 52.2*, 26.9, 25.4; IR (film, cm-1) 
3244, 3052, 2950, 2359, 1717, 1256, 1234, 771; TLC Rf = 0.19 (7:3 hexanes:EtOAc 
v/v);  HPLC 90:10 e.r., Chiral HPLC eluting at 1.0 mL/min with 98% 
hexanes:methanol. Retention times:  RT= 7.9 min, 11.6 min; HRMS (EI+) m/z Calc’d 
for C18H18O4 298.1205, found 298.1207. * denotes presumed rotamers in a 1:1 ratio. 
 
1,2-product 2.2k (23.1 mg, 29%, 90:10 e.r.) and 1,4-product 2.3k (18.5 mg, 23%, 95:5 
e.r.). No recovered epoxide 2.1. 
Analytical standards used for the characterization of 2.2k and 2.3k were prepared 
from a separate trial giving enantiomeric ratios of 92:8 and 95:5 respectively. 
Methyl (5S, 6R)-5-hydroxy-6-O-(1,3-benzodioxol-5-yl)-cyclohex-1-enecarboxylate 
(2.2k) 
[α] 020D
.  +104.4 (c 1.00, CHCl3); 1H NMR (CDCl3, 400 MHz) δ 7.14 (dd, J = 4.7, 3.0 
Hz, 1H), 6.74 (d, J = 2.5 Hz, 1H), 6.68 (d, J = 8.4 Hz, 1H), 6.60 (dd, J = 8.5, 2.5 Hz, 
1H), 5.91 (s, 2H), 5.08 (d, J = 3.7 Hz, 1H), 3.87 (ddt, J = 11.5, 9.2, 3.8 Hz, 1H), 3.65 
(s, 3H), 2.52 (dtd, J = 20.1, 5.3, 2.8 Hz, 1H), 2.37 – 2.25 (m, 1H), 2.02 – 1.91 (m, 1H), 
1.90 – 1.81 (m, 1H); 13C NMR (CDCl3, 100 MHz) δ 166.5, 155.0, 148.1, 144.0, 
142.6, 129.2, 109.8, 108.0, 101.3, 100.8, 74.8, 69.5, 51.9*, 51.9*, 25.3, 25.3; IR (film, 
cm-1) 3446, 2950, 2360, 1710, 1480, 1242, 1175, 1035, 746; TLC Rf = 0.20 (7:3 
hexanes:EtOAc v/v);  HPLC 92:8 e.r., Chiral HPLC eluting at 1.0 mL/min with 95% 
hexanes:isopropanol. Retention times:  RT= 20.4 min, 23.4 min; HRMS (EI+) m/z 
Calc’d for C15H16O6 292.0947, found 292.0952. 
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Methyl (3R, 6S)-3-hydroxy-6-O-(1,3-benzodioxol-5-yl)-cyclohex-1-enecarboxylate 
(2.3k) 
[α] 020D
.  −16.7 (c 0.75, CHCl3); M.p. 70 – 73 °C; 1H NMR (CDCl3, 400 MHz) δ 7.09 
(s, 1H), 6.70 (d, J = 8.4 Hz, 1H), 6.63 (d, J = 2.4 Hz, 1H), 6.48 (dd, J = 8.5, 2.5 Hz, 
1H), 5.92 (q, J = 1.43, 1.41 Hz, 2H), 4.93 (t, J = 2.8 Hz, 1H), 4.35 – 4.29 (m, 1H), 
3.78 (s, 3H), 2.21 – 2.10 (m, 1H), 2.04 – 1.97 (m, 1H), 1.91 – 1.76 (m, 1H), 1.54 (tt, J 
= 14.4, 3.2 Hz, 1H); 13C NMR (CDCl3, 100 MHz) δ 166.3, 153.3, 148.3, 145.7, 142.6, 
130.5, 109.8, 108.1, 101.3, 100.9, 70.2, 67.8, 52.2*, 52.2*, 26.4, 25.2; IR (film, cm-1) 
3408, 2950, 1715, 1482, 1254, 1177, 1033; TLC Rf = 0.14 (7:3 hexanes:EtOAc v/v);  
HPLC 95:5 e.r., Chiral HPLC eluting at 1.0 mL/min with 90% hexanes:isopropanol. 
Retention times:  RT= 8.9 min, 12.4 min; HRMS (EI+) m/z Calc’d for C15H16O6 
292.0947, found 292.0935. * denotes presumed rotamers in a 1:1 ratio. 
 
Allylic-oxide Regio Resolution of Estradiol 
17-O-tertbutyldimethylsilylestradiol (2.4) was prepared according to literature 
procedures using a bis-TBS protection followed by selective removal of the phenolic 
silane.12 In addition to the discussed use of the (S,S)-L2, (R,R)-L2 was also used and 
the results are included below. Products are a single diastereomer unless otherwise 
noted. 
In a flame-dried flask outfitted with a septum, racemic epoxide 2.1 (68.0 mg, 
0.44 mmol, 1.4 equiv) was dissolved in 6.5 mL of toluene followed by 17-O-
tertbutyldimethylsilylestradiol 2.4 (120.0 mg, 0.31 mmol, 1.0 equiv.). The resulting 
solution was degassed with argon and cooled to −40 °C. In a separate flask, Pd2(dba)3 
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(14.7 mg, 5.0 mol%) and (R,R)-L2 (36.7 mg, 15.0 mol%) were dissolved in 4.0 mL of 
toluene. The resulting purple solution was degassed and stirred at room temperature 
until it became yellow (approx. 10 min.). The solution was then cooled to −40 °C and 
added to the epoxide solution via syringe. After 96 hours at −40 °C, the reaction was 
concentrated to a volume of 2.0 mL and then purified by flash chromatography (9:1, 
hexanes:EtOAc v/v) to yield 2.5 (101.5 mg, 60%) and 2.6 (46.9 mg, 27%), both as 
white solids and single diastereomers. The epoxide (2.1, 22%) was recovered in 93:7 
enantiomeric ratio. 
Methyl (5R, 6S)-5-hydroxy-6-O-(17-O-tertbutyldimethylsilylestradiol)-cyclohex-
1-enecarboxylate (2.5) 
[α] 020D
.  −97.3 (c 1.00, CHCl3); M.p. 38 – 42 °C; 1H NMR (400 MHz, CDCl3) δ 7.19 
(d, J = 8.8 Hz, 1H), 7.14 (dd, J = 4.6, 3.1 Hz, 1H), 6.92 (dd, J = 8.6, 2.8 Hz, 1H), 6.87 
(d, J = 2.8 Hz, 1H), 5.25 (d, J = 3.7 Hz, 1H), 3.91 (dt, J = 11.3, 3.7 Hz, 1H), 3.66 (s, 
3H), 3.64 (t, J = 7.7 Hz, 1H), 2.88 – 2.77 (m, 1H), 2.57 – 2.48 (m, 1H), 2.37 – 2.22 
(m, 2H), 2.21 – 2.11 (m, 1H), 2.11 – 1.79 (m, 6H), 1.66 – 1.63 (m, 1H), 1.55 – 1.03 
(m, 7H), 0.89 (s, 9H), 0.73 (s, 3H), 0.03 (s, 3H), 0.02 (s, 3H); 13C NMR (75 MHz, 
CDCl3) δ 166.5, 157.3, 143.8, 138.1, 134.1, 129.4, 126.4, 117.1, 114.1, 81.8, 72.7, 
69.4, 51.8, 49.8, 44.2, 43.6, 38.9, 37.2, 31.0, 29.9, 27.4, 26.4, 25.9, 25.3, 25.1, 23.3, 
18.2, 11.4, −4.3, −4.6; IR (film, cm-1) 3433, 2926, 2854, 1717, 1495, 1246, 1094, 834, 
773; TLC Rf = 0.57 (7:3 hexanes:EtOAc v/v). HRMS (EI+) m/z Calc’d for 
C32H48SiO5 540.3271, found 540.3263. 
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Methyl (3S, 6R)-3-hydroxy-6-O-(17-O-tertbutyldimethylsilylestradiol)-cyclohex-
1-enecarboxylate (2.6) 
[α] 020D
.  −25.6 (c 1.00, CHCl3); M.p. 43 – 47 °C; 1H NMR (400 MHz, CDCl3) δ 7.20 
(d, J = 8.1 Hz, 1H), 7.10 (dd, J = 2.2, 1.3 Hz, 1H), 6.79 (dd, J = 8.6, 2.8 Hz, 1H), 6.73 
(d, J = 2.7 Hz, 1H), 5.09 (br s, 1H), 4.32 (dddd, J = 10.6, 6.1, 2.1, 1.0 Hz, 1H), 3.76 (s, 
3H), 3.64 (t, J = 7.9 Hz, 1H), 2.89 – 2.78 (m, 1H), 2.34 – 2.10 (m, 3H), 2.04 – 1.76 
(m, 5H), 1.71 – 1.03 (m, 10H), 0.89 (s, 9H), 0.74 (s, 3H), 0.04 (s, 3H), 0.02 (s, 3H); 
13C NMR (100 MHz, CDCl3) δ 166.4, 155.7, 145.8, 138.2, 133.8, 130.6, 126.5, 117.0, 
114.0, 81.8, 67.9*, 67.9*, 67.8, 52.1*, 52.1*, 49.8, 44.2, 43.7, 38.9, 37.2, 31.1, 29.9, 
27.4, 26.5, 26.4, 26.0, 25.3, 23.4, 18.2, 11.4, −4.3, −4.6; IR (film, cm-1) 3389, 2926, 
2853, 1719, 1496, 1247, 1094, 834, 773; TLC Rf = 0.43 (7:3 hexanes:EtOAc v/v). 
HRMS (EI+) m/z Calc’d for C32H48SiO5 540.3271, found 540.3263. * denotes 
presumed rotamers in a 1:1 ratio. 
In a flame-dried flask outfitted with a septum, racemic epoxide 2.1 (121.6 mg, 
0.788 mmol, 1.4 equiv) was dissolved in 7.0 mL of toluene followed by 17-O-
tertbutyldimethylsilylestradiol 2.4 (208.1 mg, 0.539 mmol, 1.0 equiv.). The resulting 
solution was degassed with argon and cooled to −40 °C. In a separate flask, Pd2(dba)3  
(26.2 mg, 5.0 mol%) and (S,S)-L2 (67.0 mg, 15.0 mol%) were dissolved in 4.0 mL of 
toluene. The resulting purple solution was degassed and stirred at room temperature 
until it became yellow (approx. 10 min.). The solution was then cooled to −40 °C and 
added to the epoxide solution via syringe. After 96 hours at −40 °C, the reaction was 
concentrated to a volume of 2.0 mL and then purified by flash chromatography (9:1, 
hexanes:EtOAc, (v/v) to yield 2.7 (127.9 mg, 44%) and 2.8 (119.2 mg, 41%) both as 
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white solids and single diastereomers. The epoxide (2.1, 18%) was recovered in 66:34 
enantiomeric ratio. 
Methyl (5S, 6R)-5-hydroxy-6-O-(17-O-tertbutyldimethylsilylestradiol)-cyclohex-
1-enecarboxylate (2.7) 
[α] 020D
.  −28.0 (c 1.00, CHCl3); M.p. 56 – 60 °C; 1H NMR (400 MHz, CDCl3) δ 7.19 
(d, J = 8.7 Hz, 1H), 7.14 (dd, J = 4.6, 3.1 Hz, 1H), 6.94 (dd, J = 8.6, 2.8 Hz, 1H), 6.85 
(d, J = 2.6 Hz, 1H), 5.25 (d, J = 3.7 Hz, 1H), 3.91 (ddt, J = 11.3, 9.1, 3.7 Hz, 1H), 3.65 
(s, 3H), 3.64 (t, J = 8.5 Hz, 1H), 2.86-2.79 (m, 1H), 2.58 – 2.47 (m, 1H), 2.37 – 2.23 
(m, 2H), 2.20 – 2.11 (m, 1H), 2.06-1.80 (m, 6H), 1.71 – 1.59 (m, 1H), 1.54-1.07 (m, 
7H), 0.89 (s, 9H), 0.74 (s, 3H), 0.04 (s, 3H), 0.02 (s, 3H); 13C NMR (100 MHz, 
CDCl3) δ 166.4, 157.3, 143.7, 138.0, 133.9, 129.3, 126.3, 116.9, 114.3, 81.8, 72.7, 
69.4, 51.7*, 51.7*, 49.7, 44.2, 43.6, 38.8, 37.2, 31.0, 29.8, 27.3, 26.4, 25.9, 25.2*, 
25.1*, 23.3, 18.1, 11.4, −4.3, −4.7; IR (film, cm-1) 3435, 2928, 2855, 1719, 1496, 
1246, 1095, 834, 774; TLC Rf = 0.57 (7:3 hexanes:EtOAc v/v). HRMS (EI+) m/z 
Calc’d for C32H48SiO5 540.3271, found 540.3264. * denotes presumed rotamers in a 
1:1 ratio. 
Methyl (3R, 6S)-3-hydroxy-6-O-(17-O-tertbutyldimethylsilylestradiol)-cyclohex-
1-enecarboxylate (2.8) 
[α] 020D
.  +27.5 (c 0.50, CHCl3); M.p. 64 – 69 °C; 1H NMR (400 MHz, CDCl3) δ 7.20 
(d, J = 8.6 Hz, 1H), 7.10 (dd, J = 2.4, 1.3 Hz, 1H), 6.80 (dd, J = 8.3, 2.5 Hz, 1H), 6.71 
(d, J = 2.6 Hz, 1H), 5.09 (br s, 1H), 4.34 – 4.30 (m, 1H), 3.75 (s, 3H), 3.64 (t, J = 8.0 
Hz, 1H), 2.88 – 2.77 (m, 1 H), 2.32 – 2.11 (m, 3H), 2.04 – 1.76 (m, 5H), 1.74 – 1.03 
(m, 10H), 0.89 (s, 9H), 0.74 (s, 3H), 0.03 (s, 3H), 0.02 (s, 3H); 13C NMR (100 MHz, 
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CDCl3) δ 166.4, 155.6, 146.0, 138.2, 133.8, 130.4, 126.4, 116.8, 114.3, 81.8, 67.9, 
67.7, 52.1, 49.7, 44.2, 43.6, 38.9, 37.2, 31.0, 29.9, 27.3, 26.4, 26.3, 25.9, 25.2, 23.3, 
18.2, 11.4, −4.3, −4.6; IR (film, cm-1) 3410, 2928, 2855, 1720, 1496, 1247, 1095, 834, 
773; TLC Rf = 0.43 (7:3 hexanes:EtOAc v/v). HRMS (EI+) m/z Calc’d for 
C32H48SiO5 540.3271, found 540.3268.  
 
Allylic-oxide Regio Resolution of Tyrosine 
In addition to the discussed use of (S,S)-L2, (R,R)-L2 was also tested and the 
results are shown below. Products are shown to be a single diastereomer unless 
otherwise noted. 
In a flame dried flask outfitted with a septum, racemic epoxide 2.1 (264.7 mg, 
1.71 mmol, 1.05 equiv.) was dissolved in 12.0 mL of toluene followed by the addition 
of Boc-L-Tyr-OMe 2.9 (482.5 mg, 1.63 mmol, 1.0 equiv.). The resulting solution was 
degassed with argon and cooled to −40 °C. In a separate flask, Pd2(dba)3  (12.4 mg, 
1.0 mol%) and (R,R)-L2  (34.2 mg, 3.0 mol%) of was dissolved in 1.0 mL of toluene. 
The resulting purple solution was degassed and stirred at room temperature until it 
became yellow (approx. 10 min.). The solution was then cooled to −40 °C and added 
to the epoxide solution via syringe. The reaction was allowed to stir for 72 hours 
before being worked up as in general procedure A. The reaction was purified by flash 
chromatography (7:3 hexanes:EtOAc v/v) to yield 664.3 mg of an inseparable mixture 
of 2.10 (45% yield, 4.37:1 diastereomeric ratio), 2.11 (36% yield as a single 
diastereomer) and 0.8 mg of recovered oxide (59:41 e.r.). Analytical standards of 2.10 
and 2.11 
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yields of 2.10 and 2.11 were determined by 1H NMR analysis of the homogenous 
mixture.  
Methyl (5S, 6R)-5-hydroxy-6-O-(Boc-L-Tyr-OMe)-cyclohex-1-enecarboxylate 
(2.10) 
Note: The following data are for the major diastereomer isolated (4.37:1). 
1H NMR (400 MHz, CDCl3) δ 7.16 (dd, J = 4.7, 3.0 Hz, 1H), 7.08 – 7.00 (m, 4H), 
5.23 (d, J = 3.7 Hz, 1H), 4.95 (br d, J = 8.1 Hz, 1H), 4.56 – 4.50 (m, 1H), 3.90 (dt, J = 
11.2, 3.8 Hz, 1H), 3.71 (s, 3H), 3.61 (s, 3H), 3.07 – 2.95 (m, 2H), 2.58 – 2.48 (m, 1H), 
2.38 – 2.25 (m, 1H), 2.04 – 1.84 (m, 2H), 1.42 (s, 9H); 13C NMR (100 MHz, CDCl3) δ 
172.5, 166.5, 158.8, 155.2, 144.1, 130.6, 130.4 129.3, 117.5, 80.1, 73.3, 69.5, 54.6, 
52.3, 51.8, 37.6, 28.4, 25.4, 23.5. Optical rotation, IR, and HRMS were not obtained 
due to mixture of diastereomers.  
Methyl (3R, 6S)-3-hydroxy-6-O-(Boc-L-Tyr-OMe)-cyclohex-1-enecarboxylate 
(2.11) 
[α] 020D
.  +36.4 (c 1.00, CHCl3); M.p. 38 – 42 °C; 1H NMR (400 MHz, CDCl3) δ 7.11 
(t, J = 1.6 Hz, 1H), 7.01 (d, J = 8.1 Hz, 2H), 6.94 – 6.88 (m, 2H), 5.07 (t, J = 2.8 Hz, 
1H), 5.01 (d, J = 8.3 Hz, 1H), 4.53 (dt, J = 8.7, 6.0 Hz, 1H), 4.36 – 4.26 (m, 1H), 3.72 
(s, 3H), 3.70 (s, 3H), 3.01 (tt, J = 14.1, 6.8 Hz, 2H), 2.17 – 2.09 (m, 1H), 2.00 – 1.92 
(m, 1H), 1.80 (tdd, J = 12.9, 10.3, 2.7 Hz, 1H), 1.57 (tt, J = 14.3, 3.2 Hz, 1H), 1.41 (s, 
9H); 13C NMR (100 MHz, CDCl3) δ 172.5, 166.3, 157.1, 155.2, 145.8, 130.5, 128.9, 
128.7, 117.0, 80.0, 68.2, 67.8, 54.6, 52.3*, 52.3*, 52.1*, 52.1*, 37.6, 28.4, 26.5, 25.3; 
IR (film, cm-1) 3370, 2951, 1718, 1508, 1255, 1167, 1031; TLC Rf = 0.17 (7:3 
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hexanes:EtOAc v/v). HRMS (EI+) m/z Calc’d for C23H31O8N 449.2049, found 
449.2056. * denotes presumed rotamers in a 1:1 ratio. 
 
In a flame-dried flask outfitted with a septum, racemic epoxide 2.1 (301.0 mg, 1.02 
mmol, 1.0 equiv.) was dissolved in 12.0 mL of toluene followed by the addition of 
Boc-L-Tyr-OMe 2.9 (562.1 mg, 1.0 mmol, 0.98 equiv.). The resulting solution was 
degassed with argon and cooled to −40 °C. In a separate flask, Pd2(dba)3 (14.5 mg, 1.0 
mol%) and (S,S)-L2 (39.3 mg, 3.0 mol%) was dissolved in 6.0 mL of toluene. The 
resulting purple solution was degassed and stirred at room temperature until it became 
yellow (approx. 10 min.). The solution was then cooled to −40 °C and added to the 
epoxide solution via syringe. The reaction was allowed to stir for 72 hours before 
being worked up as in general procedure A. The reaction was purified by flash 
chromatography (7:3 hexanes:EtOAc v/v) to yield 712.0 mg of an inseparable mixture 
of 2.12 and 2.13 and 43.4 mg of recovered oxide (53:47 e.r.). Analytical standards of 
2.12 and 2.13 were purified by preparatory HPLC (90:10 to 1:99 water:acetonitrile 
v/v) and yields of 2.12 (51% yield, 4.20 d.r. as determined by 1H NMR) and 2.13 
(40% yield as a single diastereomer) were determined by 1H NMR analysis of the 
homogenous mixture.  
Methyl (5R, 6S)-5-hydroxy-6-O-(Boc-L-Tyr-OMe)-cyclohex-1-enecarboxylate 
(2.12) 
Note: The following data are for the major diastereomer isolated (4.20:1). 
1H NMR (400 MHz, CDCl3) δ 7.15 (dd, J = 4.7, 3.0 Hz, 1H), 7.08 – 6.99 (m, 4H), 
5.22 (d, J = 3.6 Hz, 1H), 5.00 – 4.96 (m, 1H), 4.55 – 4.50 (m, 1H), 3.89 (dt, J = 11.4, 
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3.7 Hz, 1H), 3.70 (s, 3H), 3.60 (s, 3H), 3.06 – 2.96 (m, 2H), 2.57 – 2.48 (m, 1H), 2.36 
– 2.27 (m, 1H), 2.02 – 1.93 (m, 1H), 1.89 – 1.80 (m, 1H), 1.41 (s, 9H); 13C NMR (100 
MHz, CDCl3) δ 172.5, 166.5, 158.8, 155.2, 144.1, 130.6, 130.4, 129.2, 117.5, 80.0, 
73.3, 69.5, 54.6, 52.3, 51.8, 37.5, 28.4, 25.3, 25.3. Optical rotation, IR, and HRMS 
were not obtained due to mixture of diastereomers.  
Methyl (3S, 6R)-3-hydroxy-6-O-(Boc-L-Tyr-OMe)-cyclohex-1-enecarboxylate 
(2.13) 
[α] 020D
.  +10.2 (c 0.50, CHCl3); 1H NMR (400 MHz, CDCl3) δ 7.11 (t, J = 1.7 Hz, 1H), 
7.03 – 6.99 (m, 2H), 6.95 – 6.90 (m, 2H), 5.10 (t, J = 2.9 Hz, 1H), 4.96 (d, J = 8.3 Hz, 
1H), 4.54 (q, J = 6.7 Hz, 1H), 4.40 – 4.27 (m, 1H), 3.75 (s, 3H), 3.72 (s, 3H), 3.02 (qd, 
J = 14.0, 5.9 Hz, 2H), 2.19 – 2.13 (m, 1H), 2.04 – 1.96 (m, 1H), 1.87 – 1.73 (m, 1H), 
1.59 (tt, J = 14.2, 3.2 Hz, 1H), 1.42 (s, 9H); 13C NMR (100 MHz, CDCl3) δ 172.5, 
166.3, 157.1, 155.2, 146.1, 130.4, 130.2, 128.9, 117.0, 80.0, 68.2, 67.8, 54.6, 52.3*, 
52.3*, 52.2*, 52.1*, 37.4, 28.4, 26.2, 25.2; IR (film, cm-1) 3369, 2951, 1718, 1508, 
1256, 1167, 1031; TLC Rf = 0.17 (7:3 hexanes:EtOAc v/v). HRMS (EI+) m/z Calc’d 
for C23H31O8N 449.2049, found 449.2042. * denotes presumed rotamers in a 1:1 ratio.  
 
Allylic-oxide Regio Resolution of Griseofulvin 
4-des-methyl-griseofulvin 2.14 was prepared by the demethylation of griseofulvin 
following a literature procedure.14 In addition to the discussed use of (S,S)-DPEN-
ligand L2, (R,R)-DPEN-ligand L2 was also tested and the results are shown below. 
Products are shown to be a single diastereomer unless otherwise noted. 
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In flame-dried flask outfitted with a septum, racemic epoxide 2.1 (81.2 mg, 0.527 
mmol, 1.8 equiv.) was dissolved in 1.3 mL of toluene followed by the addition of 4-
des-methyl-griseofulvin 2.14 (99.5 mg, 0.294 mmol, 1.0 equiv.). The resulting 
solution was thoroughly degassed with argon and cooled to −40 °C. In a separate 
flask, Pd2(dba)3 (17.1 mg, 5.0 mol%) and (R,R)-L2 (39.9  mg, 15.0 mol%) was 
dissolved in 0.6 mL of toluene. The resulting purple solution was degassed and stirred 
at room temperature until it became yellow (approx. 10 min.). The solution was then 
cooled to −40 °C and added to the epoxide solution via syringe. The reaction was 
continued at −40 °C and monitored by 1H NMR spectroscopy until total consumption 
of the starting phenol was observed (approx. 18 hours). The reaction was then 
concentrated to dryness and was purified by flash chromatography (100% DCM, then 
95:5 DCM:MeOH v/v) using Florisil as the stationary phase to yield 132.4 mg of a 
mixture containing 2.15 (60% yield), 2.16 (31% yield), and 9.0 mg of recovered 
phenol 2.14 (9%). Degradation of the products on Florisil is suspected to regenerate 
griseofulvin 2.14. Similar degradation, but to a much greater extent, was observed 
when using silica as the stationary phase.   Analytical standards of 2.15 and 2.16 could 
be separated from one another and purified by a silica column (5:1 toluene/acetone 
v/v) then preparatory HPLC (80:20 to 35:65 water:acetonitrile v/v over 35 minutes) to 
remove 2.14. Both products were isolated as white solids. 
Methyl (5R, 6S)-5-hydroxy-6-O-(4-des-methyl-griseofulvin)-cyclohex-1-
enecarboxylate (2.15) 
[α] 020D
.  +366.6 (c 1.00, CHCl3); M.p. 90 – 92 °C; 1H NMR (CDCl3, 400 MHz) δ 7.30 
(dd, J = 4.9, 2.7 Hz, 1H), 7.18 (s, 1H), 5.55 (s, 1H), 5.24 (d, J = 3.4 Hz, 1H), 4.05 (s, 
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3H), 3.79 (dt, J = 12.0, 3.8 Hz, 1H), 3.75 (s, 3H), 3.63 (s, 3H), 2.93 (dd, J = 16.2, 13.3 
Hz, 1H), 2.82 (ddd, J = 13.4, 6.7, 4.3 Hz, 1H), 2.59 (dt, J = 20.4, 5.3 Hz, 1H), 2.48 – 
2.30 (m, 2H), 2.24 – 2.09 (m, 1H), 2.00 – 1.89 (m, 1H), 0.95 (d, J = 6.6 Hz, 3H); 13C 
NMR (CDCl3, 100 MHz) δ 196.8, 194.1, 170.8, 169.0, 166.7, 165.2, 158.6, 146.8, 
127.9, 106.8, 105.1, 98.4, 97.1, 91.1, 77.3, 69.3, 57.4, 56.8, 52.2, 40.2, 36.6, 25.8, 
24.6, 14.4; IR (film, cm-1) 3457, 2949, 1709, 1611, 1584, 1224, 1210, 753; TLC Rf = 
0.28 (1:4 acetone:toluene v/v); HRMS (DART) m/z Calc’d for C24H26ClO9 (M+H)+: 
493.1260, found 493.1269.  
Methyl (3S, 6R)-3-hydroxy-6-O-(4-des-methyl-griseofulvin)-cyclohex-1-
enecarboxylate (2.16) 
[α] 020D
.  +298.9 (c 1.00, CHCl3); M.p. 126 – 128 °C; 1H NMR (CDCl3, 400 MHz) δ 
7.18 (d, J = 1.3 Hz, 1H), 6.55 (s, 1H), 5.52 (s, 1H), 5.35 (br s, 1H), 4.33 (ddd, J = 9.2, 
6.2, 2.0 Hz, 1H), 4.02 (s, 3H), 3.71 (s, 3H), 3.63 (s, 3H), 2.95 (dd, J = 16.5, 13.4 Hz, 
1H), 2.88 – 2.73 (m, 1H), 2.60 (br s, 1H),  2.39 (dd, J = 16.6, 4.6 Hz, 1H), 2.18 – 1.92 
(m, 3H), 1.71 (tt, J = 13.7, 3.5 Hz, 1H), 0.91 (d, J = 6.6 Hz, 3H); 13C NMR (CDCl3, 
100 MHz) δ 197.0, 192.2, 171.0, 169.3, 166.2, 164.6, 156.7, 147.6, 128.9, 106.5, 
104.9, 97.8, 93.9, 90.7, 70.8, 67.4, 57.2, 56.8, 52.1, 40.0, 36.7, 27.0, 26.4, 14.3; IR 
(film, cm-1) 3399, 2950, 1711, 1611, 1585, 1357, 1224, 751; TLC Rf = 0.17 (1:4 
acetone:toluene v/v); HRMS (DART) m/z Calc’d for C24H26ClO9 (M+H)+: 493.1260, 
found 493.1268.  
 
In a flame dried flask outfitted with a septum, racemic epoxide 2.1 (81.2 mg, 
0.527 mmol, 1.8 equiv.) was dissolved in 1.3 mL of toluene followed by the addition 
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of 4-des-methyl-griseofulvin 2.14 (99.5 mg, 0.294 mmol, 1.0 equiv.). The resulting 
solution was thoroughly degassed with argon and cooled to −40 °C. In a separate 
flask, Pd2(dba)3 (16.7 mg, 5.0 mol%) of and (S,S)-L2 (38.9  mg, 15.0 mol%) was 
dissolved in 0.6 mL of toluene. The resulting purple solution was degassed and stirred 
at room temperature until it became yellow (approx. 10 min.). The solution was then 
cooled to −40 °C and added to the epoxide solution via syringe. The reaction was 
continued at −40 °C and monitored by 1H NMR spectroscopy until total consumption 
of the starting phenol was observed (approx. 18 hours). The reaction was then 
concentrated to dryness and purified by flash chromatography (100% DCM, then 95:5 
DCM:MeOH v/v) using Florisil as the stationary phase to yield 132.4 mg of a mixture 
containing 2.17 (54% yield), 2.18 (25% yield), and 6.2 mg of recovered phenol 2.14 
(6%). Degradation of the products on Florisil is suspected to regenerate griseofulvin 
2.14. Similar degradation, but to a much greater extent, was observed when using 
silica as the stationary phase. Analytical standards of 2.17 and 2.18 could be separated 
from one another and purified by a silica column (5:1 toluene/acetone v/v) then 
preparatory HPLC (80:20 to 35:65 water:acetonitrile v/v over 35 minutes) to remove 
17. Both products were isolated as white solids. 
Methyl (5S, 6R)-5-hydroxy-6-O-(4-des-methyl-griseofulvin)-cyclohex-1-
enecarboxylate (2.17) 
[α] 020D
.  +61.0 (c 1.00, CHCl3); M.p. 196 – 198 °C; 1H NMR (CDCl3, 300 MHz) δ 
7.32 – 7.27 (m, 1H), 7.20 (s, 1H), 5.53 (s, 1H), 5.23 (d, J = 3.8 Hz, 1H), 4.05 (s, 3H), 
3.81 (dt, J = 11.7, 3.9 Hz, 1H), 3.74 (s, 3H), 3.60 (s, 3H), 3.05 (dd, J = 16.5, 13.5 Hz, 
1H), 2.91 – 2.81 (m, 1H), 2.64 – 2.52 (m, 1H), 2.50 – 2.28 (m, 2H), 2.23 – 2.09 (m, 
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1H), 2.04 – 1.91 (m, 1H), 0.94 (d, J = 6.5 Hz, 3H); 13C NMR (CDCl3, 100 MHz) δ 
196.9, 194.7, 170.6, 169.1, 166.7, 165.3, 158.7, 146.8, 127.9, 107.2, 104.9, 98.6, 97.8, 
90.8, 77.7, 69.2, 57.4, 56.8, 52.2, 40.2, 36.5, 25.8, 24.6, 14.3; IR (film, cm-1) 3468, 
2949, 1709, 1611, 1224, 1046, 753; TLC Rf = 0.26 (1:4 acetone:toluene v/v); HRMS 
(DART) m/z Calc’d for C24H26ClO9 (M+H)+: 493.1260, found 493.1268.  
Methyl (3R, 6S)-3-hydroxy-6-O-(4-des-methyl-griseofulvin)-cyclohex-1-
enecarboxylate (2.18) 
[α] 020D
.  +96.9 (c 1.00, CHCl3); M.p. 102 – 104 °C; 1H NMR (CDCl3, 400 MHz) δ 
7.15 (dd, J = 2.4, 1.2 Hz, 1H), 6.53 (s, 1H), 5.51 (s, 1H), 5.34 (d, J = 3.2 Hz, 1H), 4.33 
(ddd, J = 10.3, 6.2, 2.6 Hz, 1H), 4.01 (s, 3H), 3.70 (s, 3H), 3.60 (s, 3H), 3.04 – 2.93 
(m, 1H), 2.87 – 2.78 (m, 1H), 2.47 – 2.35 (m, 2H), 2.20 – 1.94 (m, 2H), 1.73 (tt, J = 
13.9, 3.6 Hz, 1H), 0.94 (d, J = 6.7 Hz, 3H); 13C NMR (CDCl3, 100 MHz) δ 197.0, 
192.2, 171.0, 169.3, 166.2, 164.5, 156.6, 147.5, 129.0, 106.7, 104.8, 97.8, 94.1, 90.6, 
70.9, 67.5, 57.2, 56.7, 52.2, 40.1, 36.5, 27.0, 26.4, 14.4; IR (film, cm-1) 3400, 2940, 
1712, 1612, 1357, 1177, 750; TLC Rf = 0.17 (1:4 acetone:toluene v/v); HRMS 
(DART) m/z Calc’d for C24H26ClO9 (M+H)+: 493.1260, found 493.1272.  
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Predicted and Observed Enantiomeric Ratios  
From the results shown (Scheme 2.6a), a model was developed. The absolute 
stereochemistry of the 1,2-addition product derived from the conditions in Table 2.1 
was determined by comparison. Acylation and deprotection yielded (5R-6S)-Methyl-
5,6-dihydroxycyclohex-1-ene carboxylate (2.43), a known compound (Scheme 2.6b). 
Combined with the data in Table 2.1 (entry 5), the 1,2-product must be derived from 
the (+) enantiomer of (±)-2.1. This allows for a table of selectivity to be created 
(Scheme 2.6c).   Thus given a stock of (+)-2.1 with a known enantiomeric ratio, both 
the resulting enantiomeric ratios of 2.2b and 2.3b, as well as the ratio of 2.2b:2.3b can 
be estimated. A solution of (+)-2.1 in 92:8 e.r. can react in two ways with the 
palladium complex. The 92% portion (+)-2.1 will react, according to the model, when 
(S,S)-L2 is utilized, to favor 1,2-addition in a 96:4 enantiomeric ratio. Thus, the 92% 
portion (+)-2.1 will react to form 88.32% (R)-2.2b, and 3.68% of (S)-2.3b. The 8% of 
the stock of (–)-2.1 will react, favoring the 1,4-addition, to form 0.56% and 7.44% of 
(S)-2.2b and (R)-2.3b (derived from the enantiomeric ratio of 2.3b with (±)-2.1). 
Combining these numbers for both 2.2b and 2.3b provides the predicted enantiomeric 
ratio. Additionally, the ratio of 2.2b:2.3b can be predicted. The result shows excellent 
agreement between predicted and observed data (Table 2.1, entry 5). The calculations 
can be repeated employing a stock of 90:10 (−)-2.1. Excellent agreement is observed 
in the predicted verses observed e.r. of 2.3b and in the ratio of 2.2b and 2.3b . The 
increased enantiomeric ratio of observed 2.2b does between not agree with the 
predicted to the same extent as seen before; we are unable to at this time explain this 
increase in enantiomeric ratio. 
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Table 2.4. Observed versus Predicted Enantiomeric Ratios for AORR. 
 92:8 e.r. (+)-2.1 Epoxide 10:90 e.r. (−)-2.1 Epoxide 
 2.2b e.r. 2.3b e.r. Ratio 2.2b:2.3b 2.2b e.r. 2.3b e.r. 
Ratio 
2.2b:2.3b 
Predicted 99:1 33:67 8.0:1.0 60:40 1:99 1.0:5.40 
Observed 98:2 32:68 8.5:1.0 76:24 4:96 1.0:4.6 
 
Two aspects of note are:  First, (±)-2.1 reacts under normal conditions to yield a 1:1.14 
ratio of 2.2b:2.3b; these calculations do not take this into account and assume the ratio 
to be that of 1:1. Second, the model does not take into account the epoxide 
degradation. Results from each enantiomeric run (Table 2.1, entry 5 and 6), show 
substantial recovery of isolated 2.1. Thus from this only the predicted ratio of 
2.2b:2.3b can be determined. Work is ongoing to understand the increased 
degradation when employing enantiopure epoxides.  
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Scheme 2.6. Allylic oxide regio-resolution predictive model.
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 (5R-6S)-Methyl-5,6-dihydroxycyclohex-1-ene carboxylate (2.43) 
 To a solution of 2.2b (129.0 mg, 0.464 mmol, 1.0 equiv, 78:22 e.r.) in 
dichloromethane (4.5 mL) was added DMAP (5.0 mg, 0.041 mmol, 0.09 equiv), 
imidazole (63.1 mg, 0.464 mmol, 1.0 equiv), and TBSCl (140.0 mg, 0.183 mmol, 1.0 
equiv). Upon completion, the reaction was concentrated in vacuo and purified via 
flash chromatography (2:1 hexanes/EtOAc, v/v) to yield 167.6 mg (43% yield). 1H 
NMR (300 MHz, CDCl3) δ 7.14 (m, 1H), 7.10 (m, 2H), 6.60 (m, 2H), 5.03 (d, J = 2.9 
Hz, 1H), 3.81 (dt, J = 11.9, 3.5 Hz, 1H), 3.75 (m, 1H), 3.75 (s, 3H), 3.73 (s, 3H), 2.51 
(m, 1H), 2.3 (m, 1H), 2.18 (m, 1H), 1.68 (m, 1H), 0.71 (s, 9H), −0.01 (s, 3H), −0.14 
(s, 3H). 
The protected alcohol above (167.6 mg, 0.427 mmol, 1.0 equiv) was 
suspended in 1.0 mL MeCN and 1.0 mL H2O. The reaction was cooled to 0 °C and 
ceric ammonium nitrate (538.4 mg, 0.982 mmol, 2.3 equiv) was added in one portion. 
The reaction was stirred at 0 °C for 5 minutes and then passed through a plug of silica 
(eluting with EtOAc) and concentrated. The residue was purified by flash 
chromatography (1:1 hexanes/EtOAc, v/v) to yield 40.0 mg of product (33 % yield). 
1H NMR (400 MHz, CDCl3) δ 7.11 (dd, J = 4.8, 2.9 Hz, 1H), 4.45 (d, J = 4.1 Hz, 1H), 
3.78 (s, 3H), 7.76 (m, 1H) 2.81 (d, J = 1.6 Hz, 1H), 2.41 (dtd, J = 20.1, 5.4, 2.2 Hz, 
1H), 2.30 – 2.11 (m, 1H), 1.97 – 1.77 (m, 1H), 1.62 (m, 1H), 0.92 (s, 9H), 0.11 (s, 
6H). 
To the alcohol above (40.0 mg, 0.140 mmol, 1.0 equiv) in THF (1.0 mL), was 
added TBAF (14.0 µL, 0.14 mmol, 1.0 equiv, 1M in THF) at 0 °C. The reaction was 
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warmed to 23 °C and stirred. Upon completion, the reaction was concentrated and 
purified by flash chromatography (1:1 hexanes/EtOAc, v/v) to yield 11.0 mg (45% 
yield) of 2.43 as a colorless oil and compared to authentic spectra of the known 
compound.32 
 
Methyl (5S, 6R)-5,6-dihydroxycyclohex-1-ene carboxylate (2.43) 
[α] 020D
.  −48.0 (c 1.00, CHCl3, 78:22 e.r.); 1H NMR (400 MHz, CDCl3) δ 7.09 (t, J = 
3.9 Hz, 1H), 4.53 (bs, 1H), 3.84 (m, 1H), 3.53 (d, J = 3.0 Hz, 1H), 2.43 (m, 1H), 2.21 
(m, 1H), 1.85 (m, 1H), 1.70 (m, 1H); 13C NMR (75 MHz, CDCl3) δ 167.34, 143.34, 
129.90, 67.72, 65.37, 51.81, 24.79, 23.95; TLC Rf = 0.10 (1:1 hexanes/EtOAc v/v). 
Literature (Org. Biomol. Chem. 2009, 7, 2619 – 2627)32: [α] 020D
.  −52.9 (c 2.9, >99:1 
e.r.); 1H NMR (300 MHz, CDCl3) δ 7.02 (dd, J = 4.4, 3.3 Hz, 1H), 4.46 (d, J = 3.1 
Hz, 1H), 4.05 (s, 1H), 3.70 (m, 4H), 3.52 (s, OH), 2.42-2.30 (m, 1H), 2.21 – 2.09 (m, 
1H), 1.18 – 1.61 (m, 1H); 13C NMR (75 MHz, CDCl3) δ 167.2, 143.3, 130.4, 68.5, 
64.8, 51.8, 24.7, 24.2; TLC: Rf = 0.29 (1:1 hexanes/EtOAc v/v). 
 
Scheme 2.7. Synthesis of dioxolane epoxide (2.19). 
!
2.44 was prepared according to modified literature procedures.33   
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 A flame dried round bottom flask was charged with methyl acrylate (70.0 mL) 
and cooled to −20 °C. AlCl3 (3.5 g) was then added portionwise followed by the 
dropwise addition of furan (60 mL). Once the addition was complete (0.5 h), the 
reaction was warmed to 23 °C and stirred for 5 h. Water (20 mL) was added and the 
layers separated and the organic layer was concentrated. The red oil was diluted with 
DCM, dried over Na2SO4 and concentrated to yield a red oil, which was used without 
further purification. 
 The red oil (57.0 g) from above was dissolved in 1.5 L of acetone and 140.0 
mL of water. NMO (112.6 g total weight of solution, 50% in water) was added 
followed by the addition of OsO4 (12.0 mL, 185 mmol, 0.5mol%, 0.15 M in DCM). 
The reaction was stirred for 48 hours or until starting material disappeared. Sodium 
sulfite (20.0 g) was then added to the reaction and stirred for 0.5 h before the solvent 
was removed under reduced pressure. The resulting oil was dissolved in a minimal 
amount (ca. 15 mL) of EtOAc and cooled to 0 °C.  The precipitate was collected and 
washed with Et2O. This procedure was repeated to yield 40.0 g of diol whose spectra 
agreed with known data.33 
Methyl (3aS,4S,7R,7aR)-hexahydro-4,7-epoxybenzo[d][1,3]dioxole-5-carboxylate 
(2.45) 
The diol above (7.0 g, 37.5 mmol) was dissolved in a solution of CH2(OMe)2 (60.0 
mL) and DCM (65.0 mL)  and was cooled to 0 °C. BF3·OEt2 (18.0 mL, 0.106 mol, 3 
equiv) in DCM (65.0 mL) was added dropwise via an addition funnel over 0.5 h. The 
reaction was then stirred for 0.5 h at 0 °C and then diluted with water (20.0 mL). The 
organic layer was dried with Na2SO4 and concentrated under reduced pressure to yield 
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a black oil which was purified by flash chromatography (1:1 EtOAc/hexanes, v/v) to 
yield 6.67 g (33.1 mmol, 88% yield) as a mixture of endo and exo isomers of 2.43 (the 
isomers can be separated using flash chromatography [2:1 hexanes/EtOAc, v/v]). 
 
Endo (major) Isomer: 1H NMR (300 MHz, CDCl3) δ 5.06 (d, J = 1.0 Hz, 1H), 4.77 (d, 
J = 1.0 Hz, 1H), 4.64 (d, J = 6.0 Hz, 1H), 4.55 (d, J = 6.0 Hz, 1H), 4.22 (s, 2H), 3.69 
(s, 3H), 2.95 (dt, J = 11.3, 5.5 Hz, 1H), 1.90 (dddd, J = 12.6, 11.4, 6.0, 1.1 Hz, 1H), 
1.72 (ddd, J = 13.1, 5.2, 1.1 Hz, 1H); 13C NMR (75 MHz, CDCl3) δ 171.9, 97.0, 81.9, 
81.0, 80.2, 79.4, 52.3, 43.3, 27.6; IR (film, cm-1) 2955, 1729, 1200, 1048; TLC Rf = 
0.80 (2:1 EtOAc/hexanes, v/v); HRMS (DART)  m/z calc for C9H12O5 (M+H)+: 
201.0757, found 201.0752. 
Methyl (3aS,7R,7aR)-7-hydroxy-3a,6,7,7a-tetrahydrobenzo[d][1,3]dioxole-5-
carboxylate (2.46) 
A solution of HMDS (8.5 mL, 39.0 mmol, 1.2 equiv) in dry THF (150.0 mL) was 
cooled to −78 °C and n-BuLi (23.3 mL, 37.3 mmol, 1.1eq, 1.6M in hexanes) was 
added slowly. The reaction was stirred for 20 minutes at −78 °C before 2.45 (6.70 g, 
33.9 mmol) in THF (50.0 mL) was added via cannula in one portion. After stirring for 
20 minutes the flask was allowed to warm to 0 °C, quenched with water (10.0 mL), 
and extracted with EtOAc (2 x 20.0 mL). Drying over Na2SO4, concentration in vacuo 
and flash chromatography (1:1 hexanes/EtOAc, v/v) yielded an amber oil (6.2 g, 31 
mmol, 91%).  
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1H NMR (500 MHz, CDCl3) δ 6.71 (s, 1H), 4.96 (s, 1H), 4.95 (s, 1H), 4.72 (bs, 1H), 
4.22 (dd, J = 6.2, 2.7 Hz, 1H), 3.93 (m, 1H), 3.73 (s, 3H), 2.72 (d, J = 6.2 Hz, 1H), 
2.61 (dd, J = 16.9, 5.0 Hz, 1H), 2.41 (dd, J = 16.9, 9.2 Hz, 1H); 13C NMR (126 MHz, 
CDCl3) δ 166.5, 132.9, 131.3, 95.0, 75.6, 72.7, 67.1, 52.2, 27.9;  IR (film, cm-1) 3452, 
2952, 1713, 1436, 1241, 1049, 728; TLC Rf = 0.45 (1:1 hexanes/EtOAc, v/v); HRMS 
(DART)  m/z  calc for C9H12O5 (M+H)+: 201.0757, found 201.0753.  
Methyl (3aS,7R,7aS)-7-(((trifluoromethyl)sulfonyl)oxy)-3a,6,7,7a-
tetrahydrobenzo[d][1,3]dioxole-5-carboxylate (2.47) 
2.46 (9.553g, 47.7 mmol) was dissolved in DCM (230.0 mL) and cooled to 0 °C. 
Pyridine (7.60 mL, 95.5 mmol, 2 equiv) was added followed by the dropwise addition 
of Tf2O (9.60 mL, 57.3 mmol, 1.1 equiv) in DCM (25.0 mL). The reaction was stirred 
at 0 °C for 20 minutes and then rapidly washed with 1M HCl (2 x 10 mL), dried over 
Na2SO4 and concentrated. Purification via flash chromatography (1:1 hexanes/EtOAc, 
v/v) yields unstable triflate (12.4 g, 38.5 mmol, 80% yield) as a pale oil. 
 
 1H NMR (500 MHz, CDCl3) δ 6.84 (m, 1H), 5.16 (ddd, J = 8.2, 5.0, 2.6 Hz, 1H), 5.06 
(s, 1H), 5.05 (s, 1H), 4.84 (m, 1H), 4.39 (dd, J = 5.7, 2.3 Hz, 1H), 3.80 (s, 3H), 2.91 
(ddt, J = 17.0, 8.7, 2.2 Hz, 1H), 2.82 (dd, J = 17.1, 5.1 Hz, 1H). 13C NMR (126 MHz, 
CDCl3) δ 165.5, 133.0, 129.6, 122.4, 119.8, 117.3, 114.8, 95.9, 82.8, 73.1, 72.9, 52.7, 
25.9; IR (film, cm-1) 2957, 1719, 1657, 1409, 1268, 1141, 913; TLC Rf = 0.75 (1:1 
hexanes/EtOAc, v/v); HRMS (DART)  m/z calc for C10H11F3O7S: 333.0150 (M+H)+, 
found 333.0241. 
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Methyl (3aS,7aR)-3a,7a-dihydrobenzo[d][1,3]dioxole-5-carboxylate (2.48) 
Triflate, 2.47 (2.80 g, 8.6 mmol) was dissolved in DMF (40.0 mL) and anhydrous 
CsOAc (1.73 g, 10.1 mmol, 1.05 equiv) was added in one portion. The reaction was 
stirred for 1.75 h. Saturated NaHCO3 (50.0 mL) was added carefully and the organic 
layer was extracted with Et2O (2 x 50.0 mL) and washed (2 x 100.0 mL) with brine. 
Drying over Na2SO4 and concentration under reduced pressure yields unstable diene 
2.48 as white needles, which were sufficiently pure for the next step. Analytical 
samples were purified by flash chromatography (5:1 Et2O/pentane, v/v) to yield a 
white powder. 
 
M.p. 55 – 57 °C; 1H NMR (300 MHz, CDCl3) δ 6.85 (d, J = 3.8 Hz, 1H), 6.55 (d, J = 
10.0 Hz, 1H), 6.03 (dd, J = 10.0, 3.9 Hz, 1H), 4.78 (s, 1H), 4.77 (s, 1H), 4.72 (dd, J = 
9.3, 3.8 Hz, 1H), 4.55 (dd, J = 9.3, 4.4 Hz, 1H), 3.87 (s, 3H); 13C NMR (126 MHz, 
CDCl3) δ 165.6, 132.0, 127.7, 124.6, 122.9, 91.0, 69.9, 69.6, 52.2; IR (film, cm-1) 
2851, 1717, 1441, 1250, 1089; HRMS (DART)  m/z calc for C9H10O4: 183.0652 
(M+H)+, found 183.0649.  
Methyl (3aS,5aS,6aS,6bS)-3a,5a,6a,6b-tetrahydrooxireno[2',3':3,4]benzo[1,2-
d][1,3]dioxole-5-carboxylate (2.19) & Methyl (3aR,5aR,6aS,6bR)-6a,6b-
dihydrooxireno[2',3':3,4]benzo[1,2-d][1,3]dioxole-5a(3aH)-carboxylate (2.49) 
To a flame dried round bottom flask was added crude diene 2.48 (2.5 g, 13.7 mmol) in 
DCM (60.0 mL). m-CPBA (3.50 g, 15.1 mmol, 1.1 equiv, 75%) in DCM (40.0 mL) 
was then added dropwise and the reaction heated to 40 °C for 18 h. The reaction was 
cooled and washed with saturated sodium thiosulfate (30.0 mL) and saturated sodium 
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bicarbonate (2 x 30.0 mL), dried over Na2SO4 and concentrated.  The oil obtained was 
purified by flash chromatography (9:1 hexanes/EtOAc, v/v) to yield 1.30 g (6.54 
mmol, 24% yield) of a 2:1 ratio of inseparable epoxides.  
Based on analysis of the 1H NMR spectrum and literature precedence, the 1H NMR for 
both 2.49 and 2.19 can be determined, the 13C NMR however is a mixture of the two 
compounds and is consistent with literature2,3: 1H NMR (2.49) (500 MHz, CDCl3) δ 6. 
76 (bs, 1H), 4.96 (s, 1H), 4.90z (m, 1H), 4.60 (m, 2H), 3.94 (dd, J = 3.9, 1.7 Hz, 1H), 
3.80 (s, 3H), 3.67 (dd, J = 3.7, 1.5 Hz, 1H); 1H NMR (2.19) (500 MHz, CDCl3) δ 6.51 
(dd, J = 10.6, 1.6 Hz, 1H), 5.80 (dd, J = 10.5, 2.6 Hz, 1H), 4.96 (s, 1H), 4.86 (s, 1H), 
4.60 (m, 1H), 4.52  (m, 1H), 3.89 (d, J = 1.8 Hz, 1H), 3.78 (s, 3H); 13C NMR (2.49 & 
2.19) (75 MHz, CDCl3) δ 168.7, 165.2, 137.7, 129.7, 129.4, 124.4, 95.3, 94.7, 70.4, 
70.4, 70.1, 69.9, 55.0, 53.1, 52.4, 51.6, 49.3, 45.9; TLC Rf = 0.40 (4:1 
hexanes/EtOAc, v/v). 
 
Allylic Oxide Regio Resolution of (±)-2.19  
 
328.7 mg (1.65 mmol, 1.0 equiv) of a mixture containing racemic epoxide 2.19 and 
2.49 (2:1 by 1H NMR respectively) was dissolved in 5.5 mL of toluene in a flame-
dried round bottom flask outfitted with a septum followed by the addition of 253.7 mg 
(2.04 mmol, 1.2 equiv) of p-methoxyphenol. The resulting solution was thoroughly 
degassed with argon. In a separate round bottom flask, 77.0 mg (5 mol%) of Pd2(dba)3 
and 198.3 mg (15 mol%) of DPEN-ligand L2 was dissolved in toluene (2.8 mL). The 
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purple solution was degassed and stirred at room temperature until it became yellow 
(approx. 10 min.) and then added to the epoxide solution via syringe. The reaction was 
allowed to stir for 18 hours before an additional 61.1 mg (4 mol%) Pd2(dba)3 and 
158.0 mg (12 mol%) of DPEN-ligand L2 in 4.0 mL of toluene was added. The 
reaction was stirred for an additional 12 hours at room temperature before being 
concentrated. The crude oil was then purified by column chromatography (4:4:1 
DCM/hexanes/EtOAc) to give 56.2 mg of 1,4-product 2.31 (16% yield, 90:10 er) and 
139.5 mg (39% yield) of a mixture of 1,2-products 2.30 and 2.32 as a pale yellow oil. 
1H NMR spectroscopy analysis determined the ratio of products to be 14% 2.30 (90:10 
er) and 25% 2.32 (92:8 er). The 1,2-products were separated by column 
chromatography (95:5 DCM/ether) to give pure anti-1,2 product 2.30 and syn-1,2 
product 2.32 as pale yellow oils. Anti-1,4 product 2.33 was observed by 1H NMR 
spectrum in 1-2%, but could not be isolated. 
 Additional regio resolutions were attempted and provided the following data: 
1) 2.30 was obtained in 16% yield (94:6 er), 2.31 in 8% yield (89:11 er), and 2.32 in 
24% yield (90:10 er); 2) 2.30 was obtained in 10% yield (96:4 er), 2.31 in 12% yield 
(84:16 er), and 2.32 in 23% yield (90:10 er). 
Methyl (3aR,6S,7R,7aS)-7-hydroxy-6-(4-methoxyphenoxy)-3a,6,7,7a-
tetrahydrobenzo[d][1,3]dioxole-5-carboxylate (2.30) 
 [α] 020D
.  +11.8 (c 0.50, CHCl3); 1H NMR (300 MHz, CDCl3) δ 7.10 – 7.03 (m, 2H), 
6.91 (d, J = 3.8 Hz, 1H), 6.88 – 6.80 (m, 2H), 5.13 (s, 1H), 5.07 (s, 1H), 4.97 (d, J = 
4.3 Hz, 1H), 4.80 (dd, J = 6.4, 3.8 Hz, 1H), 4.34 (dd, J = 4.8, 4.7 Hz, 1H), 4.27 (dd, J 
= 6.3, 5.2 Hz, 1H), 3.78 (s, 3H), 3.76 (s, 3H); 13C NMR (100 MHz, CDCl3) δ 166.0, 
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155.0, 152.6, 134.2, 132.5, 119.1, 114.7, 94.8, 75.1, 75.0, 70.8, 68.0, 55.8, 52.3; IR 
(film, cm-1) 3465, 2954, 1719, 1505, 1246, 1214, 104, 1033; TLC Rf = 0.28 (9:1 
DCM/Ether v/v); HPLC 94:6 e.r., Chiral HPLC eluting at 1.00 mL/min with 90% 
hexanes/isopropanol. Retention times: RT= 15.6 min, 21.9 min; HRMS (ESI) m/z 
Calc’d for C16H18O7Na (M+Na)+ 345.09447, found 345.0933.  
Methyl (3aR,4S,7R,7aS)-7-hydroxy-4-(4-methoxyphenoxy)-3a,4,7,7a-
tetrahydrobenzo[d][1,3]dioxole-5-carboxylate (2.31) 
 [α] 020D
.  +44.5 (c 0.50, CHCl3); 1H NMR (400 MHz, CDCl3) δ 7.51 (d, J = 6.4 Hz, 
1H), 7.05 – 6.97 (m, 2H), 6.88 – 6.80 (m, 2H), 5.38 (d, J = 1.9 Hz, 1H), 4.96 (s, 1H), 
4.67 (s, 1H), 4.65 (dd, J = 6.9, 2.2 Hz, 1H), 4.55 (d, J = 7.0 Hz, 1H), 4.51 – 4.44 (m, 
1H), 3.80 (s, 3H), 3.78 (s, 3H); 13C NMR (100 MHz, CDCl3) δ 165.7, 155.5, 150.5, 
143.7, 132.7, 118.5, 114.9, 94.2, 77.2, 74.7, 64.8, 55.7, 52.4; IR (film, cm-1) 3490, 
2948, 1719, 1505, 1246, 1211, 1089, 1032; TLC Rf = 0.27 (7:3 hexanes/EtOAc v/v); 
HPLC 89:11 e.r., Chiral HPLC eluting at 1.00 mL/min with 90% 
hexanes/isopropanol. Retention times: RT= 21.4 min, 26.5 min; HRMS (ESI) m/z 
Calc’d for C16H18O7Na (M+Na)+: 345.09447, found 345.09420.  
Methyl (3aS,6S,7S,7aR)-7-hydroxy-6-(4-methoxyphenoxy)-3a,6,7,7a-
tetrahydrobenzo[d][1,3]dioxole-5-carboxylate (2.32) 
 [α] 020D
.  +96.6 (c 1.00, CHCl3); 1H NMR (300 MHz, CDCl3 δ 7.05 – 6.99 (m, 3H), 
6.84 – 6.78 (m, 2H), 5.23 (d, J = 3.2 Hz, 1H), 5.12 (s, 1H), 5.01 (s, 1H), 4.85 (dd, J = 
7.0, 3.1 Hz, 1H), 4.53 (dd, J = 7.7, 7.2 Hz, 1H), 3.92 (dd, J = 7.8, 3.3 Hz, 1H), 3.76 (s, 
3H), 3.70 (s, 3H); 13C NMR (100 MHz, CDCl3) δ 165.4, 155.0, 152.3, 137.6, 132.1, 
118.9, 114.5, 94.8, 75.9, 74.6, 73.1, 70.7, 55.6, 52.3; IR (film, cm-1) 3445, 2951, 1721, 
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1504, 1253, 1211, 1078, 1033; TLC Rf = 0.17 (9:1 DCM/Ether v/v); HPLC 90:10 
e.r., Chiral HPLC eluting at 1.25 mL/min with 95% hexanes/methanol. Retention 
times:  RT= 58.6 min, 62.9 min; HRMS (ESI) m/z Calc’d for C16H18O7Na (M+Na)+ 
345.09447, found 345.09426.  
 
Thermodynamic pathway: isolation of anti-addition products 
To test whether the thermodynamic pathway (anti addition modes) was operable, 
racemic acetonide-protected trans-epoxide 2.38 was synthesized in 7 steps from furan 
and methyl acrylate according to literature procedures and was obtained as an 
inseparable mixture of oxide isomers 2.38 and 2.50 (68:32 ratio).20 Exposure to 
standard conditions resulted in both 1,2 and 1,4 anti addition modes. The syn-1,2 
addition product was isolated in 20% yield (97:3 er); the anti-1,4 addition product was 
isolated in a 3% yield (80:20 er). Due to the low yield of the 1,4-anti addition product, 
we examined our model (vide supra) and determined that we could use enantiopure 
epoxide (−)-2.38 (obtained from quinic acid)20, employ ligand (S,S)-L2 and augment 
our 1,4-anti product.   
 81 
Scheme 2.8. Thermodynamic AAOR pathway. 
!
 
Preparation of (−)-2.41 – from racemic oxide: 876.0 mg (3.87 mmol) of a racemic 
mixture of 2.38 and 2.50 (68:32 respectively) was dissolved in 30 mL of toluene with 
368.8 mg (2.97 mmol, 1.2 equiv with respect to epoxide 2.38) of p-methoxyphenol 
and degassed with argon, then cooled to 0 °C. In a separate flask, 122.6 mg (5 mol%) 
Pd2(dba)3 was added to a solution of 312.1 mg (15 mol%) L2 in 15 mL of toluene and 
degassed with argon until the purple solution became yellow. The solution was then 
cooled to   0 °C. The palladium solution was then added to the epoxide solution and 
the resulting yellow solution was warmed to room temperature. After 72 h, an 
additional 5.0 mL toluene solution containing 63.0 mg (2.5 mol%) Pd2(dba)3 and 
157.6 mg (7.5 mol%) ligand, was added. After an additional 24 h, the reaction was 
purified by column chromatography (4:1 hexanes/EtOAc v/v) using silica that was 
previously deactivated with triethylamine to give 183.1 mg of 1,2-addition product 
(−)-2.51 (20% yield) and 22.8 mg (3%) of 1,4-addition product 2.41. Both products 
were isolated as pale yellow oils. The recovered oxides (2.38 and 2.50, 63%) was 
obtained in 64:36 and 51:49 enantiomeric ratios respectively. 
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Methyl (3aR,6S,7R,7aS)-7-hydroxy-6-(4-methoxyphenoxy)-2,2-dimethyl-
3a,6,7,7a-tetrahydrobenzo[d][1,3]dioxole-5-carboxylate (2.51) 
[α] 020D
.  −20.2 (c 1.00, CHCl3); 1H NMR (400 MHz, CDCl3) δ 7.03 (d, J = 9.0 Hz, 2H), 
6.85 (dd, J = 3.8, 1.1 Hz, 1H), 6.81 (d, J = 9.1 Hz, 2H), 4.94 (dd, J = 5.3, 1.0 Hz, 1H), 
4.75 (ddd, J = 6.2, 3.8, 1.1 Hz, 1H), 4.29 (td, J = 6.2, 0.7 Hz, 1H), 4.22 (dd, J = 6.3, 
5.2 Hz, 1H), 3.76 (s, 3H), 3.70 (s, 3H), 1.52 – 1.49 (s, 3H), 1.40 (s, 3H). 13C NMR 
(101 MHz, CDCl3) δ 168.4*, 165.8*, 154.4*, 152.8*, 134.3*, 134.2*, 131.9, 118.2, 
114.3, 110.8, 75.8*, 75.7*, 70.8*, 70.7*, 70.0, 55.5*, 55.4*, 51.9*, 51.8*, 27.7, 25.8; 
IR (film, cm-1) 3451, 2967, 2933, 1720, 1504, 1250, 1030; TLC Rf = 0.53 (1:1 
hexanes/EtOAc v/v);  HPLC 97:3 e.r., Chiral HPLC eluting at 1.0 mL/min with 90% 
hexanes/isopropanol. Retention times:  RT= 9.6 min, 22.6 min; HRMS (DART) m/z 
Calc’d for C14H16O4 (M+H)+ 350.1366, found 350.1369. * denotes presumed rotamers 
in a 1:1 ratio. 
 
Methyl (3aS,4S,7S,7aR)-7-hydroxy-4-(4-methoxyphenoxy)-2,2-dimethyl-
3a,4,7,7a-tetrahydrobenzo[d][1,3]dioxole-5-carboxylate (2.41) 
[α] 020D
.  −141.1 (c 1.00, CHCl3); M.p. 55 – 58 °C; 1H NMR (CDCl3, 400 MHz) δ 7.03 
– 6.99 (m, 3H), 6.83 – 6.77 (m, 2H), 5.20 (d, J = 3.2 Hz, 1H), 4.97 (dd, J = 6.8, 3.1 
Hz, 1H), 4.56 (dd, J = 7.7, 6.8 Hz, 1H), 3.92 (ddd, J = 7.6, 6.1, 3.2 Hz, 1H), 3.76 (s, 
3H), 3.69 (s, 3H), 1.48 (s, 3H), 1.43 (s, 3H); 13C NMR (CDCl3, 126 MHz) δ 165.68, 
155.10, 152.43, 138.34, 131.39, 119.02, 114.57, 110.28, 76.18, 74.73, 72.73, 72.01, 
55.71, 52.35, 27.66, 25.29; IR (film, cm-1) 3340, 2934, 1720, 1505, 1211, 1054; TLC 
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Rf = 0.23 (7:3 hexanes/EtOAc v/v); HRMS (DART) m/z Calc’d for C18H23O7: 
351.1444 (M+H)+, found 351.1441. 
 
A mixture of enantiopure epoxide (−)-2.38 and 2.50 were synthesized in 5 steps from 
quinic acid according to literature procedure.6 Exposure of (−)-2.38 to the general 
conditions, increased the yield of 2.41 to 44% with no loss of enantiopurity. It is worth 
nothing that a switch in the catalyst to (R,R)-L2 did result in a population shift to favor 
the 1,2 anti addition product. 
 
Preparations of 2.41 from (−)-2.38 – enantiopure augmentation: 244.9 mg (0.99 
mmol, 1 equiv) of a mixture containing enantiopure epoxide 2.38 and 2.50 (68:32 
respectively) was dissolved in 6.0 mL of toluene. 161.5 mg (1.30 mmol, 1.3 equiv) of 
p-methoxyphenol was added and the resulting pale yellow solution was degassed 
thoroughly with argon. In a separate flask, 50.2 mg (5 mol%) of Pd2(dba)3 and 129.4 
mg (15 mol%) L2 were added to 4.0 mL of toluene and degassed with argon until the 
purple solution became yellow. The solution was added via syringe at room 
temperature to the reaction containing the epoxide. The reaction stirred under inert 
atmosphere for 24 h before an additional 50.1 mg (5 mol%) Pd2(dba)3 and 130.3 mg 
(15% mol) L2 dissolved in 4.0 mL of toluene was added. The reaction stirred for an 
additional 12 hours before being concentrated to give a yellow oil. The reaction was 
then purified by column chromatography (4:1 hexanes/EtOAc) to give 112.3 mg (44% 
yield) of anti-1,4 product 2.41 and 38.0 mg (15% yield) of anti-1,2 product 2.51 with 
no recovered starting material. 
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Total synthesis of streptol and MK7607 
 
Scheme 2.9. Total synthesis of streptol and MK7606. 
!
 
Reduction of 2.30 and 2.32:  
2.32 (70.0 mg, 0.217 mmol) was dissolved in dichloromethane (1.0 mL) and cooled to 
−78 °C under argon. DIBAl-H (700 µL, 0.694 mmol, 3.2 equiv, 1M in DCM) was 
added dropwise over 5 minutes. The reaction was stirred for 0.5 h at −78 °C and 
quenched with methanol. The reaction was warmed to room temperature and 2.0 mL 
of a 1:1 solution of 30% sodium potassium tartrate and a 30% aqueous ethanolamine 
were added and stirred for 1 h.  The now clear solution was extracted with hot EtOAc 
(5 x 2.0 mL), washed with cold 1M HCl (1.0 mL), dried over Na2SO4 and 
concentrated. Flash chromatography (1:1 hexanes/EtOAc, v/v) yielded 20.0 mg (0.068 
mmol, 28% yield) 2.54.  
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(3aR,4S,5S,7aS)-6-(hydroxymethyl)-5-(4-methoxyphenoxy)-3a,4,5,7a-
tetrahydrobenzo[d][1,3]dioxol-4-ol (2.54) 
[α] 020D
.  +45.5 (c 1.00, CHCl3); M.p. 109 – 112 °C; 1H NMR (400 MHz, CDCl3) δ 
6.99 (d, J = 9.0 Hz, 1H), 6.83 (d, J = 9.0 Hz, 1H), 5.92 (d, J = 3.5 Hz, 1H), 5.04 (s, 
1H), 4.96 (s, 1H), 4.85 (d, J = 3.4 Hz, 1H), 4.72 (t, J = 5.0 Hz, 1H), 4.37 (t, J = 6.2 Hz, 
1H), 4.23 (dd, J = 6.2, 3.4 Hz, 1H), 4.18 (d, J = 6.4 Hz, 1H), 3.77 (s, 2H); 13C NMR 
(126 MHz, CDCl3) δ 155.3, 152.1, 140.0, 122.1, 118.6, 115.0, 94.6, 76.0, 75.5, 72.4, 
69.5, 63.9, 55.8; IR (film, cm-1) 3330, 1608, 1214, 1184, 811; TLC Rf = 0.20 (1:1 
hexanes/EtOAc, v/v); HRMS (DART)  m/z calc for C15H22NO6 (M+NH4)+ 312.1447, 
found 312.1432.  
 
2.30 (55.0 mg, 0.171 mmol) was converted to 2.52 (19.0 mg, 0.065mmol, 38 % yield) 
in the same manner as above. 
(3aS,4R,5S,7aR)-6-(hydroxymethyl)-5-(4-methoxyphenoxy)-3a,4,5,7a-
tetrahydrobenzo[d][1,3]dioxol-4-ol (2.52) 
[α] 020D
.  −42.0  (c 1.00, CHCl3); M.p. 109–112 °C; 1H NMR (600 MHz, CDCl3) δ 7.03 
(m, 2H), 6.83 (m, 2H), 5.98 (dq, J = 3.3, 1.5 Hz, 1H), 5.22 (s, 1H), 5.03 (s, 1H), 4.75 
(ddd, J = 8.4, 2.3, 1.2 Hz, 1H), 4.51 (ddd, J = 6.9, 3.6, 1.5 Hz, 1H), 4.27 (m, 2H), 4.24 
(dd, J = 8.6, 6.8 Hz, 1H), 3.96 (td, J = 8.5, 2.6 Hz, 1H), 3.77 (s, 3H), 3.48 (s, 1H), 2.56 
(d, J = 2.8 Hz, 1H); 13C NMR (101 MHz, CDCl3) δ 154.9, 153.5, 143.1, 119.7, 117.6, 
115.0, 95.4, 79.7, 76.8, 72.9, 72.5, 62.8, 55.8; IR (film, cm-1) 3310, 33239, 2926, 
1506, 1210; TLC Rf = 0.30 (2:1 EtOAc/hexanes, v/v); HRMS: (DART)  m/z calc for 
C15H22NO6 (M+NH4+) 312.1447, found 312.1437. 
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Acylation and oxidative deprotection 
2.54 10.0 mg, 0.034 mmol) was dissolved in 0.30 mL DCM. iPr2NEt (17.0 µL, 0.102 
mmol, 3 equiv), DMAP (2.0 mg) and Ac2O (10 µg, 0.102 mmol, 3equiv) was added 
and stirred for 0.5 h. The reaction was diluted with saturated sodium bicarbonate 
solution (1.0 mL) and extracted with EtOAc (2 x 2.0 mL). The organic layers were 
combined and dried over Na2SO4 and concentrated to yield diacetate that was used 
without further purification.  
 The diacetate from above (11.5 mg, 0.030 mmol) was dissolved in 4:1 
MeCN/H2O (0.15 mL) and cooled to 0 °C. To this was added ceric ammonium nitrate 
(36.6 mg, 0.067 mmol, 2.2 equiv) and the reaction stirred for 15 minutes. The solution 
was washed with saturated sodium bicarbonate (1.0 mL) and extracted with EtOAc (2 
x 2.0 mL). The organic layers were combined, dried over Na2SO4 and concentrated 
under reduced pressure. Flash chromatography (2:1 hexanes/EtOAc to 1:1 
hexanes/EtOAc, v/v) yielded 2.0 mg (0.007 mmol, 21% yield over two steps) of 2.55. 
((3aS,6S,7S,7aS)-7-acetoxy-6-hydroxy-3a,6,7,7a-tetrahydrobenzo[d][1,3]dioxol-5-
yl)methyl acetate (2.55) 
[α] 020D
.  +52.5  (c 0.20, CHCl3); 1H NMR (400 MHz, CDCl3) δ 6.00 (m, 1H), 5.10 (m, 
1H), 5.09 (s, 1H), 4.96 (s, 1H), 4.68 (q, J = 13.6 Hz, 2H), 4.60 (m, 1H), 4.48 (dd, J = 
8.1, 6.5 Hz, 1H), 4.38 (t, J = 3.8 Hz, 1H), 2.17 (s, 3H), 2.11 (s, 3H); 13C NMR (101 
MHz, CDCl3) δ 13170.9, 170.7, 137.6, 124.4, 94.8, 77.4, 72.9, 72.6, 66.0, 64.7, 21.3, 
21.0; IR (film, cm-1) 3229, 1615, 1505, 1230; TLC Rf = 0.33 (1:1 hexanes/EtOAc, 
v/v); HRMS (DART)  m/z calc for C12H27O7 (M+H)+: 273.0974, found 273.0964.  
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2.52 (20.0 mg, 0.068 mmol) was converted to 2.53 (9.0 mg, 0.033 mmol, 48.5 % 
yield) in the same manner as above.  
((3aR,6S,7R,7aR)-7-acetoxy-6-hydroxy-3a,6,7,7a-tetrahydrobenzo[d][1,3]dioxol-5-
yl)methyl acetate (2.53) 
[α] 020D
.  −2.5 (c 0.90, CHCl3); 1H NMR (500 MHz, CDCl3) δ 5.87 (m, 1H), 5.17 (m, 
1H), 5.15 (s, 1H), 5.01 (s, 1H), 4.83 (d, J = 13.7 Hz, 1H), 4.65 (d, J = 13.7 Hz, 1H), 
4.54 (m, 1H), 4.25 (t, J = 6.8 Hz, 1H), 4.15 (d, J = 6.9 Hz, 1H), 2.14 (s, 3H), 2.10 (s, 
3H); 13C NMR (126 MHz, CDCl3) δ 171.3, 170.9, 139.2, 121.1, 95.2, 74.1, 72.9, 72.4, 
68.3, 63.8, 21.2, 21.0; IR (film, cm-1) 3466, 2922, 1738, 1227, 1040; TLC Rf = 0.39 
(1:1 hexanes/EtOAc, v/v); HRMS (DART)  m/z calc for C12H27O7 (M+H)+: 273.0974, 
found 273.0964.  
 
Deprotection of dioxolane 
A round bottom flask was charged with 2.55 (5.8 mg, 0.021 mmol) under argon and 
cooled to 0 °C. Freshly distilled AcCl (0.25 mL) was then added and the solution 
stirred for 10 minutes at 0 °C. Anhydrous ZnCl2 (ca 1 mg,) was added and the reaction 
stirred at 0 °C for 0.3 h before being warmed to room temperature and stirred for an 
additional 0.3 h. Disappearance of nonpolar (high Rf) compound by TLC indicated 
completion of reaction. The solution was diluted with 1.0 mL THF and concentrated to 
a third of its volume. Water (0.5 mL) was then added and stirred for 10 minutes. The 
reaction is then extracted with EtOAc (2 x 3.0 mL), dried over Na2SO4 and 
concentrated. The material is passed through a plug of silica gel (1:1 hexanes/EtOAc, 
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v/v) to yield MK7607-tetracetate (5.5 mg, 0.015 mmol, 70% yield). 1H-NMR (400 
MHz, CDCl3) δ 6.04 (d, J = 4.8 Hz, 1H), 5.74 (d, J = 4.2 Hz, 1H), 5.50 (dd, J = 10.4, 
4.2 Hz, 1H), 5.34 (dd, J = 10.5, 4.3 Hz, 1H), 4.58 (d, J = 13.8 Hz, 1H), 4.56 (m, 1H) 
4.50 (d, J = 13.8 Hz, 1H), 2.14 (s, 3H), 2.09 (s, 3H), 2.08 (s, 3H), 2.02 (s, 3H). 
  The above tetraacetate (5.5 mg, 0.15 mmol) was dissolved in anhydrous 
methanol (0.10 mL) and cooled to 0 °C. NaOMe in MeOH (15 µL, 0.15 mmol, 1 
equiv, 1M solution, freshly prepared from Na and MeOH is then added. The reaction 
was warmed and stirred at room temperature for 12 h. Water (0.1 mL) was added 
followed by DOWEX 50X2-200 (washed with methanol) until the pH of the solution 
was 2. After filtration, the solution was concentrated to yield 1.50 mg (0.0085 mmol, 
57% yield) of MK7607 (2.36).  
[α] 020D
.  +41.3  (c 0.15, H2O); 1H NMR (500 MHz  D2O)  δ 5.85 (dt, J = 5.0, 1.6 Hz, 
1H), 4.31 (ddd, J = 5.1, 3.2, 2.0 Hz, 1H), 4.24 (d, J = 3.6 Hz, 1H), 4.14 (s, 2H), 3.88 
(dd, J = 10.4, 3.9 Hz, 1H), 3.85 (dd, J = 10.4, 3.7 Hz, 1H); 13C NMR (126 MHz, D2O) 
δ 142.2, 126.0, 70.6, 70.3, 68.6, 68.0, 64.0; IR (film, cm-1) 3316, 2946, 2833, 1651, 
1447, 1258, 1010; HRMS (DART) m/z calc for C7H12O5: 177.0763 (M+H)+, found 
177.0758.  
 
2.53 (9.0 mg, 0.033 mmol) was converted to streptol (2.34) (3.1 mg, 0.018 mmol, 55% 
yield) in the same manner as above. 
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[α] 020D
.  -24.0 (c 0.1, H2O); 1H NMR (500 MHz D2O) δ 5.84 (dd, J = 5.5, 1.7 Hz, 1H), 
4.27 (t, J = 4.8 Hz, 1H), 4.23 (d, J = 14.2 Hz, 1H), 4.14 (d, J = 14.1 Hz, 1H), 4.07 (d, J 
= 7.6 Hz, 1H), 3.69 (dd, J = 10.7, 7.8 Hz, 1H), 3.57 (dd, J = 10.7, 4.2 Hz, 1H);  13C 
NMR (126 MHz, D2O) δ 142.1, 122.1, 72.5, 72.2, 70.6, 66.1, 61.2; IR (film, cm-1) 
3298, 2906, 1671, 1374, 1008, 878, 824; HRMS (ESI+) m/z calc for C7H12O5Na 
(M+Na)+, 199.0582, found 199.0581. 
Scheme 2.10. Total synthesis of cyathiformine B type. 
 
!
Total synthesis of cyathiformine B type 
26.3 mg (0.082 mmol, 1 equiv) of 2.31 was dissolved in 1.0 mL of DCM. To the clear 
colorless solution was added a catalytic amount (0.8 mg) of Rh2(OAc)4 turning the 
solution a pale green. The solution was heated to 85 °C and a separate solution 
containing 35.2 mg (0.149 mmol, 1.8 equiv) of diazophosphate, 2.37 in 1.5 mL of 
DCM was added dropwise over 10 minutes. The reaction continued at reflux for 3 h 
before cooling to room temperature. The reaction was then concentrated and purified 
by column (2:1 then 1:1 hexanes/EtOAc, v/v) to give 27.9 mg (64%) of 2.56 as a clear 
colorless oil (mixture of diastereomers) and 3.8 mg (14%) of recovered starting 
material 2.31. 
MeO
O
O
O
O
OPMP
P(OEt)2
OMe
O
O
MeO
O
OH
O
O
OPMP
MeO
O
P
N2
O
2.31
b. CAN
MeO
O
O
O
O
OH
P(OEt)2
OMe
O
O
2.57
2.37
OEt
OEt
a. Rh2(OAc)4
2.56
c. LiHMDS
    (CH2O)n
cyathiformine B type
O
OH
O
MeO
MeO
O
2.35
O
O
 90 
Methyl (3aR,4S,7R,7aS)-7-(1-(diethoxyphosphoryl)-2-methoxy-2-oxoethoxy)-4-(4-
methoxyphenoxy)-3a,4,7,7a-tetrahydrobenzo[d][1,3]dioxole-5-carboxylate (2.56) 
[α] 020D
.  −12.3 (c 1.00, CHCl3); 1H NMR (CDCl3, 300 MHz) δ 7.08 (d, J = 3.7 Hz, 1H), 
7.04 – 6.97 (m, 5H), 6.86 – 6.80 (m, 4H), 5.23 – 5.20 (m, 2H), 5.04 (s, 2H), 4.89 (d, J 
= 19.7 Hz, 1H), 4.82 (d, J = 6.3 Hz, 2H), 4.71 (d, J = 18.6 Hz, 1H), 4.51 (dd, J = 6.2, 
4.0 Hz, 1H), 4.47 – 4.41 (dd, J = 6.2, 4.2 Hz,  1H), 4.35 (td, J = 4.0, 1.1 Hz, 1H), 4.32 
– 4.28 (m, 2H), 4.28 – 4.18 (m, 9H), 3.83 (d, J = 2.6 Hz, 5H), 3.78 – 3.74 (m, 18H), 
1.37 – 1.31 (m, 12H); 13C NMR (CDCl3, 75 MHz) δ 168.7, 167.9, 165.5, 165.4, 
155.0, 151.8, 151.7, 137.6, 137.0, 131.5, 130.8, 118.0, 117.9, 114.8, 94.3, 76.2, 75.9, 
75.0, 74.7, 71.3, 71.2, 64.1, 55.8, 53.0, 52.3, 16.6; IR (film, cm-1) 2953, 1725, 1506, 
1260, 1214, 1024; TLC Rf = 0.11, 0.19 (1:2 hexanes/EtOAc, v/v); HPLC 86:14 e.r.; 
HRMS (DART) m/z Calc’d for C23H32O12P (M+H)+: 531.1626, found 531.1603. 
Characterization was performed on a 1:1 mixture of inseparable diastereomers. 
 
39.0 mg (0.074 mmol, 1 equiv) of 2.56 was dissolved in 4.0 mL of 4:1 MeCN/H2O v/v 
solution. The solution was cooled to 0 °C and ceric ammonium nitrate (88.9 mg, 0.162 
mmol, 2.2 equiv) was added in a single portion.  After 5 minutes the solutions had 
become orange the starting material had been consumed by this time. The reaction was 
diluted with water and the organics extracted with EtOAc (3 x 7.0 mL). The extracts 
were dried with Na2SO4, filtered, and concentrated. Purification by column (2:1 
EtOAc/hexanes, v/v) gave 23.6 mg (76%) of 2.57 as a red oil. 
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Methyl (3aR,4S,7R,7aS)-7-(1-(diethoxyphosphoryl)-2-methoxy-2-oxoethoxy)-4-
hydroxy-3a,4,7,7a-tetrahydrobenzo[d][1,3]dioxole-5-carboxylate (2.57) 
[α] 020D
.  −17.8 (c 1.00, CHCl3); 1H NMR (CDCl3, 400 MHz) δ 7.09 (t, J = 4.2 Hz, 3H), 
5.01 (s, 1H), 4.98 (s, 1H), 4.76 (s, 1H), 4.72 (s, 1H), 4.70 – 4.63 (m, 2H), 4.57 (d, J = 
19.0 Hz, 1H), 4.45 (dd, J = 7.1, 3.8 Hz, 1H), 4.42 – 4.36 (m, 3H), 4.36 – 4.28 (m, 3H), 
4.26 – 4.15 (m, 8H), 3.86 – 3.80 (m, 12H), 1.37 – 1.29 (m, 12H); 13C NMR (CDCl3, 
75 MHz) δ 168.8, 167.8, 167.3, 165.9, 137.7, 137.3, 136.4, 134.9, 94.4, 94.3, 79.0, 
78.9, 76.0, 75.8, 75.7, 75.6, 75.1, 75.0, 66.0, 65.6, 64.1, 64.0, 53.2, 53.1, 52.6, 16.6, 
16.5; IR (film, cm-1) 3481, 2912, 1723, 1253, 1092, 1021, 980; TLC Rf = 0.29 
(EtOAc); HPLC 87:13 e.r.; HRMS (DART) m/z Calc’d for C16H19O11P (M+H)+: 
425.1207, found 425.1188. Characterization performed on a 1:1 mixture of 
inseparable diastereomers 
 
71.2 mg (0.168 mmol, 1.0 equiv) of 2.57 was dissolved in 4.0 mL of anhydrous THF 
and cooled to −78 °C under argon to give a pale yellow solution. Fresh LiHMDS, 
prepared from the addition of 225.0 µL n-BuLi to 75.0 µL of HMDS in 4.0 mL of 
THF at −78 °C, was added slowly turning the solution brown. The reaction stirred for 
0.5 h at −78 °C before the dropwise addition of a 9.0 mL solution of THF containing 
freshly cracked formaldehyde (711.1 mg, 100 equiv). After stirring at bath temp for 
0.3 h, the reaction was transferred to a bath at 0 °C and allowed to stir for 0.5 h, upon 
which it was quenched with 8.0 mL of a saturated NH4Cl. The product was extracted 
in EtOAc (3 x 10.0 mL) and dried with Na2SO4. The crude product was filtered though 
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a pad of celite then purified by column (1:1 EtOAc/hexanes, v/v) to give 36.1 mg 
(71%) of product 2.35 as a yellow oil. 
 
Methyl (3aR,4S,7R,7aS)-4-hydroxy-7-((3-methoxy-3-oxoprop-1-en-2-yl)oxy)-
3a,4,7,7a-tetrahydrobenzo[d][1,3]dioxole-5-carboxylate (2.35) 
[α] 020D
.  −39.9 (c 1.00, CHCl3); 1H NMR (CDCl3, 400 MHz) 7.14 (d, J = 4.6 Hz, 1H), 
5.60 (d, J = 3.2 Hz, 1H), 5.04 (s, 1H), 4.93 (d, J = 3.3 Hz, 1H), 4.82 (dd, J = 4.6, 3.1 
Hz, 1H), 4.79 – 4.73 (m, 2H), 4.53 – 4.44 (m, 2H), 3.82 (s, 3H), 3.80 (s, 3H); 13C 
NMR (CDCl3, 125 MHz) δ 165.8, 163.1, 148.6, 136.8, 136.3, 98.2, 94.4, 78.4, 74.8, 
71.4, 65.2, 52.9, 52.6; IR (film, cm-1) 3477, 2923, 1721, 1438, 1255, 1168, 1091, 
1032; TLC Rf = 0.77 (EtOAc);  HPLC 87:13 e.r.; HRMS (DART) m/z Calc’d for 
C13H17O8 (M+H)+: 301.0918, found 301.0903.  
 
Scheme 2.11. Synthesis of new cyclitol 2.42. 
!!
Total Synthesis of Cyclitol 2.42 
214.6 mg (0.613 mmol, 1 equiv) of 2.41 was dissolved in 10 mL of anhydrous DCM. 
200 µL (2.12 mol, 3.5 equiv) of acetic anhydride was added followed by 330 µL (1.89 
mmol, 3.0 equiv) of diisopropylethylamine and 1 mg (cat.) of DMAP. The reaction 
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stirred for 1 h at room temperature before TLC showed consumption of starting 
material. The reaction was then quenched with 2.0 mL of 1M HCl and organic layer 
separated then dried with MgSO4. Filtration and concentration yielded the crude 
acetate which was used without further purification. 1H NMR (CHCl3, 300 MHz) δ 
7.15 (d, J = 3.3 Hz, 1H), 7.04 – 7.98 (m, 2H), 6.83 – 6.76 (m, 2H), 5.42 (d, J = 2.9 Hz, 
1H), 5.02 (dd, J = 6.7, 3.4 Hz, 1H), 4.91 – 4.77 (m, 2H), 3.78 (d, J = 0.6 Hz, 3H), 3.76 
(s, 3H), 1.79 (s, 3H), 1.47 (s, 3H), 1.44 (s, 3H). 
The crude acetate was dissolved in a 10.5 mL of 4:1 MeCN/H2O (v/v) solution. 
The solution was cooled to 0 °C and 760.0 mg (1.39 mmol, 2.1 equiv) of ceric 
ammonium nitrate was added in a single portion. After 5 minutes, TLC showed 
consumption of the starting material. The resulting yellow solution was diluted with 
10.0 mL of water and the organic  layer was extracted with EtOAc (3 x 10.0 mL). The 
extracts were combined and dried with Na2SO4. Filtration and concentration gave the 
crude product that was purified by column (7:3 hexanes/EtOAc v/v) yielding 78.3 mg 
of 2.58 (45% over 2 steps) of a yellow oil.  
Methyl (3aR,4R,7R,7aS)-7-acetoxy-4-hydroxy-2,2-dimethyl-3a,4,7,7a-
tetrahydrobenzo[d][1,3]dioxole-5-carboxylate (2.58) 
[α] 020D
.  −96.3 (c 1.00, CHCl3); 1H NMR (CDCl3, 300 MHz) δ 7.01 (d, J = 3.5 Hz, 1H), 
5.02 (dd, J = 8.6, 3.4 Hz, 1H), 4.85 (dd, J = 6.5, 3.6 Hz, 1H), 4.81 (d, J = 3.4 Hz, 1H), 
4.56 (dd, J = 8.6, 6.5 Hz, 1H), 3.80 (s, 3H), 2.16 (s, 3H), 1.44 (s, 3H), 1.39 (s, 3H); 
13C NMR (CDCl3, 75 MHz) δ 170.5, 165.8, 136.6, 132.7, 110.5, 73.4, 72.7, 72.3, 
64.3, 52.5, 27.6, 25.6, 21.2; IR (film, cm-1) 3371, 3072, 2987, 1722, 1237, 1062, 853; 
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TLC Rf = 0.29 (7:3 hexanes/EtOAc v/v); HRMS (DART) m/z Calc’d for C13H19O7 
(M+H)+: 287.1125, found 287.1119. 
 
29.0 mg (0.101 mmol, 1 equiv) of starting material 2.58 was dissolved in 1.0 mL of 
anhydrous MeOH under argon and cooled to 0 °C to give a yellow solution. In a 
separate flask, 7.1 mg (0.309 mmol, 3 equiv) of sodium metal was added to 1 mL of 
anhydrous MeOH under argon. This solution was then added dropwise to the solution 
containing the starting material causing it to brown. After 5 minutes, all the starting 
material had been consumed and the reaction was acidified to pH = 3 using 1M HCl 
causing the solution to lighten in color. The product was the extracted with EtOAc (3 
x 3 mL) and dried with Na2SO4. Filtration and concentration gave 19.7 mg (80%) of 
the diol (2.59) as a yellow oil. 1H NMR (CDCl3, 400 MHz) δ 6.91 (d, J = 3.5 Hz, 
1H), 4.79 (ddd, J = 6.0, 3.4, 0.8 Hz, 1H), 4.66 (d, J = 3.6 Hz, 1H), 4.43 (t, J = 6.2 Hz, 
1H), 4.05 (dd, J = 6.4, 3.6 Hz, 1H), 3.81 (s, 3H), 1.39 (s, 3H), 1.38 (s, 3H). 
 
The crude diol 2.59 was dissolved in 2.5 mL of anhydrous acetone and 2.5 mL 2,2-
dimethoxypropane to give a yellow solution. 900.0 mg (6.34 mmol, excess) of Na2SO4 
was added and a catalytic amount of p-TsOH. The reaction was heated to reflux under 
N2 for 1 hour. Once the starting material was consumed by TLC, the reaction was 
cooled and washed with a saturated NaHCO3 solution. The product was extracted with 
DCM (3 x 3.0 mL) and dried with Na2SO4. Filtration and concentration gave 17.8 mg 
(78%) of the product as a yellow oil. No further purification was necessary. 
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Methyl (3aR,5aR,8aS,8bR)-2,2,7,7-tetramethyl-3a,5a,8a,8b-tetrahydrobenzo[1,2-
d:3,4-d']bis([1,3]dioxole)-4-carboxylate (2.60) 
[α] 020D
.  +26.8 (c 1.00, CHCl3); 1H NMR (CDCl3, 300 MHz) δ 6.72 – 6.70 (m, 1H), 
4.96 (d, J = 5.6Hz, 1H), 4.69 – 4.64 (m, 2H), 4.58 (ddd, J = 4.9, 2.9, 1.3 Hz, 1H), 3.82 
(s, 3H), 1.39 (s, 3H), 1.37 (s, 3H), 1.32 (s, 3H), 1.30 (s, 3H); 13C NMR (CDCl3, 75 
MHz) δ 166.5, 136.8, 129.1, 109.8, 109.3, 73.6, 72.4, 70.7, 69.2, 52.4, 28.0, 27.7, 
26.4, 26.0; IR (film, cm-1) 2986, 2934, 1726, 1247, 1059, 851; TLC Rf = 0.80 (1:1 
hexanes/EtOAc v/v); HRMS [M+H]+ m/z Calc’d for C15H18O5 285.1333, found 
285.1326. 
 
5.4 mg (0.022 mmol, 1 equiv) of the crude diol 2.59 was dissolved in 0.5 mL of 
methanol and 100 µL of water. Trifluoroacetic acid (15 µL, 10 equiv) was then added. 
The resulting solution was heated to 40 °C. Once the starting material was consumed 
by TLC (approx. 7 h), the reaction was diluted with toluene and concentrated to 
dryness. The resulting film was washed with ether (3 x 1.0 mL) and then dried under 
vacuum to yield 2.3 mg (51%) as an off-white foam as streptol (2.42). 
[α] 020D
.  −193.0 (c 0.10, CH3OH); 1H NMR (D2O, 400 MHz) δ 7.00 (d, J = 4.9 Hz, 
1H), 4.71 (d, J = 4.0 Hz, 1H), 4.51 (t, J = 4.6 Hz, 1H), 3.98 (dd, J = 10.4, 4.3 Hz, 1H), 
3.92 (dd, J = 10.4, 4.0 Hz, 1H), 3.84 (s, 3H); 13C NMR (CD3OD, 125 MHz) δ 167.9, 
139.5, 132.0, 68.2, 67.7, 65.5, 65.5, 52.6; IR (film, cm-1) 3285, 2948, 2837, 1651, 
1405, 1010; TLC (reverse phase) Rf = 0.89 (9:1 H2O/MeCN v/v); HRMS (DART) 
m/z Calc’d for C8H13O6 (M+H)+: 205.0707, found 205.0709.  
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Table 2.5. Comparison of natural and synthetic samples. 
 
 
 
 
 
 
 
 
 
!
  
Natural Streptol Current synthesis of Streptol 
1H NMR (D2O, 400MHz) 24 
3.61 (dd   J = 11, 4 Hz) 
3.73 (dd   J =11, 8 Hz) 
4.11 (dq   J = 8, 1 Hz) 
4.17 (d  J =  14 Hz) 
4.26 (dq   J = 14, 1 Hz) 
4.33 (dd J = 5, 4 Hz) 
5.88 (dq J = 5, 1 Hz) 
3.57 (dd, J = 10.7, 4.2 Hz)   
3.69 (dd, J = 10.7, 7.8 Hz)  
4.07 (d, J = 7.6 Hz)  
4.14 (d, J = 14.1 Hz)  
4.23 (d, J = 14.2 Hz)  
4.27 (t, J = 4.8 Hz) 
5.84 (dd, J = 5.5, 1.7 Hz) 
13C NMR (D2O, 100MHz) 34 
62.0 
 66.0  
71.2 
 72.7 
73.0  
122.8 
142.8  
62.0 
 66.0  
71.2 
 72.7 
73.0  
122.8 
142.8  
Optical Rotation8, [α] 020D
.   
+88.1 (c 0.3, H2O)   −70.6 (c 0.17, H2O) 
  
Natural MK7607 Current synthesis of MK7607 
1H NMR (D2O, 400MHz) 25 
3.86( dd, J  = 3.6, 10.2, 1H) 
3.89(dd, J = 3.6, 10.2, 1H) 
4.16 (s, 2H) 
4.25(d, J = 3.6, 1H) 
4.32(dd, J = 4.2, 4.2, 1H) 
5. 85(d, J = 4.9. 1H). 
3.85 (dd, J = 10.4, 3.7 Hz, 1H) 
3.88 (dd, J = 10.4, 3.9 Hz, 1H) 
4.14 (bs, 2H) 
4.24 (d, J = 3.6 Hz, 1H) 
4.31 (ddd, J = 5.1, 3.2, 2.0 Hz, 
1H) 
5.85 (dt, J = 5.0, 1.6 Hz, 1H) 
13C NMR (D2O, 100MHz) 34 
63.0 
67.0 
67.6 
69.3 
69.6 
125.1 
142.2 
64.0 
68.0 
68.6 
70.3 
70.6 
126.0 
142.2 
Optical Rotation8, [α] 020D
.  
+210 (c 1.0, H2O)  +41.3 (c 0.15, H2O) 
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A Brief Introduction to the History of Polyolefins and Chain Walking 
Polymerizations 
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3.1  Introduction to Polymer Structures and Properties 
Polymer properties and their applications are inescapably linked to their 
molecular weight, architecture, and topology.1,2 Changes in any of these characteristics 
can produce profound effects on the behavior of the final material. As a result, a 
primary focus in polymer chemistry is the development of new methods for 
controlling these variables. One topological property of particular interest is tacticity, 
which refers to the relative arrangement of adjacent chiral centers along a polymer 
backbone (Figure 3.1a). Atactic polyolefins (Figure 3.1a, left) are amorphous 
(noncrystalline), soft waxy materials with low physical strength. Conversely, iso- 
(Figure 1.3a, right) and syndiotactic (Figure 1.3a, center) polyolefins are usually 
highly crystalline with high physical strength. This strength comes from the ability of 
the regular structures to pack into a crystal lattice, whereas unordered structures 
cannot, and the crystallinity leads to higher physical strength and increased resistance 
to chemical degradation. Some of the most profound effects of tacticity are observed 
in polypropylene (PP). Isotactic polypropylene (iPP) is a strong, semi-crystalline 
polymer used as plastic and fiber with a melting point of ~165 °C.3,4 Its annual 
production is around 55 million tons worldwide. Atactic polypropylene, on the other 
hand, is amorphous and ranges from oily to waxy in appearance. Its major use is in 
asphalt blends or formulations for lubricants, adhesives, or sealants, but the volumes 
produced are trivial compared to its isotactic counterpart. Although syndiotactic 
polypropylene (sPP) is also crystalline and shows good physical properties, its 
production volumes are also lower than that of iPP because historically iPP has been 
easier to produce and more popular.5 
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Figure 3.1. a) Different tacticities of polymer side chains. b) Types of dyads and triads 
in polymer sequences. 
  
Polymer tacticity is easily measured using high-resolution 1H and 13C NMR 
spectroscopy and is most commonly accomplished by measuring the dyad and triad 
ratios.6 Dyad tacticity refers to the fraction of pairs of adjacent repeating units that are 
iso- or syndiotactic to one another. The dyads are usually referred to as meso (m) 
(Figure 1.3b, right) or racemic (r) (Figure 1.3b, center) depending on the relative 
orientation of two adjacent stereocenters, as shown in Figure 3.1b, which depicts a 
segment of polymer as a horizontal line and configuration of the stereocenter in the 
repeating unit as a vertical line. The direction of the branch denotes the relative 
stereochemistry. When branches are on the same side of the polymer, it is a meso dyad 
(m) with an isotactic structure, while opposite sides gives a racemic dyad (r) with 
syndiotactic structure. Triad tacticity measures three adjacent stereocenters, or two 
adjacent dyads, and is designated as (mm), (rr), or (mr) (Figure 1.3b, left). 
 If (r) = (m) = 0.5, or (mm) = (rr) = 0.25 and (mr) = 0.5, and the dyads and 
triads are randomly distributed throughout the polymer, then the material is atactic. If 
the polymer is completely isotactic, then (m) = (mm) = 1, and if the polymer is 
completely syndiotactic, then (r) = (rr) = 1. In reality, most polymers lie somewhere 
in-between. If isotacticity predominates, then (m) > 0.5 and (mm) > 0.25, and if 
n
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syndiotacticity predominates, then (r) > 0.5 and (rr) > 0.25. By measuring the dyads 
and triads by NMR spectroscopy, the overall tacticity of the polymer can be resolved. 
Using high-resolution 13C NMR spectroscopy, tetrad, pentad, and higher sequences 
can be observed to further elucidate the polymer microstructure.6,7 
The crystalline melting temperature (Tm) in crystalline and semi-crystalline 
polymers can be understood by looking at physical changes that occur upon cooling a 
liquid polymer. When cooled, a polymer’s rotational, translational, and vibrational 
energies decrease. When the rotational and translational energies have fallen to 
effectively zero, and if certain symmetry requirements are met (ex: stereoregularity), 
crystallization occurs. During crystallization, polymer chains pack in an ordered lattice 
structure;8 the temperature at which this occurs is the Tm of the polymer. Above this 
temperature, the polymer is a liquid. Below this temperature, crystallites can exist, and 
they are responsible for the high mechanical properties observed in PE and PP. Tm is 
measured by differential scanning calorimetry (DSC).9  
 
!
Figure 3.2. Types of polymer architecture and branching. 
 
A second important property of polymers is the architecture of their 
backbones, which is classified as linear, branched, or cross-linked (Figure 3.2). In a 
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linear polymer, monomer molecules are linked in one continuous path such that there 
are only two end groups per polymer chain. A branched polymer contains side chains 
that protrude from the main chain at various branch points, resulting in more than two 
end groups per polymer chain. These branches can be of various lengths, distances 
from one another, and densities to yield a variety of structures. Typically, as branching 
increases, polymer crystallinity decreases because branched polymers do not pack as 
well as linear molecules into crystal lattices.10 This is also true for polymers that 
contain branches of varying length. It is crucial to note that branched polymers differ 
from linear polymers with side groups, such as PP, where the side group (methyl) is 
part of the monomer structure. Finally, cross-linked polymers (Figure 3.2, bottom) are 
structures in which the polymer molecules are linked to one another at points other 
than their end groups.11 The cross-links can be installed during or after the 
polymerization and can be of varying lengths. Further, the number of links can be 
varied to change properties of the material. 
 
!
Figure 3.3. Different structures for PE. 
 
The importance of polymer architecture, namely its effects on polymer 
properties, is clearly demonstrated by PE (Figure 3.3). Linear production results in 
high-density polyethylene (HDPE), which has few branches (0.5-3 per 500 monomer 
UHMWPE
LLDPE LDPE
HDPE
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units) and high crystallinity (133–138 °C). This material is typically derived from 
traditional Ziegler-Natta catalysts and shows good mechanical properties such as 
stiffness, high tensile strength, chemical resistance, and a high melting temperature.3,12 
It has a variety of uses, including blow-molded products such as bottles, toys, and 
pails, injection-molded objects, and extruded products like piling, tubing, and truck 
bed liners. Similarly, ultra-high molecular weight polyethylene (UHMWPE) is 
produced in highly crystalline forms with molecular weights exceeding 2.5 million 
g/mol, compared to HDPE’s molecule weights of 50-250 kg/mol. UHMWPE is often 
spun into fibers for bulletproof vests and other high-impact-resistant materials.13 
Alternatively, the branching of linear low-density polyethylene (LLDPE) is controlled 
by copolymerizing it with α-olefins such as propene, butene, and hexene, but 
maintains a mostly linear structure.14 This material is also generated from Ziegler-
Natta catalysts or metallocene catalysts. The branching reduces crystallinity, making 
this material more flexible for applications like plastic bags, stretch wrap, lids, and 
flexible tubing. Low density polyethylene (LDPE) has uncontrolled amounts (15-30 
methyl groups per 500 monomers) and types of branching because it is generated 
using radical polymerization.15 It is even more flexible than LLDPE due to the higher 
branch content. Its applications include very soft and pliable snap on lids, six-pack 
rings, and foam-type packaging. All of these polymers and their applications stem 
from the same monomer that has been polymerized with simple changes in molecular 
weight and architecture, hence the importance of these crucial features.  
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Figure 3.4. Stress-strain curves for different types of plastics. 
 
As discussed above, a polymer’s molecular weight, tacticity, and architecture 
affect its mechanical properties. Other important polymer properties include 
deformation and flow characteristics under stress, which are often determined from 
stress-strain properties, i.e. by measuring elongation (strain) while applying tension 
(stress) until the polymer pulls apart (Figure 3.4).16 Four important quantities can be 
characterized from stress-strain studies: 1) modulus, or resistance to deformation, 2) 
tensile strength, or the stress required to pull apart the sample, 3) ultimate elongation, 
or the amount of elongation before the sample pulls apart, and 4) elastic elongation, or 
the extent of reversible elongation (return back to original shape). These properties are 
often dictated by the degree of crystallinity and crosslinking as well as the glass 
transition temperature (Tg) and Tm. Typically, high degrees of cross-linking or 
crystallinity result in a material that has high strength with low extensibility. 
 Given the global importance of polymers, it is clear why novel polymers and 
structures are of significant interest. More specifically, because of the critical role that 
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structure plays in a polymer’s properties and, therefore, possible applications, we seek 
greater control over polymer topology. Achieving this goal requires developing new 
structures and catalysts as well as methods that allow total control over the synthesis. 
In the next section, we review on one particular class of polymer, polyolefins, whose 
properties we are particularly interested in controlling.  
 
3.2 Brief History of Polyolefins and Chain walking 
Polyolefins constitute the largest class of polymers in terms of production. 
They are formed from the polymerization of olefin precursors, such as ethylene or 
propylene, to make plastics and have revolutionized society. Annually, 80 million tons 
of polyethylene (PE),17 55 million tons of polypropylene (PP),18 and 39 million tons of 
polyvinylchloride (PVC)19 are produced globally, making them the three largest 
manufactured polymers, all of which are polyolefins. There are several reasons why 
polyolefins dominate the global market, including their significantly lower cost of 
production, but it is their highly desirable mechanical properties and ease of tunability 
that have allowed polyolefins to flourish and become indispensable in our daily lives. 
Karl Ziegler20 first discovered that ethylene could be polymerized at 
atmospheric pressure to produce high molecular weight PE. This method was later 
expanded to include higher olefins, such as propylene, by Giulio Natta,21 who also 
discovered that stereoregular polymers are possible. For their contributions, both 
scientists shared the 1963 Nobel Prize in chemistry. What eventually became known 
as Ziegler-Natta catalysis started with a heterogeneous mixture of TiCl3 and alkyl 
aluminums such as Et3Al or Et2AlCl. Early industrial processes were very inefficient, 
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with isoselectivity of PP ranging from 20–40% and only 1% of the Ti species being 
active. Over two decades, this process was improved to produce PP with isotacticity 
above 90% and with significantly improved activity.22 Today, the combination of 
catalyst and co-catalyst has become more complex, but the general principle remains 
the same, with the majority of commercial polyolefins being produced through 
Ziegler-Natta catalysis.  
  Due to its heterogeneous nature, the mechanism of polymerization remains 
poorly understood,23 although it is believed to involve π-complexation of monomer to 
transition metal (Scheme 3.1, 3.1). This step is followed by an insertion process with 
both cationic and anionic features that involves a concerted nucleophilic attack from 
the carbanion on the end of the polymer chain with the α-carbon of a momoner’s 
double bond (3.2). This is coupled with an electrophilic attack by the cationic metal on 
the alkene π-electrons.24 Using an isoselective Ziegler-Natta catalyst, the insertion of 
the monomer occurs exclusively via primary insertion, i.e. 1,2-addition. The observed 
isoselectivity25 is believed to arise from a back-skip mechanism, also known as the 
Cossee-Arlman mechanism (Scheme 3.2).26 Here, a monomer coordinates to a vacant 
site around the titanium center (3.5). A migratory insertion of the polymer chain 
occurs, according to the mechanism described above, to generate a new vacant site 
(3.7) and lengthen the growing polymer. If this new vacant site were to coordinate a 
monomer and proceed through a migratory insertion, then the resulting polymer would 
be syndiotactic (3.8). Therefore, the polymer chain migrates back to its original 
position to regenerate the vacant site and proceed isoselectively (3.9). Propagation 
occurs via a site control mechanism. 26d, 27 
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Scheme 3.1 Monomer insertion into a propagating polymer chain.24 
!!
Scheme 3.2 The Cossee-Arlman mechanism, or back-skip mechanism, for iso-
selectivity.26 
!!
In an attempt to better understand heterogeneous Ziegler-Natta catalysts and 
their isoselective nature, chemists turned their focus to metallocenes as soluble 
initiator model systems. It quickly became clear that homogeneous catalysts offered 
alternative means of olefin polymerization, while solving many of the issues seen in 
heterogeneous systems. For example, metallocenes are nearly 100-fold more active 
than heterogeneous systems because of their enhanced solubility and the fact that 
every transition metal site is active.23a Furthermore, each metal center resides in an 
identical coordination environment, which results in polymers with narrower 
molecular weight distributions and regular regio- and stereochemistry. This class of 
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catalyst can also be purified, isolated, and fully characterized by techniques such as 
NMR spectroscopy, allowing for easy reproducibility and mechanism determination, 
since the molecular structure can be well-established. The first metallocenes studied 
where titanocene and zirconocence dichlorides,28 but the catalysts were later expanded 
to include numerous transition metals and structures. Metallocene research spanned 
several decades and produced many notable advancements (see Ref. 29). 
Although metallocenes are highly active and valuable, the search for new and 
interesting initiators/catalysts extended beyond the metallocenes, since new catalysts 
offer new ways to control molecular architecture, molecular weight, and regio- or 
stereoregularity. Commercial interests also required new catalysts that had not yet 
been patented. One such class of catalyst was the bisphenoxy-imines (Scheme 3.3). 
Pioneered by Fujita and Coates, these catalysts showed good ethylene polymerization 
activity with both zirconium and titanium, giving high molecular weights.30 They also 
exhibited unique stereoselectivity in propylene polymerizations, generating sPP even 
though a C2-symmetric catalyst was expected to produce iPP. This phenomenon 
results from an interesting ligand isomerization procedure caused by a steric clash 
between the propagating species and inserting monomer (3.11). The isomerization 
event relieves the steric decompression (3.13) and produces the observed 
stereoselectivity. Additionally, fluorination of the aniline dramatically increases 
activity, and the catalyst is “living” if fluorination occurs at the ortho-positions.31 
Living polymerizations are of interest because of their ability to produce block 
copolymers and functionalized polymers, but they do not occur with standard Ziegler-
Natta catalysts, and there exist few examples with metallocenes.  
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Scheme 3.3 Ligand isomerization of phenoxy-imine catalyst during polymerization. 
!
 
Another class of catalyst includes α-diimine chelates of late transition metals, 
shown in Figure 3.5. This particular class became the focus of intense study because 
of certain unique properties, including their reduced oxophilicity, which allows for the 
incorporation of polar monomers. This feat was previously impossible with early 
transition metallocenes (zirconium, titanium, chromium). Unlike early transition 
metals, late transition metals such as palladium or nickel had been previously 
unexplored because of their tendency to dimerize or oligomerize olefins along a 
competing β-hydride elimination pathway.32 However, chemists later discovered that, 
with the appropriate choice of ligand, these metals could be harnessed as useful 
polymerization catalysts. Bulky α-diimine ligands in Figure 3.5 favored monomer 
insertion over β-hydride pathways and allowed access to weight-average molecular 
weights of 104–106 PE in the presence of MAO and ethylene.22a, 33 Simultaneously 
with these studies, it was discovered that late transition metal catalysts can undergo 
chain walking during polymerization.  
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Figure 3.5. Original Brookhart α-diimine  catalysts. 
 
Chain walking is a unique phenomenon during which the catalyst of an 
actively propagating polymer chain (Scheme 3.4, 3.19) can undergo consecutive β-
hydrogen elimination reactions (3.21) followed by reinsertion reactions with the 
opposite regiochemistry (3.22). This process positions the active species at various 
locations along the polymer backbone from which further propagation can occur. 
Chain walking was first observed by Mörhing and Fink when investigating the 
polymerization of α-olefins using a nickel aminobis(imino)phosphorane catalyst.34 
They described their observation as a “migration” of the catalyst along the propagating 
polymer chain.  
 
Scheme 3.4 Proposed chain walking mechanism. 
 
 
Brookhart and coworkers performed the first detailed studies on this 
mechanism. They first investigated the polymerization of ethylene, propylene, and 1-
hexene using nickel or palladium α-diimine.35 In all cases, the polymerization yielded 
high molecular weight materials that were amorphous due to high branch content. 
Further, they determined that the branching content could be modulated by simple 
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changes in reaction conditions such as pressure and temperature. For example, running 
the reaction at cooler temperatures suppressed branching and produced semi-
crystalline PE with Tm = 132 °C. Since Brookhart’s seminal work over 20 years ago, 
important advancements have been made in the field of chain walking polymerization, 
making it an even more valuable process. Although a variety of different catalysts 
have been used for chain walking,36 here we focus on α-diimine catalysts, particularly 
those containing  nickel. 
α-Diimines constitute a versatile class of bidentate ligands. They are easily 
synthesized, typically from an acid catalyzed condensation of amines with dicarbonyls 
or from a nucleophilic attack on a bis-imidoyl chloride precursor. Because the scaffold 
is modular and easily manipulated, a wide breadth of ligands can be rapidly 
synthesized. In most cases, bulky axial substituents on the ligands were necessary in 
order to substantially reduce the rate of chain transfer (Scheme 3.5).33a,34 Moreover, 
axial bulk destabilized the catalytic ground state and led to faster monomer insertion. 
Both of these features are credited for the high molecular weights observed with these 
catalysts.37 Activation of these complexes, among other methods,38 is typically 
accomplished through the use of alkylaluminium reagents such as methylaluminoxane 
(MAO).39 Generally, palladium is nearly 1000x less active than nickel35 but produces 
more branches and can tolerate as well as incorporate polar monomers.40 The degree 
of branching can be altered by a variety of experimental variables, including pressure, 
temperature, and concentration. As mentioned previously, a simple change in metal 
center from nickel to palladium can cause an increase in the number of branches, often 
producing hyperbranched (branch on branch) materials.  
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Scheme 3.5 Associative displacement of propagating polymer chain through 
coordination of new olefin at axial site. 
 
 
Another interesting result of chain walking polymerization stems from how the 
monomer inserts into the propagating polymer chain (Scheme 3.6). For any given 
monomer, there are two main modes of insertion: 1,2 or 2,1. For a 1,2 pathway, the 
polymer chain is added to the 2-position of the α-olefin monomer while the active 
metal center migrates to 1-position. If the metal center then chain walks to the ω-
position (last carbon of the monomer) before inserting a new monomer, the process is 
known as ω,2-enchainment and results in regular methyl branching along an otherwise 
linear PE backbone.41  Conversely, if a 2,1 insertion occurs, the growing polymer 
chain is added to the 1-position of the monomer while the active metal species is 
added to the 2-position. If the metal catalyst chain walks to the ω-position before 
reinsertion, this is termed ω,1-enchainment and produces linear PE regardless of the 
simple α-olefin monomer used. This latter process is also referred to as chain-
straightening.42 Regardless of the insertion (1,2 vs 2,1), if complete chain walking to 
the ω-position does not occur before insertion of a new monomer, branches of various 
lengths along the polymer backbone result. This interesting outcome means that, for 
any given monomer feedstock, there exists a variety of different microstructures that 
can be produced through chain walking. Therefore, controlling the insertion pathway 
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as well as degree of chain walking remains a critical challenge for chemists and often 
requires significant optimization for every new system. 
 
Scheme 3.6 Different modes of monomer insertion leading to different structures. 
 
  
As previously discussed, tacticity plays a crucial role in a polymer’s 
crystallinity and mechanical properties. iPP is typically produced using early metal 
catalysts such as titanium or zirconium. However, although highly active, early metal 
catalysts are easily poisoned by heteroatoms, therefore they require rigorous air-free 
conditions, which make it impossible to incorporate polar monomers. To resolve these 
issues, chemists have turned to late transition metal catalyst such as nickel and 
palladium; however, uncontrolled chain walking has limited the development of these 
catalysts for commercial use. Although chain walking polymerizations have made 
great progress over the last two decades in controlling molecular weights, dispersities, 
degree of branching, and insertion mode, stereoselective chain walking 
polymerizations remain an elusive challenge.43   
 Notable achievements have been made using α-diimine catalysts in 
stereoselective polymerizations. Specifically, Brookhart with DuPont reported that 
polymerization of cyclopentene using α-diimine nickel(II) and palladium(II) 
complexes (3.27) forms modestly isotactic ([mm] = 0.44) cis-1,3-polycyclopentene 
(Scheme 3.7a).44 Although only modestly isotactic, the polymer still had an impressive 
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Tm = 330 and molecular weights up to 251 kg/mol for samples soluble enough for 
GPC analysis. However, in addition to low stereoselectivity, the polymers also 
suffered from broad dispersities (Mw/Mn = 2.5) and long reaction times (6 days). 
Furthermore, the catalyst never chain-walks through the stereocenter generated from 
monomer insertion. Therefore, this reaction is an example of a stereoselective 
insertion followed by chain walking and not stereoselective chain walking. Similarly, 
the Osakada-Takeuchi group has also accessed a variety of stereoregular structures 
through the polymerization of non-conjugated dienes and cyclo-olefins (Scheme 3.7b, 
3.31).45 As in Brookhart’s reaction, the stereoselectivity is derived from the insertion 
of the monomer and not chain walking.  
 
Scheme 3.7 a) Brookhart’s stereoselective polymerization of cyclopentene.44 b) 
Taceuchi’s stereoselective polymerization of non-conjugated dienes.45 
!!
There are very few reports of chain walking polymerization of simple linear 
olefins into stereoregular polymers. The Coates group has made progress in this field. 
For instance, they previously reported the polymerization of trans-2-butene into iso-
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1,3-poly(2-butene)46 (3.37) but with a catalyst system that was only modestly 
isoselective (Scheme 3.8). The resulting polymers exhibited low melting temperatures 
(Tm < 67 °C), and the reaction suffered from low yields, long reaction times, and 
reliance upon using symmetrical monomors due to regio-irregular insertion by the 
catalyst. Similar to the previously described systems, the stereoselectivity of the 
reaction is derived from the insertion event and not stereoselective chain walking. 
 
Scheme 3.8 Coates's iso-selective polymerization of trans-2-butene. 
!
 
Subsequently, the Coates group developed highly isoselective nickel catalysts 
for the polymerization of propylene (Scheme 3.9a, 3.40).47 However, application to 
higher α-olefins resulted in decreased ω,2-enchainment and tacticity, and 
stereoselectivity was only observed at low temperatures (−60 °C). At ambient 
temperatures, a variety of regio- and stereo-errors were formed, yielding an 
amorphous material. Exploiting this behavior, the authors were able to synthesize 
block copolymers by simply warming and cooling the reaction to produce a 
thermoplastic elastomer. Bazan et. al. also demonstrated the ability to polymerize 
propylene in a stereoselective manner, achieving low crystallinity (Tm = 59  °C) 
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(Scheme 3.9b).48  Similar to Coates’s reaction, this system could only achieve 
selectivity at low temperatures. 
In summary, chain walking polymerizations offer an attractive way to generate 
new polymer architectures from previously explored monomers. Given the strong 
structure-property relationship observed in polymers, it remains crucial that 
polymerizations are carried out in a controlled manner; however, exercising control 
over these systems is complicated by the nature of the chain walking mechanism. 
Although significant progress has been made, stereocontrol in chain walking remains a 
challenge. Specifically, there exists no polymerization system where the stereocenter 
is eliminated through chain walking and subsequently re-installed in a stereospecific 
manner. Catalysts capable of better controlling this process would allow access to new 
architectures with improved mechanical properties. With these goals in mind, the next 
chapter focuses on the development of a new isotatic polyolefin material and catalysts 
for its generation. 
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Scheme 3.9 a) Coates’s strategy for the production of elastomers by changing 
temperature.47 b) Iso-selective polymerization of PP at low temperatures to yield iPP.48 
!
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CHAPTER 4 
 
Synthesis of Semi-Crystalline Polyolefin Materials: Precision Methyl Branching 
Using Chiral Isoselective α-Diimine Nickel Catalysts 
  
 ! 130 
4.1. Introduction 
Given the massive global production of PE and iPP and the importance of 
these materials to modern society, new semicrystalline polyolefins produced from 
readily available, inexpensive feedstocks would be of significant interest. 1-Butene 
meets these criteria, and can easily be accessed from both petroleum and biorenewable 
sources. It can be produced by the dehydration of 1-butanol,1 a biomass-derived fuel,2 
or by the dimerization of sugar-derived ethylene.3 Polymerization of 1-butene using 
Ziegler-Natta catalysis results in isotactic 1,2-poly(1-butene) which exhibits superior 
mechanical properties relative to iPP and PE.4 However, its complex crystallization 
hinders its use in many applications.5 Crystallization from the melt gives a kinetically 
favored polymorph (form II), which slowly transforms over several days at room 
temperature to yield a more thermodynamically stable structure (form I), resulting in 
dimensional changes of the material. Recent advances have attempted to address this 
issue, potentially allowing 1,2-poly(1-butene) to be more widely utilized.5  
 ! 131 
Scheme 4.1. Nickel (II) catalyzed 4,2-enchainment polymerization of 1-butene. 
 
 
Since their discovery for olefin polymerization, α-diimine nickel(II) and 
palladium(II) catalysts have received considerable attention.6 The major hallmark of 
these catalysts is their ability to undergo an isomerization event known as chain 
walking, where consecutive β-hydrogen elimination followed by reinsertion into metal 
hydride bond relocates the metal center along the polymer chain. These reactions place 
the active species at various positions along the polymer backbone, allowing for the 
preparation of numerous polymer topologies from simple olefin feedstocks.7 The 
relative rates of chain walking versus insertion can be tuned by catalyst choice and 
reaction conditions which directly impacts the resulting polymer microstructure.8 
  Exhibiting control over polymer tacticity using late metal catalysts is a 
challenge. By nature of the chain walking mechanism, previously installed 
stereocenters can easily be scrambled during polymerization. Notable advancements 
have been achieved, with Brookhart and DuPont reporting the polymerization of 
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cyclopentene using α-diimine Ni(II) and Pd(II) complexes to form modestly isotactic 
cis-1,3-polycyclopentene.9 The Osakada-Takeuchi group has also accessed a variety of 
stereoregular structures through the polymerization of non-conjugated dienes and 
cycloolefins.10 Sigman and coworkers identified a rare example of enantioselective 
chain walking in a redox-relay oxidative Heck-arylation using chiral palladium 
catalysts.  After arylation, the catalyst walks through a branch point and maintains a 
high enantiomeric ratio of the original stereocenter.11   
Despite this progress, there are very few reports for the chain walking 
polymerization of simple linear olefins into stereoregular structures.  We previously 
reported the polymerization of trans-2-butene into iso-1,3-poly(2-butene);12 however, 
the catalyst system was only modestly isoselective ([mm] = 0.41–0.64) with the 
resulting polymers exhibiting low melting temperatures (Tm < 67 °C).  Additionally, 
we developed nickel catalysts that produced iPP presumably through the isoselective 
enchainment of propylene.13 However, application to higher α-olefins resulted in 
materials with poor thermal properties due to increased long chain branching and 
decreased tacticity.14 Based on our previous results yielding semicrystalline iso-1,3-
poly(2-butene), we believed an isoselective catalyst capable of preserving the 
stereochemistry from the insertion event could produce a similar polymer with a high 
melt transition temperature from 1-butene (Scheme 4.1). To the best of our 
knowledge, there have been no reports of late metal polymerization catalysts that can 
perform both isoselective monomer insertion and stereocontrolled chain walking in 
tandem.  
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Figure 4.1. α-Diimine nickel complexes used in this study. 
4.2. Polymerization of 1-Butene 
Herein, we report on the synthesis and utilization of a family of nickel α-
diimine complexes for the polymerization of 1-butene (Figure 4.1). Complex 4.1 
activated with methylaluminoxane (4.1/MAO) has previously been shown to produce 
iPP with melting temperatures up to 137 °C.15 However, the polymerization of 1-
butene generates an amorphous material.14 Analysis of the material by 13C NMR 
spectroscopy revealed that 1,2-insertion followed by isomerization to the chain end 
before subsequent insertion (4,2-enchainment) is the primary insertion mode. 
However, limited stereocontrol as evidenced by a low [mm] triad value limits polymer 
crystallinity (Table 4.1, entry 1). We hypothesized that increasing the steric bulk 
around the metal center using a cumyl-derived complex (Figure 4.1, complex 4.2) may 
be more effective for the regio- and stereoselective polymerization of 1-butene, with 
the additional steric bulk potentially preserving the stereochemical information 
imparted by the initial insertion event. 
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Activation of complex 4.2 with MAO in the presence of 1-butene resulted in 
the production of a white, powdery material. GPC and DSC analysis revealed a 
polymer with modest molecular weight (12.8 kDa), controlled unimodal molecular 
weight distribution (1.60), and a melting temperature (Tm) of 77 °C (Table 4.1, entry 
2). Analysis by 13C NMR spectroscopy revealed a microstructure composed primarily 
of 4,2-poly(1-butene) units from 4,2-enchainment (4, 2 = 0.94) and high amounts of 
isotacticity ([mm] = 0.75). The observed tacticity is considerably higher than that 
reported previously for the polymerization of trans-2-butene ([mm] = 0.41–0.64).12 
 
Scheme 4. 2. Proposed source of stereoselectivity in chain walking polymerization of 
1-butene. 
 
 
The addition of ortho-cumyl groups had a dramatic effect on the isoselectivity of 
the resulting 4,2-poly(1-butene). We believe that the steric environment created from 
this specific substitution pattern facilitates both the necessary enantioface coordination 
event and stereoselective chain isomerization. Enantioface traversion during the chain 
isomerization event is limited by the methyl substituent in the cumyl group, resulting 
in the observed isoselectivity (Scheme 4.2). Additionally, a π-stacking interaction with 
the ortho-aryl substituents and the acenaphthene backbone can be observed in the 
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solid state for complex 4.2.13 We believe this π-stacking interaction persists in solution 
at the low reaction temperature, causing the catalyst to maintain a very specific steric 
environment, which contributes to the observed selectivity.  
 
Figure 4.2. 13C NMR spectrum of 4,2-poly(1-butene) produced by complex 4.7/MAO 
(Table 4.1, entry 7). 
 To probe our assumptions regarding the source of selectivity for 1-butene 
polymerization, perturbations to the ligand framework were made. Electronic variants 
of the ortho-cumyl nickel complexes were first studied. It was found that MAO-
activated 4.3 bearing electron withdrawing fluoro-substituents produced materials with 
higher molecular weight (23.3 kDa), slightly elevated Tm (80 °C), and improved 
isotacticity ([mm]= 0.79) compared to 4.2/MAO. MAO-activated 4.4, bearing electron 
donating methoxy-substituents, however, produced materials with a decreased Tm (73 
°C) and lower isotacticity ([mm]= 0.73). Selectivity for 4,2-enchainment also 
decreased slightly for 4.4/MAO (0.91). We also studied a tert-butyl substituted 
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complex 4.5, which is slightly more electron donating than complex 4.2 with the 
methyl substituent. To our surprise, 4.5/MAO produced 4,2-poly(1-butene) with the 
highest levels of isotactity in the whole electronic series ([mm] = 0.80) and a Tm of 85 
°C. From analysis of the crystal structure, we believe distal steric effects may rigidify 
the active catalyst structure and inhibit rotation of the aryl side chains away from the 
acenaphthene backbone, allowing for the π-stacking interaction to be better 
maintained. Another viable possibility is that the tert-butyl substituents in 4.5 affect 
the ion pairing interaction of the cationic nickel complex and the MAO activator, such 
that an improvement in selectivity is observed.16 
We continued probing this system by modifying the aryl substituent of the 
cumyl group from phenyl (4.2) to 1-napthyl (4.6). Complex 4.6/MAO exhibited 
similar tacticity to that of complex 4.5/MAO ([mm] = 0.80) and a similar Tm of 86 °C. 
We believe the π-stacking interaction between the 1-napthyl group and the 
acenapthene backbone is enhanced due to the additional π-cloud overlap, resulting in a 
more rigidified structure that contributes to the desired regio- and stereoselectivity. 
After observing the enhanced selectivities for materials produced by MAO-activated 
4.5 and 4.6, we attempted to further rigidify the system by synthesizing complex 4.7, 
bearing both tert-butyl and 1-napthyl substituents (Figure 4.1). The polymer produced 
by 4.7/MAO exhibited improved isotacticity ([mm] = 0.84) compared to the polymers 
produced by 4.5/MAO and 4.6/MAO (Figure 4.2). Interestingly, despite the increase 
in tacticity, there was no improvement in the observed thermal properties of the 
resulting material (Table 4.1, entry 7). 
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Table 4.2. Effects of Varying REaction Conditions on the Polymerization of 1-Butene.a 
entry 
Trxn 
(°C) 
conc 
(M) 
yield 
(mg) 
Mnb 
(kDa) 
Đb 
(Mw/Mn) 
Tmc 
(°C) 
1 −10 7.8 262 10.8 1.95 –d 
2 −30 7.8 420 23.7 1.80 66 
3 −40 7.8 234 14.7 1.57 85 
4 −50 7.8 173 10.6 1.81 85 
5 −40 6.0e 163 12.4 1.46 80 
6 −40 9.1f 464 16.3 2.17 73 
aPolymerization conditions: 3.0 ± 0.2 g 1-butene (53.5 mmol), 10 µmol of complex 
4.5 in 2 mL CH2Cl2, 100 equiv. MAO; trxn = 24 h, Trxn = −40 °C. bDetermined by 
gel permeation chromatography at 150 °C in 1,2,4-trichlorobenzene versus 
polyethylene standards. cDetermined by differential scanning calorimetry, 
endotherm from 2nd heating cycle. dNo detectable Tm. e1.5 ± 0.2 g 1-butene (26.8 
mmol). f6.0 ± 0.2 g 1-butene (107.0 mmol). 
  
The thermal properties of 4,2-poly(1-butene) are influenced not only by 
tacticity, but also by branch composition. A small percent of ethyl branches were 
detected in these systems, which can be installed through 1,2-insertion of 1-butene 
without chain walking. Ethyl branches can considerably reduce Tm and crystallinity.17 
When 1,2-enchainment pathways are minimized in these systems, increased melting 
temperatures are generally observed (Table 4.1, entry 5).  Another defect observed in 
this system arises from 4,1-enchainment, where 2,1-insertion followed by complete 
chain walking produces a linear polyethylene segment. Due to the small amount of 
these units (< 5%), it is difficult to quantify its effect on the properties of the resulting 
4,2-poly(1-butene).18 Recent studies have shown that iPP with < 5% 3,1-insertions, 
made with related cumyl-substituted catalysts retained most of its crystallinity, 
suggesting that the effect in this system may also be small.19 
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We further studied the effects of reaction conditions on the thermal properties 
of the resulting polymers produced by 4.5/MAO. Reaction temperature had a dramatic 
effect on polymer thermal properties.  By increasing the temperature from −40 °C to 
−30 °C, the melting temperature of the resulting material dropped considerably from 
85 °C to 66 °C.  Increasing the reaction temperature further to −10 °C resulted in a 
complete loss of crystallinity.  Cooling the reaction to −50 °C decreased the reaction 
rate and polymer yield, and resulted in materials with similar thermal properties to 
those produced at −40 °C. The effect of 1-butene concentration was also studied. 
Increasing the concentration from the standard 7.8 M to 9.1 M resulted in a higher 
yield but a decrease in tacticity ([mm] = 0.61) and melting temperature (Table 4.2, 
entry 6). Decreasing the concentration of 1-butene to 6.0 M resulted in a material with 
a slightly depressed melting temperature compared to the standard conditions (Table 
4.2, entry 5) caused by a decrease in polymer tacticity ([mm] = 0.70). 
Reaction solvent also played an important role in material properties. 
Dichloromethane was found to be the most suitable solvent for this system (Table 4.3, 
entry 1).  Using aromatic solvents generally resulted in a decrease in the Tm of the 
polymer. We suspect that aromatic solvents may have competitive interactions with at 
the acenaphthene backbone, disrupting of the π-stacking interaction with the cumyl 
side-chain. Unexpectedly, 1,2-difluorobenzene produced a high Tm material, contrary 
to the other aromatic solvents screened. This may be a result of its significantly higher 
polarity potentially affecting the ion pairing interaction.   
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Table 4.3. Solvent Effects on the Polymeriztion of 1-Butene.a 
entry solvent TOF
b 
(h−1) 
yield 
(mg) 
Mnc 
(kDa) 
Đc 
(Mw/Mn) 
Tmd 
(°C) 
1 CH2Cl2 17 234 14.7 1.57 85 
2 PhMe 15 198 12.2 1.96 79 
3 PhCl 25 338 21.1 1.85 76 
4 C6H4F2e 17 223 10.9 2.05 82 
aPolymerization conditions: 3.0 ± 0.2 g 1-butene (53.5 mmol), 10 µmol of complex 
4.5 in 2 mL solvent, 1.0 mmol MAO; trxn = 24 h, Trxn = −40 °C. bTurnover 
frequency, TOF = (mol monomer consumed)(mol catalyst)−1(time)−1. cDetermined 
by gel permeation chromatography at 150 °C in 1,2,4-trichlorobenzene versus 
polyethylene standards. dDetermined by differential scanning calorimetry, endotherm 
from 2nd heating cycle. e1,2-difluorobenzene.  
 
Returning to our assertion of stereoselective insertion versus chain walking, it 
is not immediately clear why complex 1/MAO produces iPP from propylene but 
atactic polymer from higher α-olefins. Conceivably, propylene polymerization can 
proceed through two different mechanisms that lead to the same iPP product: (1) 
consecutive isoselective insertions without chain walking, or (2) consecutive 
isoselective insertions with stereocontrolled chain walking. To confirm which 
mechanism is operative for propylene, we performed a deuterium study using [3-
d3]propylene at −78 °C and 4.1/MAO. If chain walking is occurring, the deuterium 
atoms should scramble throughout the polymer backbone. Under these conditions, 
however, the deuterium atoms remained on the methyl branches of the polymer, 
demonstrating that chain walking during the polymerization of propylene does not 
occur (Scheme 4.3). This strongly suggests that tacticity is lost in the chain walking 
step of the polymerization of higher α-olefins using 4.1/MAO. Since the formation of 
4,2-poly(1-butene) requires chain isomerization, we believe the isotactic enchainment 
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of 1-butene presented in this work is the first example of stereoselective chain 
walking. 
Scheme 4.3. Deuterated Propylene Study. 
 
Finally, we examined the mechanical properties of 4,2-poly(1-butene). 
Polymer films were melt-pressed, directly into a tensile bar mold, at 95 °C under a 
pressure of 5.2 MPa for 15 min and cooled at a rate of ∼6 °C/min to 22 °C. The tensile 
bars were subsequently used for analysis of mechanical properties. Tensile strength 
was measured for a sample produced by 4.5 and Figure 4.3 shows a representative 
tensile strength curve. Interestingly, the resulting material experiences yielding at 
relatively low stress values (~5 MPa) in comparison to other thermoplastics such as 
iPP.1 After yielding, the material experiences high elongations up to 600% strain 
before breaking with a gradual increase in stress during elongation.  
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Figure 4.3. Representative tensile strength curve for 4,2-poly(1-butene). 3.0 ± 0.2 g 1-
butene, 10 µmol of Ni complex 4.5 in 2 mL CH2Cl2, 100 equiv. MAO; trxn = 168 h, 
Trxn = −40 °C. yield = 3.52 g, Mn = 29.5 kDa, Đ = 1.60, Tm = 80 °C. 
 
In summary, we performed the iso- and regioselective polymerization of 1-
butene using cationic α-diimine nickel(II) complexes to produce semi-crystalline 4,2-
poly(1-butene). The methyl substituents on the cumyl-groups of the ligand are crucial 
for preventing enantioface traversion and retaining stereochemical information. 
Furthermore, rigidifying the structure of the active catalyst through π-stacking 
interactions with the catalyst backbone was also beneficial for improving tacticity. 
This system represents the first example of re-establishing stereochemistry of a branch 
unit after it has been eliminated through the chain walking mechanism. This method 
allows access to isotactic polymers from simple, inexpensive feedstocks. Additional 
catalyst development is currently in progress to further increase the selectivity of this 
unique process. 
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4.3. Experimental 
General Considerations 
All manipulations of air- and/or water-sensitive compounds were carried out 
under dry nitrogen using a Braun UniLab drybox or standard Schlenk techniques. 
NMR spectra were acquired using either a Varian Mercury (300 MHz) or a Varian 
Inova (400 MHz) and were referenced versus residual nondeuterated solvent solvent 
shifts (1H, 13C). Polymer NMR spectra were acquired using a Bruker AV III HD with 
broadband Prodigy cryoprobe and were referenced versus residual nondeuterated 
solvent solvent shifts (1H, 13C).  The mass spectrum was recorded using a Exactive 
Plus Orbitrap Mass Spectrometer with a DART SVP ion source from Ion Sense or a 
Waters MALDI Micro MX system. The sample was prepared by using the dried 
droplet method with no matrix present. Ionization was by a 257 nm UV nitrogen laser 
and the accelerating potential was 17.2 keV.  The spectrum was recorded using the 
reflectron in positive ion mode. Molecular weights (Mn and Mw) and polydispersities 
(Mw/Mn) were determined by high temperature gel permeation chromatography (GPC) 
using a Waters Alliance GPCV 2000 GPC equipped with a Waters DRI detector and 
viscometer. The column set (four Waters HT 6E and one Waters HT2) was eluted 
with 1,2,4-trichlorobenzene containing 0.01 wt. % di-tert-butylhydroxytoluene (BHT) 
at 1.0 mL/min at 150 °C. Data were calibrated using monomodal polyethylene 
standards. Polymer melting points (Tm) and glass transition temperatures (Tg) were 
measured by differential scanning calorimetry (DSC) using a TA Instruments Q1000 
calorimeter equipped with an automated sampler. Analyses were performed in 
crimped aluminum pans under nitrogen and data were collected from the second 
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heating run at a heating rate of 10 °C/min from -70 to 200 °C, and processed with TA 
Q series software. 
Materials 
Toluene and hexanes were purified over columns of alumina and copper (Q5). 
Methylene chloride was purified over an alumina column and degassed by three 
freeze-pump-thaw cycles before use.  1,2-difluorobenzene, chloroform, 
dibromomethane, and chlorobenzene were dried over crushed CaH2 for 24 hours and 
degassed by three freeze-pump-thaw cycles before use. Acenaphthenequinone 
(Aldrich), α-methylstyrene (Aldrich), 4-fluoroaniline (Aldrich), formic acid (Aldrich), 
trifluoromethanesulfonic acid (CF3SO3H, Aldrich), 1-Butene (Aldrich), and 
(dimethoxyethane)NiBr2 ((DME)NiBr2, Strem) were used without further purification. 
Methylaluminoxane (MAO) was generously donated from Albemarle Corporation as 
a 30% wt solution in toluene which was dried by evaporation of volatiles giving a 
white powder.  Complexes 4.1, 4.2, and 4.6 were synthesized as previously 
reported.13,15 
4-Fluoro-2-(2-phenylpropan-2-yl)aniline (4.8). CF3SO3H (0.54 mL, 6.0 mmol) was 
added to a mixture of 4-fluoroaniline (2.85 mL, 30.0 mmol) and 
 α-methylstyrene (3.90 mL, 30.0 mmol). The mixture was heated 
to 160 °C and allowed to react for 20 h. The reaction was 
quenched with a solution of saturated NaHCO3, followed by an 
extraction with dichloromethane. Organics were combined, dried over MgSO4, 
filtered, and concentrated. The crude product was chromatographed on silica (95:5 
hexanes:ethyl acetate) and dried to give a light purple solid (2.98 g, 43 %). 1H NMR 
NH2
F 4.8
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(500 MHz, CDCl3):  δ 7.34–7.28 (m, 4H, ArH), 7.25–7.18 (m, 2H, ArH) 6.79 (m, 1H, 
ArH), 6.47 (dd, J = 5.23 Hz, J =  8.62 Hz, 1H, ArH), 3.02 (broad s, 2H, NH2), 1.68 (s, 
6H, C(CH3)2). 13C NMR (125 MHz, CDCl3): δ 156.5 (d, JCF = 235.0 Hz), 148.6, 
140.6 (d, JCF = 2.1 Hz), 135.3 (d, JCF = 5.7 Hz), 129.0, 126.5, 125.9, 118.0 (d, JCF = 
7.7 Hz), 113.7 (d, JCF = 2.9 Hz), 113.5, (d, JCF = 1.4 Hz) , 42.5 (d, JCF = 1.1 Hz), 28.9. 
HRMS (DART) m/z calc for C15H17NF (M+H)+: 230.1345, found 230.1345.  
rac-ArN=C(An)C=NAr (Ar = 4-flouro-2-(2-phenylpropan-2-yl)phenyl; An = 
acenaphthene) (4.9). In a sealed vial a mixture of 
4.8 (0.504 g, 2.20 mmol), acenaphthenequinone 
(0.182 g, 1.00 mmol), and anhydrous ZnCl2 (0.157 
g, 1.15 mmol) in glacial acetic acid (2.2 mL) was 
heated to 130 °C with stirring for 1 h.  Upon 
stirring, bright yellow solids precipitated. The solution was cooled briefly (5 minutes) 
and then filtered over a Buchner funnel. The yellow solids were washed with AcOH 
(3x2 mL) and then washed with Et2O (8x3 mL).  Drying in vacuo afforded a yellow 
solid (58 %). A small portion was set aside, wit the rest immediately used in the next 
step. The intermediate (0.317 g) was dissolved in DCM (100 mL) in an Erlenmeyer 
flask. A solution of excess potassium oxalate hydrate in water (4 mL) was added.  The 
biphasic reaction was stirred vigorously for 1 h.  The organic layer was separated and 
dried over Na2SO4, filtered, and concentrated to give a bright yellow solid (0.206 g, 
80 %, 69% over two steps). 1H NMR (500 MHz, d2-TCE, 100 °C)  δ 7.77 (d, J = 7.9 
Hz, 2H, ArH), 7.39 (d, J = 10.6 Hz, 2H, ArH), 7.28 (br s, 2H, ArH), 7.11 (d, J = 7.5 
Hz, 4H, ArH), 7.02 (m, 2H, ArH), 6.88–6.58 (m, 8H, ArH), 6.36 (br s, 2H, ArH ), 
1.85 (br s, 12H, C(CH3)2). 13C NMR (125 MHz, d2-TCE, 100 °C): δ 159.9 (d, JCF = 
241.8 Hz), 148.8, 141.2, 130.1, 127.7, 126.9, 126.6 (br s), 126.2, 124.2, 122.7 (br s), 
4.9
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119.3 (br s), 114.2 (d, JCF = 21.8 Hz), 112.9 (d, JCF = 21.8 Hz), 42.8, 28.4 (br s). 
HRMS (DART) m/z calc for C42H35N2F2 (M+H)+: 605.2762, found 605.2762.  
 
rac-(ArN=C(An)C=NAr)NiBr2 (Ar = 4-flouro-2-(2-phenylpropan-2-yl)phenyl; 
An = acenaphthene) (4.3). 4.9 (0.388 g, 0.642 
mmol) and (DME)NiBr2 (0.198 g, 0.0.642 mmol) 
were combined under N2. CH2Cl2 (ca. 15mL) was 
added to afford a dark red solution, which was 
allowed to stir for 18 h. The reaction mixture was filtered through Celite under N2 and 
volatiles were then removed in vacuo. The crude red solid was redissolved in CH2Cl2 
and layered with hexanes to afford a dark red microcrystalline solid (0.092 g, 17 %). 
MALDI (m/z): 822.8.  
4-OMe-2-(2-phenylpropan-2-yl)aniline (4.10). CF3SO3H (0.30 mL, 3.38 mmol) was 
added to a mixture of p-Anisidine (3.13 g, 25.4 mmol) and  α-
methylstyrene (2.20 mL, 16.9 mmol). The mixture was heated to 
160 °C and allowed to react for 20 h. The crude product was 
chromatographed on silica (90:10 hexanes:ethyl acetate) and dried 
in vacuo to afford a light beige solid (2.77 g, 68 %). 1H NMR (CDCl3, 500 MHz):  δ 
7.32–7.27 (m, 4H, ArH), 7.24–7.18 (m, 2H, ArH),  7.10 (d, J = 2.8 Hz, 1H, ArH), 
6.67 (dd, J = 2.9 Hz, J = 8.5 Hz, 1H, ArH), 6.50 (d, J = 8.5 Hz, 1H, ArH) 3.81 (s, 3H, 
OCH3), 2.90 (s, 2H, NH2), 1.69 (s, 6H, C(CH3)2). 13C NMR (125 MHz, CDCl3): δ 
152.6, 149.2, 138.3, 135.5, 128.9, 126.3, 126.0, 118.3, 114.0, 111.5, 55.8, 42.6, 29.1. 
HRMS (DART) m/z calc for C16H20NO (M+H)+: 242.1545, found 242.2544. 
4.3
OMe
NH2
4.10
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rac-ArN=C(An)C=NAr (Ar = 4-OMe-2-(2-phenylpropan-2-yl)phenyl; An = 
acenaphthene) (4.11). In a sealed vial a 
mixture of 4.10 (0.600 g, 2.49 mmol), 
acenaphthenequinone (0.216 g, 1.18 mmol), 
and glacial acetic acid (0.43 mL, 7.58 mmol) 
in toluene (3.1 mL) was heated and stirred at 100 °C for 16 h. The solution was 
removed from heat for 5 minutes, followed by filtration over Celite® and washing 
with DCM. Volatiles were removed in vacuo until a sticky, orange solid was obtained. 
The crude mixture was triturated in cold hexanes (~20 mL), filtered, and then washed 
with copious cold hexanes (~100 mL). Drying in vacuo afforded a bright orange 
powder (0.191 g, 26 %). 1H NMR (500 MHz, d2-TCE, 100 °C)  δ 7.74 (d, J = 7.1 Hz, 
2H, ArH), 7.23 (br s, 4H, ArH), 7.15 (d, J = 6.7 Hz, ArH), (broad s, 12H, C(CH3)2). 
13C NMR (125 MHz, d2-TCE, 100 °C) δ 158.9, 156.6, 149.4, 144.0, 140.6, 130.1, 
128.9, 127.3, 126.8, 126.5, 126.3, 124.0, 122.6, 119.1, 114.4, 111.1, 55.5, 42.9, 28.6. 
HRMS (DART) m/z calc for C44H41N2O2 (M+H)+: 629.3162, found 629.3177. 
rac-(ArN=C(An)C=NAr)NiBr2 (Ar = 4-OMe-2-(2-phenylpropan-2-yl)phenyl; An 
= acenaphthene) (4.4). 4.11 (0.191g, 0.304 
mmol) and (DME)NiBr2 (0.092 g, 0.298 
mmol) were combined under N2 in a Schlenk 
flask. CH2Cl2 (7 mL) was added to afford a 
dark red solution, which was allowed to stir at 22 °C for 18 hours. The reaction 
mixture was filtered through Celite under N2 and volatiles were removed in vacuo. 
The crude red solid was redissolved in CH2Cl2 and layered with hexanes to afford 
dark red blocky crystals (0.155 g, 62 %).  
N N
Ph
MeO OMe
Ph
4.11
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4-tBu-2-(2-phenylpropan-2-yl)aniline (4.12). CF3SO3H (0.10 mL, 1.1 mmol) was 
added to a mixture of 4-tbutylaniline (2.52 g, 16.9 mmol) and  α-
methylstyrene (0.40 g, 3.4 mmol). The mixture was heated to 160 
°C and allowed to react for 20 hours before it was diluted with 
EtOAc and washed with a saturated solution of NaHCO3.  The 
organic solution was dried over Na2SO4, filtered, and concentrated to give a crude 
brown oil. The crude product was chromatographed on silica (95:5 hexanes/ethyl 
acetate) to give a pale yellow oil (0.399 g, 44 %). 1H NMR (400 MHz, CDCl3) δ 7.45 
(d, J = 2.3 Hz, 1H), 7.30 – 7.21 (m, 4H), 7.19 – 7.11 (m, 1H), 7.06 (dd, J = 8.2, 2.3 
Hz, 1H), 6.44 (d, J = 8.2 Hz, 1H), 2.98 (br s, 2H), 1.65 (s, 6H), 1.30 (s, 9H). 13C 
NMR (126 MHz, CDCl3) δ 149.6, 141.9, 140.9, 133.0, 128.8, 126.1, 125.9, 124.0, 
123.3, 117.1, 42.6, 34.2, 31.8, 29.2. HRMS (DART) m/z calc for C19H26N (M+H)+: 
268.2065, found 268.2061.  
rac-ArN=C(An)C=NAr (Ar = 4-tBu-2-(2-phenylpropan-2-yl)phenyl; An = 
acenaphthene) (4.13). In a sealed vial a mixture 
of 4.12 (0.399 g, 1.5 mmol), acenaphthenequinone 
(0.108 g, 0.60 mmol), and ZnCl2 (0.092 g, 0.67 
mmol) in glacial acetic acid (3 mL) was heated to 
130 °C with stirring for 2 h.  Upon cooling to 
room temperature, a brown solid crashed out.  The solid was filtered and washed with 
Et2O.  The solid was then dissolved in DCM (5 mL) and added to a solution of water 
(5 mL) and excess potassium oxalate hydrate.  The biphasic reaction was stirred 
vigorously for 12 h.  The organic layer was separated and dried over Na2SO4, filtered, 
and concentrated to give a red orange solid (0.260 g, 64 %). 1H NMR (400 MHz, 
CDCl3) δ 7.71 – 7.60 (m, 4H), 7.28 (s, 2H), 7.14 (t, J = 7.7 Hz, 2H), 7.06 (d, J = 7.9 
tBu
NH2
4.12
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Hz, 4H), 6.71 (d, J = 8.1 Hz, 2H), 6.48 (d, J = 8.3 Hz, 4H), 6.14 (s, 2H), 1.82 (s, 12H), 
1.44 (s, 18H). 13C NMR (126 MHz, CDCl3) δ 158.8, 150.0, 148.1, 146.93, 141.1, 
138.1, 130.1, 129.1, 127.5, 126.9, 126.7, 126.6, 124.0, 123.8, 123.6, 123.1, 117.9, 
43.0, 34.8, 31.9. HRMS (DART) m/z calc for C50H53N2 (M+H)+: 681.4209, found 
681.4208.  
rac-(ArN=C(An)C=NAr)NiBr2 (Ar = 4-tBu-2-(2-phenylpropan-2-yl)phenyl; An = 
acenaphthene) (4.5). 4.13 (0.260 g, 0.38 mmol) 
and (DME)NiBr2 (0.117 g, 0.38 mmol) were 
combined under N2. CH2Cl2 (ca. 5mL) was added 
to afford a dark red solution, which was allowed to 
stir for 18 h.  The reaction mixture was filtered 
through Celite under N2 and volatiles were then removed in vacuo. The crude red 
solid was redissolved in a minimum amount of CH2Cl2 and layered with hexanes (4 x 
the volume of DCM) to afford a dark red crystalline solid (0.226 g, 66 %).  
 4-tBu-2-(2-(naphthalen-1-yl)propan-2-yl)aniline (4.14). CF3SO3H (0.40 mL, 4.5 
mmol) was added to a mixture of 4-tBu-aniline (12.0 g, 80.4 
mmol) and 1-(prop-1-en-2-yl)naphthalene (2.54 g, 15.1 mmol) 
and 2 mL xylenes. The mixture was heated to 160 °C and 
allowed to react for 20 h.  The material was then cooled to room 
temperature and washed with a saturated solution of NaHCO3 and dried over Na2SO4. 
The crude product was chromatographed on silica (95:5 hexanes:ethyl acetate) to give 
an off-white solid (596 mg, 12 %). 1H NMR (500 MHz, CDCl3) δ 7.90 (d, J = 8.8 Hz, 
1H), 7.84 – 7.81 (m, 2H), 7.80 (d, J = 8.2 Hz, 1H), 7.73 (d, J = 2.3 Hz, 1H), 7.52 (t, J 
= 7.8 Hz, 1H), 7.36 (ddd, J = 8.0, 6.7, 1.1 Hz, 1H), 7.13 (ddd, J = 8.5, 6.8, 1.4 Hz, 
1H), 7.08 (dd, J = 8.2, 2.3 Hz, 1H), 6.35 (d, J = 8.1 Hz, 1H), 3.03 (s, 2H), 1.94 (s, 
N N
Ph
tBu tBu
Ph
Br2
Ni
4.5
tBu
NH2
4.14
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6H), 1.44 (s, 9H). 13C NMR (125 MHz, CDCl3) δ 145.3, 142.0, 141.7, 134.9, 133.3, 
131.4, 129.0, 128.2, 125.9, 125.5, 125.4, 125.0, 123.8, 123.1, 122.6, 117.1, 43.2, 34.4, 
31.9. HRMS (DART) m/z calc for C23H28N (M+H)+: 318.2222, found 318.2215.  
 rac-ArN=C(An)C=NAr (Ar = 4-tBu-2-(2-(naphthalen-1-yl)propan-2-yl)aniline; 
An = acenaphthene) (4.15). In a sealed vial a 
mixture of 4.14 (0.597 g, 1.9 mmol), 
acenaphthenequinone (0.114 g, 0.62 mmol), 
glacial acetic acid (0.244 g, 4.1 mmol) were 
dissolved in anhydrous PhMe (3 mL). 4Å mol 
sieves were added and the solution was heated to 130 °C with stirring for 12 h.  After 
cooling to room temperature, a crude solution was purified by column 
chromatography (95:5 hexanes/ethyl acetate) with no additional workup.  Analytical 
samples were prepared by dissolving the purified material in a minimum amount of 
DCM and layering with MeOH, producing orange needles upon crystallization (180 
mg, 37%). 1H NMR (500 MHz, d2-TCE, 100 °C) δ 8.01 (d, J = 8.6 Hz, 2H), 7.85 (br 
s, 2H), 7.58 (d, J = 7.4 Hz, 2H), 7.45 (br s, 2H), 7.32 (d, J = 8.1 Hz, 2H), 7.12 – 6.96 
(m, 8H), 6.92 – 6.70 (m, 6H), 6.25 (br s, 2H), 2.10 (br s, 12H), 1.50 (br s, 18H). 13C 
NMR (125 MHz, d2-TCE, 100 °C) δ 157.7, 147.1, 146.9, 145.5, 140.1, 138.3, 134.2, 
131.0, 129.5, 128.3, 126.8, 126.4, 125.9, 124.3, 124.3, 123.8, 123.4, 123.4, 122.7, 
121.8, 117.7, 43.8, 34.3, 31.4, 29.2. HRMS (DART) m/z calc for C58H57N2 (M+H)+: 
781.4522, found 781.4532. 
 
rac-(ArN=C(An)C=NAr)NiBr2 (Ar = 4-tBu-2-(2-(naphthalen-1-yl)propan-2-
yl)aniline; An = acenaphthene) (4.7). 4.15 (0.180 g, 0.231 mmol) and (DME)NiBr2 
(0.071 g, 0.231 mmol) were combined under N2. CH2Cl2 (ca. 15 mL) was added to 
N N
1-Naphth
tBu tBu
1-Naphth
4.15
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afford a dark red solution, which was allowed to 
stir at 23°C for 18 h. The reaction mixture was 
filtered through Celite under N2 and volatiles 
were then removed in vacuo. The crude red solid 
was then dissolved in a minimum amount of DCM and layered with 4x volume of 
hexanes to afford red needles  (0.116 g, 50 %).  
General Procedure for the Polymerization of 1-Butene 
A 60 mL Fisher Porter tube was charged with a stir bar and dMAO (0.060 g, 1.0 
mmol) under N2. 1-Butene (3.0 g ± 0.2 g, 0.05 mol) was condensed into the vessel at -
78 °C. The reaction vessel was then transferred to a cooling bath at −40 °C and the 
solution was allowed to equilibrate at this temperature for 15 min. The appropriate 
pre-catalyst (10 µmol) was dissolved in 2 mL of DCM, drawn into a gas-tight syringe 
and then injected to initiate the polymerization. The reaction was stirred at −40 °C for 
24 h before quenching with ~2 mL MeOH.  The polymer was precipitated with 
copious amounts of acidic methanol (5% HCl/MeOH), followed by stirring of the 
suspension until the color faded, giving a white suspension. The polymer was filtered, 
washed with methanol, and dried to constant weight in vacuo. 
 
!
 
 
 
  
N N
1-Naphth
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13C NMR Signal Assignments 
Signals were assigned based on DEPT-135 and previous assignments performed 
in the literature.20 Chemical shifts were normalized to the residual nondeuterated 
tetrachloroethane signal at 73.78 ppm. The naming convention developed by Usami 
and Takayami is listed in the table below.21 Common structural motifs found in these 
polymers are also drawn below with their respective peak assignments for clarity. 
 
Table 4.4. 13C NMR signal assignments for 
4,2-poly(1-butene) produced by nickel 
catalysts in this study. 
 
Signal
Label 
Chemical 
Shift (ppm) 
Assignment
(xBn) Reference 
A 19.26–19.76 1B1 21a 
B 32.71–33.49 brB1 21a 
C 33.78–34.36 αβB1 21a 
D 36.48–37.54 αB1 21b 
E 26.25–27.30 βB1 21c 
F 25.65 γB1 21c 
G 29.25 δB1-n 21b, 21c 
H 10.22–10.68 1B2 21b 
I 26.05 2B2 21b 
J 36.97 brB2 This Work 
K 41.70 ααB1B2 21c 
L 30.68 brB1 21d 
M 19.96 1B1 21d 
N 39.01 brB2 21c 
 
C
C
B
A
4,2-unit
(1,2-insertion, full walk)
4,1-unit
(2,1-insertion, full walk)
D
E
F
F
E
D
D F G
GE
EG
G F D
consecutive 4,1-units
(2,1-insertion, full walk)
HM
L JK
I
1,2-unit
(1,2-insertion, no walk,
then 1,2-insertion)
H
I
N
1,2-unit
(1,2-insertion, no walk,
then 2,1-insertion)
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Derivation of Values for Enchainment Pathways 
Signals A, B, and C all arise from the main 4,2-poly(1-butene) structure which 
comes from ω,2-enchainment. Signals L and M are included as part of ω,2-
enchainment because they are part of a 4,2-unit. If ω,1-enchainment occurs after ω,2-
enchainment, signals D, E, and F are installed. However, this enchainment causes 
signals C from the 4,2-unit to change into D and E. When ω,2-enchainment occurs 
after ω,1-enchainment, additional D and E signals are observed which are associated 
with the 4,1-unit. This means that half of the signals from D and E are associated with 
a 4,2-unit and the other half with a 4,1-unit. Thus. we split the integrations for these 
signals between ω,2 and ω,1-enchainment. Successive ω,1-enchainments lead to 
signal G in the 4,1-unit. Signals H, I, J, K and N all arise solely from 1,2-
enchainment. There is evidence of a small portion of isolated ethyl branches in these 
materials which give signals H, I, N, and D. We chose not to correct for D in this 
situation since the effect of the correction is very small. In some cases, there are signs 
of longer chain branches that arise from multiple insertion pathways. These are small 
and not included in the main calculations. 
 
Figure 4.4. Equations used to calculate enchainment pathways. 
(4,2) =
(4,1) = (1,2) =
[A+B+C+0.5(D+E)+L+M]
Σ(A-N)
[0.5(D+E)+F+G]
Σ(A-N)
[H+I+J+K+N]
Σ(A-N)
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Expanded Tables for Effect of Reaction Conditions on the Polymerization of 1-
Butene using 4.5. 
!
Table 4.5. Effect of Reaction Conditions on the Polymerization of 1-Butene using 
complex 4.5.a 
 
 
Table 4.6. Effect of Solvent on the Polymerization of 1-Butene using Complex 4.5.a 
  
1. Expanded Tables for Effect of Reaction Conditions on the 
Polymerization of 1-Butene using 5 
 
Table S1. Effect of Reaction Conditions on the Polymerization of 1-Butene using Complex 4.5a !
entry temp (°C) 
conc 
(M) 
yield 
(mg) 
Mnb 
(kDa) 
Đb 
(Mw/Mn) 
Tmc 
(°C) 4,1
d 4,2 d 1,2 d [mm]d 
1 −10 7.8 262 10.8 1.95 – n.d.g n.d. g n.d. g n.d. g 
2 −30 7.8 420 23.7 1.80 66 0.17 0.79 0.04 0.53 
3 −40 7.8 234 14.7 1.57 85 0.03 0.93 0.03 0.80 
4 −50 7.8 173 10.6 1.81 85 0.02 0.96 0.02 0.80 
5 −40 6.0e 163 12.4 1.46 80 0.05 0.91 0.04 0.70 
6 −40 9.1f 464 16.3 2.17 73 0.14 0.83 0.03 0.59 
aPolymerization conditions: 3.0 ± 0.2 g 1-butene (53.5 mmol), 10 µmol of complex 4.5 in 2 
mL CH2Cl2, 100 equiv. MAO; trxn = 24 h, Trxn = −40 °C. bDetermined by gel permeation 
chromatography at 150 °C in 1,2,4-trichlorobenzene versus polyethylene standards. 
cDetermined by differential scanning calorimetry, endotherm from 2nd heating cycle. 
dDetermined by 13C NMR spectroscopy. No detectable Tm. e1.5 ± 0.2 g 1-butene (26.8 
mmol). f6.0 ± 0.2 g 1-butene (107.0 mmol). gNot determined. 
 
 
Table S2. Effect of Solvent on the Polymerization of 1-Butene using Complex 4.5a !
entry solvent yield (mg) 
Mnc 
(kDa) 
Đc 
(Mw/Mn
) 
Tmd 
(°C
) 
4,1e 4,2 e 1,2 e [mm]e 
1 CH2Cl2 234 14.7 1.57 85 0.03 0.93 0.03g 0.80 
2 PhMe 198 12.2 1.96 79 0.02 0.95 0.03 0.79 
3 PhCl 338 21.1 1.85 76 0.07 0.90 0.03 0.76 
4 C6H4F2f 223 10.9 2.05 82 0.06 0.86 0.06g 0.72 
aPolymerization conditions: 3.0 ± 0.2 g 1-butene (53.5 mmol), 10 µmol of complex 4.5 
in 2 mL solvent, 1.0 mmol MAO; trxn = 24 h, Trxn = −40 °C. bTurnover frequency, TOF 
= (mol monomer consumed)(mol catalyst)−1(time)−1. cDetermined by gel permeation 
chromatography at 150 °C in 1,2,4-trichlorobenzene versus polyethylene standards. 
dDetermined by differential scanning calorimetry, endotherm from 2nd heating cycle. 
eDetermined by 13C NMR spectroscopy. f1,2-difluorobenzene. gAdditional signals are 
present that correspond to long chain branching. 
 !
1. Expanded Tables for Effect of Reaction Conditions on the 
Polymerization of 1-Butene using 5 
 
Table S1. Effect of Reaction Conditions on the Polymerization of 1-Butene using Complex 5a !
entry temp (°C) 
conc 
(M) 
yield 
(mg) 
Mnb 
(kDa) 
Đb 
(Mw/Mn) 
Tmc 
(°C) 4,1
d 4,2 d 1,2 d [mm]d 
1 −10 7.8 26  10.8 1.95 – n.d g n.d. g n.d. g n.d. g 
2 −30 7.8 420 23.7 1.80 66 0.17 0.79 0.04 0.53 
3 −40 7.8 234 14.7 1.57 85 0. 3 0.93 0.03 0.80 
4 −50 7.8 173 10.6 1.81 85 0. 2 0.96 0.02 0.80 
5 −40 6.0e 163 12.4 1.46 80 0. 5 0.91 0.04 0.70 
6 −40 9.1f 464 16.3 2.17 73 0.14 0.83 0.03 0.59 
aPolymerization conditions: 3.0 ± 0.2 g 1-butene (53.5 m ol), 10 µmol of complex 4.5 in 2 
mL CH2Cl2, 100 equiv. MAO; trxn = 24 h, Trxn = −40 °C. bDetermined by gel permeation 
chromatography at 150 °C in 1,2,4-trichlorobenzene versus polyethylene standards. 
cDetermined by differential scanning calorimetry, endotherm from 2nd heating cycle. 
dDetermined by 13C NMR spectroscopy. No detectable Tm. e1.5 ± 0.2 g 1-butene (26.8 
mmol). f6.0 ± 0.2 g 1-butene (107.0 mmol). gNot determined. 
 
 
Table S2. Effect of Solvent on the Polymerization of 1-Butene using Complex 5a !
entry solvent yield (mg) 
Mnc 
(kDa) 
Đc 
(Mw/Mn) 
Tmd 
(°C) 4,1
e 4,2 e 1,2 e [m ]e 
1 CH2Cl2 234 14.7 1.57 85 0.03 0.93 0.03g 0.80 
2 PhMe 198 12.2 1.96 79 0.02 0.95 0.03 0.79 
3 PhCl 338 21.1 1.85 76 0.07 0.90 0.03 0.76 
4 C6H4F2f 223 10.9 2.05 82 0.06 0.86 0.06g 0.72 
aPolymerization conditions: 3.0 ± 0.2 g 1-butene (53.5 mmol), 10 µmol of complex 4.5 
in 2 mL solvent, 1.0 mmol MAO; trxn = 24 h, Trxn = −40 °C. bTurnover frequency, TOF 
= (mol monomer consumed)(mol catalyst)−1(time)−1. cDetermined by gel permeation 
chromatography at 150 °C in 1,2,4-trichlorobenzene versus polyethylene standards. 
dDetermined by differential scanning calorimetry, endotherm from 2nd heating cycle. 
eDetermined by 13C NMR spectroscopy. f1,2-difluorobenzene. gAdditional signals are 
present that correspond to long chain branching. !
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Representative Differential Scanning Calorimetry (DSC) Traces of 4,2-poly(1-
butene) Samples. 
!
Figure 4.6. 4,2-poly(1-butene) produced by 4.1 (Table 4.1, entry 1). 
 
 
Figure 4.7. 4,2-poly(1-butene) produced by 4.2 (Table 4.1, entry 2). 
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Crystallographic Data for Complex 4.5 
Table 4.7. Crystal data and structure refinement for Rdv1. 
Identification code  rdv1_abs2 
Empirical formula  C50 H52 Br2 N2 Ni 
Formula weight  899.46 
Temperature  100.01(10) K 
Wavelength  1.54184 Å 
Crystal system  Monoclinic 
Space group  P 1 21/c 1 
Unit cell dimensions a = 9.04574(5) Å α= 90°. 
 b = 25.29692(13) Å β= 103.1909(5)°. 
 c = 19.03833(11) Å γ = 90°. 
Volume 4241.58(4) Å3 
Z 4 
Density (calculated) 1.409 Mg/m3 
Absorption coefficient 3.134 mm-1 
F(000) 1856 
Crystal size 0.198 x 0.08 x 0.019 mm3 
Theta range for data collection 2.956 to 70.075°. 
Index ranges -11<=h<=8, -26<=k<=30, -22<=l<=23 
Reflections collected 36578 
Independent reflections 8040 [R(int) = 0.0259] 
Completeness to theta = 67.684° 100.0 %  
 ! 158 
Absorption correction Gaussian 
Max. and min. transmission 1.000 and 0.628 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 8040 / 0 / 506 
Goodness-of-fit on F2 1.036 
Final R indices [I>2sigma(I)] R1 = 0.0254, wR2 = 0.0661 
R indices (all data) R1 = 0.0274, wR2 = 0.0671 
Extinction coefficient n/a 
Largest diff. peak and hole 0.673 and -0.416 e.Å-3 
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 Table 4.8. Atomic   coordinates   ( x 104)   and   equivalent   isotropic   displacement 
parameters (Å
2
x 10
3
)  for  4.5.  U(eq)  is  defined  as one  third of  the trace  of  the  
orthogonalized U
ij tensor. 
______________________________________________________________________________  
 x y z U(eq) 
_____________________________________________________________________  
Br(1) 4210(1) 2760(1) 7917(1) 24(1) 
Br(2) 7352(1) 3023(1) 6740(1) 23(1) 
Ni 4806(1) 2930(1) 6803(1) 18(1) 
N(1) 4012(1) 2490(1) 5904(1) 14(1) 
N(2) 2941(1) 3385(1) 6386(1) 14(1) 
C(1) 2067(2) 1746(1) 6909(1) 22(1) 
C(2) 585(2) 1925(1) 6848(1) 27(1) 
C(3) -476(2) 1877(1) 6203(1) 26(1) 
C(4) -58(2) 1639(1) 5622(1) 26(1) 
C(5) 1415(2) 1460(1) 5683(1) 22(1) 
C(6) 2509(2) 1519(1) 6322(1) 18(1) 
C(7) 4137(2) 1330(1) 6358(1) 18(1) 
C(8) 4721(2) 1548(1) 5716(1) 16(1) 
C(9) 5310(2) 1212(1) 5267(1) 18(1) 
C(10) 5984(2) 1385(1) 4715(1) 16(1) 
C(11) 6134(2) 1926(1) 4635(1) 16(1) 
C(12) 5513(2) 2275(1) 5053(1) 16(1) 
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C(13) 4761(2) 2092(1) 5564(1) 14(1) 
C(14) 5274(2) 1502(1) 7050(1) 23(1) 
C(15) 4098(2) 721(1) 6358(1) 26(1) 
C(16) 6451(2) 978(1) 4208(1) 20(1) 
C(17) 4992(2) 736(1) 3742(1) 26(1) 
C(18) 7419(2) 537(1) 4643(1) 24(1) 
C(19) 7356(2) 1227(1) 3704(1) 24(1) 
C(20) 2776(2) 2691(1) 5527(1) 14(1) 
C(21) 1765(2) 2572(1) 4826(1) 16(1) 
C(22) 1805(2) 2231(1) 4267(1) 19(1) 
C(23) 544(2) 2223(1) 3670(1) 24(1) 
C(24) -705(2) 2539(1) 3628(1) 24(1) 
C(25) -773(2) 2898(1) 4191(1) 21(1) 
C(26) -1973(2) 3254(1) 4221(1) 25(1) 
C(27) -1870(2) 3584(1) 4806(1) 26(1) 
C(28) -588(2) 3591(1) 5394(1) 21(1) 
C(29) 592(2) 3251(1) 5376(1) 17(1) 
C(30) 484(2) 2906(1) 4778(1) 17(1) 
C(31) 2095(2) 3152(1) 5842(1) 14(1) 
C(32) 2327(2) 3823(1) 6715(1) 16(1) 
C(33) 1291(2) 3693(1) 7126(1) 19(1) 
C(34) 680(2) 4079(1) 7489(1) 21(1) 
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C(35) 1106(2) 4606(1) 7455(1) 20(1) 
C(36) 2112(2) 4727(1) 7023(1) 20(1) 
C(37) 2745(2) 4350(1) 6638(1) 17(1) 
C(38) 3863(2) 4517(1) 6176(1) 22(1) 
C(39) 3339(2) 4292(1) 5409(1) 22(1) 
C(40) 1959(2) 4458(1) 4979(1) 31(1) 
C(41) 1447(2) 4274(1) 4280(1) 39(1) 
C(42) 2311(3) 3914(1) 3995(1) 38(1) 
C(43) 3676(2) 3742(1) 4414(1) 32(1) 
C(44) 4194(2) 3930(1) 5115(1) 25(1) 
C(45) 453(2) 5029(1) 7876(1) 26(1) 
C(46) 1143(2) 5576(1) 7822(2) 44(1) 
C(47) 755(2) 4867(1) 8675(1) 40(1) 
C(48) -1262(2) 5066(1) 7575(1) 29(1) 
C(49) 5454(2) 4334(1) 6562(1) 28(1) 
C(50) 3957(2) 5124(1) 6104(1) 35(1) 
________________________________________________________________________________ 
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Table 4.9. Bond lengths [Å] and angles 
[°] for 4.5. 
______________________________________ 
Br(1)-Ni  2.3446(3) 
Br(2)-Ni  2.3449(3) 
Ni-N(1)  2.0310(13) 
Ni-N(2)  2.0473(13) 
N(1)-C(13)  1.4460(19) 
N(1)-C(20)  1.288(2) 
N(2)-C(31)  1.282(2) 
N(2)-C(32)  1.4442(19) 
C(1)-H(1)  0.9300 
C(1)-C(2)  1.395(2) 
C(1)-C(6)  1.393(2) 
C(2)-H(2)  0.9300 
C(2)-C(3)  1.381(3) 
C(3)-H(3)  0.9300 
C(3)-C(4)  1.385(3) 
C(4)-H(4)  0.9300 
C(4)-C(5)  1.387(2) 
C(5)-H(5)  0.9300 
C(5)-C(6)  1.390(2) 
C(6)-C(7)  1.535(2) 
C(7)-C(8)  1.540(2) 
C(7)-C(14)  1.538(2) 
C(7)-C(15)  1.540(2) 
C(8)-C(9)  1.396(2) 
C(8)-C(13)  1.408(2) 
C(9)-H(9)  0.9300 
C(9)-C(10)  1.400(2) 
C(10)-C(11)  1.386(2) 
C(10)-C(16)  1.536(2) 
C(11)-H(11)  0.9300 
C(11)-C(12)  1.391(2) 
C(12)-H(12)  0.9300 
C(12)-C(13)  1.387(2) 
C(14)-H(14A)  0.9600 
C(14)-H(14B)  0.9600 
C(14)-H(14C)  0.9600 
C(15)-H(15A)  0.9600 
C(15)-H(15B)  0.9600 
C(15)-H(15C)  0.9600 
C(16)-C(17)  1.539(2) 
C(16)-C(18)  1.538(2) 
C(16)-C(19)  1.533(2) 
 ! 163 
C(17)-H(17A)  0.9600 
C(17)-H(17B)  0.9600 
C(17)-H(17C)  0.9600 
C(18)-H(18A)  0.9600 
C(18)-H(18B)  0.9600 
C(18)-H(18C)  0.9600 
C(19)-H(19A)  0.9600 
C(19)-H(19B)  0.9600  
C(19)-H(19C)  0.9600 
C(20)-C(21)  1.467(2) 
C(20)-C(31)  1.506(2) 
C(21)-C(22)  1.377(2) 
C(21)-C(30)  1.421(2) 
C(22)-H(22)  0.9300 
C(22)-C(23)  1.414(2) 
C(23)-H(23)  0.9300 
C(23)-C(24)  1.371(3) 
C(24)-H(24)  0.9300 
C(24)-C(25)  1.417(2) 
C(25)-C(26)  1.420(2) 
C(25)-C(30)  1.402(2) 
C(26)-H(26)  0.9300 
C(26)-C(27)  1.380(3) 
C(27)-H(27)  0.9300 
C(27)-C(28)  1.415(2) 
C(28)-H(28)  0.9300 
C(28)-C(29)  1.378(2) 
C(29)-C(30)  1.419(2) 
C(29)-C(31)  1.466(2) 
C(32)-C(33)  1.392(2) 
C(32)-C(37)  1.403(2) 
C(33)-H(33)  0.9300 
C(33)-C(34)  1.383(2) 
C(34)-H(34)  0.9300 
C(34)-C(35)  1.393(2) 
C(35)-C(36)  1.393(2) 
C(35)-C(45)  1.533(2) 
C(36)-H(36)  0.9300 
C(36)-C(37)  1.401(2) 
C(37)-C(38)  1.543(2) 
C(38)-C(39)  1.537(2) 
C(38)-C(49)  1.531(2) 
C(38)-C(50)  1.545(2) 
C(39)-C(40)  1.391(3) 
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C(39)-C(44)  1.397(2) 
C(40)-H(40)  0.9300 
C(40)-C(41)  1.385(3) 
C(41)-H(41)  0.9300 
C(41)-C(42)  1.389(3) 
C(42)-H(42)  0.9300 
C(42)-C(43)  1.378(3) 
C(43)-H(43)  0.9300 
C(43)-C(44)  1.394(3) 
C(44)-H(44)  0.9300 
C(45)-C(46)  1.530(3) 
C(45)-C(47)  1.540(3) 
C(45)-C(48)  1.529(2) 
C(46)-H(46A)  0.9600 
C(46)-H(46B)  0.9600 
C(46)-H(46C)  0.9600 
C(47)-H(47A)  0.9600 
C(47)-H(47B)  0.9600 
C(47)-H(47C)  0.9600 
C(48)-H(48A)  0.9600 
C(48)-H(48B)  0.9600 
C(48)-H(48C)  0.9600 
C(49)-H(49A)  0.9600 
C(49)-H(49B)  0.9600 
C(49)-H(49C)  0.9600 
C(50)-H(50A)  0.9600 
C(50)-H(50B)  0.9600 
C(50)-H(50C)  0.9600 
Br(1)-Ni-Br(2) 119.735(13) 
N(1)-Ni-Br(1) 123.48(4) 
N(1)-Ni-Br(2) 100.04(4) 
N(1)-Ni-N(2) 83.07(5) 
N(2)-Ni-Br(1) 96.59(4) 
N(2)-Ni-Br(2) 131.01(4) 
C(13)-N(1)-Ni 130.34(10) 
C(20)-N(1)-Ni 110.41(10) 
C(20)-N(1)-C(13) 117.45(13) 
C(31)-N(2)-Ni 109.97(10) 
C(31)-N(2)-C(32) 119.06(13) 
C(32)-N(2)-Ni 128.84(10) 
C(2)-C(1)-H(1) 119.6 
C(6)-C(1)-H(1) 119.6 
C(6)-C(1)-C(2) 120.87(16) 
C(1)-C(2)-H(2) 119.8 
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C(3)-C(2)-C(1) 120.34(16) 
C(3)-C(2)-H(2) 119.8 
C(2)-C(3)-H(3) 120.4 
C(2)-C(3)-C(4) 119.21(16) 
C(4)-C(3)-H(3) 120.4 
C(3)-C(4)-H(4) 119.8 
C(3)-C(4)-C(5) 120.39(17) 
C(5)-C(4)-H(4) 119.8 
C(4)-C(5)-H(5) 119.4 
C(4)-C(5)-C(6) 121.16(16) 
C(6)-C(5)-H(5) 119.4 
C(1)-C(6)-C(7) 122.75(15) 
C(5)-C(6)-C(1) 117.96(15) 
C(5)-C(6)-C(7) 119.29(14) 
C(6)-C(7)-C(8) 110.61(13) 
C(6)-C(7)-C(14) 113.39(13) 
C(6)-C(7)-C(15) 106.85(13) 
C(14)-C(7)-C(8) 107.19(13) 
C(14)-C(7)-C(15) 107.03(14) 
C(15)-C(7)-C(8) 111.77(13) 
C(9)-C(8)-C(7) 121.05(13) 
C(9)-C(8)-C(13) 115.98(14) 
C(13)-C(8)-C(7) 122.91(13) 
C(8)-C(9)-H(9) 117.9 
C(8)-C(9)-C(10) 124.19(14) 
C(10)-C(9)-H(9) 117.9 
C(9)-C(10)-C(16) 119.36(14) 
C(11)-C(10)-C(9) 117.45(14) 
C(11)-C(10)-C(16) 123.12(14) 
C(10)-C(11)-H(11) 119.9 
C(10)-C(11)-C(12) 120.17(14) 
C(12)-C(11)-H(11) 119.9 
C(11)-C(12)-H(12) 119.5 
C(13)-C(12)-C(11) 121.01(14) 
C(13)-C(12)-H(12) 119.5 
C(8)-C(13)-N(1) 123.45(13) 
C(12)-C(13)-N(1) 115.84(13) 
C(12)-C(13)-C(8) 120.69(14) 
C(7)-C(14)-H(14A) 109.5 
C(7)-C(14)-H(14B) 109.5 
C(7)-C(14)-H(14C) 109.5 
H(14A)-C(14)-H(14B) 109.5 
H(14A)-C(14)-H(14C) 109.5 
H(14B)-C(14)-H(14C) 109.5 
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C(7)-C(15)-H(15A) 109.5 
C(7)-C(15)-H(15B) 109.5 
C(7)-C(15)-H(15C) 109.5 
H(15A)-C(15)-H(15B) 109.5 
H(15A)-C(15)-H(15C) 109.5 
H(15B)-C(15)-H(15C) 109.5 
C(10)-C(16)-C(17) 107.91(13) 
C(10)-C(16)-C(18) 110.71(13) 
C(18)-C(16)-C(17) 109.27(14) 
C(19)-C(16)-C(10) 112.30(13) 
C(19)-C(16)-C(17) 108.18(14) 
C(19)-C(16)-C(18) 108.40(13) 
C(16)-C(17)-H(17A) 109.5 
C(16)-C(17)-H(17B) 109.5 
C(16)-C(17)-H(17C) 109.5 
H(17A)-C(17)-H(17B) 109.5 
H(17A)-C(17)-H(17C) 109.5 
H(17B)-C(17)-H(17C) 109.5 
C(16)-C(18)-H(18A) 109.5 
C(16)-C(18)-H(18B) 109.5 
C(16)-C(18)-H(18C) 109.5 
H(18A)-C(18)-H(18B) 109.5 
H(18A)-C(18)-H(18C) 109.5 
H(18B)-C(18)-H(18C) 109.5 
C(16)-C(19)-H(19A) 109.5 
C(16)-C(19)-H(19B) 109.5 
C(16)-C(19)-H(19C) 109.5 
H(19A)-C(19)-H(19B) 109.5 
H(19A)-C(19)-H(19C) 109.5 
H(19B)-C(19)-H(19C) 109.5 
N(1)-C(20)-C(21) 135.07(14) 
N(1)-C(20)-C(31) 117.73(13) 
C(21)-C(20)-C(31) 107.18(12) 
C(22)-C(21)-C(20) 135.36(15) 
C(22)-C(21)-C(30) 119.26(15) 
C(30)-C(21)-C(20) 105.38(13) 
C(21)-C(22)-H(22) 120.9 
C(21)-C(22)-C(23) 118.12(15) 
C(23)-C(22)-H(22) 120.9 
C(22)-C(23)-H(23) 118.6 
C(24)-C(23)-C(22) 122.77(15) 
C(24)-C(23)-H(23) 118.6 
C(23)-C(24)-H(24) 119.8 
C(23)-C(24)-C(25) 120.50(16) 
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C(25)-C(24)-H(24) 119.8 
C(24)-C(25)-C(26) 127.02(16) 
C(30)-C(25)-C(24) 116.42(15) 
C(30)-C(25)-C(26) 116.56(15) 
C(25)-C(26)-H(26) 119.9 
C(27)-C(26)-C(25) 120.30(16) 
C(27)-C(26)-H(26) 119.9 
C(26)-C(27)-H(27) 118.7 
C(26)-C(27)-C(28) 122.58(16) 
C(28)-C(27)-H(27) 118.7 
C(27)-C(28)-H(28) 120.9 
C(29)-C(28)-C(27) 118.17(16) 
C(29)-C(28)-H(28) 120.9 
C(28)-C(29)-C(30) 119.48(15) 
C(28)-C(29)-C(31) 135.14(15) 
C(30)-C(29)-C(31) 105.34(13) 
C(25)-C(30)-C(21) 122.92(15) 
C(25)-C(30)-C(29) 122.91(15) 
C(29)-C(30)-C(21) 114.17(14) 
N(2)-C(31)-C(20) 117.10(13) 
N(2)-C(31)-C(29) 135.23(14) 
C(29)-C(31)-C(20) 107.36(13) 
C(33)-C(32)-N(2) 115.94(13) 
C(33)-C(32)-C(37) 121.03(14) 
C(37)-C(32)-N(2) 123.02(13) 
C(32)-C(33)-H(33) 119.6 
C(34)-C(33)-C(32) 120.71(15) 
C(34)-C(33)-H(33) 119.6 
C(33)-C(34)-H(34) 119.8 
C(33)-C(34)-C(35) 120.48(15) 
C(35)-C(34)-H(34) 119.8 
C(34)-C(35)-C(45) 119.97(15) 
C(36)-C(35)-C(34) 117.51(14) 
C(36)-C(35)-C(45) 122.52(15) 
C(35)-C(36)-H(36) 118.0 
C(35)-C(36)-C(37) 124.06(15) 
C(37)-C(36)-H(36) 118.0 
C(32)-C(37)-C(38) 123.09(13) 
C(36)-C(37)-C(32) 116.11(14) 
C(36)-C(37)-C(38) 120.78(14) 
C(37)-C(38)-C(50) 112.24(13) 
C(39)-C(38)-C(37) 109.89(13) 
C(39)-C(38)-C(50) 107.09(15) 
C(49)-C(38)-C(37) 108.09(14) 
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C(49)-C(38)-C(39) 113.36(14) 
C(49)-C(38)-C(50) 106.17(15) 
C(40)-C(39)-C(38) 119.27(15) 
C(40)-C(39)-C(44) 117.76(17) 
C(44)-C(39)-C(38) 122.96(16) 
C(39)-C(40)-H(40) 119.2 
C(41)-C(40)-C(39) 121.55(18) 
C(41)-C(40)-H(40) 119.2 
C(40)-C(41)-H(41) 120.0 
C(40)-C(41)-C(42) 120.0(2) 
C(42)-C(41)-H(41) 120.0 
C(41)-C(42)-H(42) 120.3 
C(43)-C(42)-C(41) 119.43(19) 
C(43)-C(42)-H(42) 120.3 
C(42)-C(43)-H(43) 119.8 
C(42)-C(43)-C(44) 120.48(18) 
C(44)-C(43)-H(43) 119.8 
C(39)-C(44)-H(44) 119.6 
C(43)-C(44)-C(39) 120.78(18) 
C(43)-C(44)-H(44) 119.6 
C(35)-C(45)-C(47) 109.15(15) 
C(46)-C(45)-C(35) 112.58(15) 
C(46)-C(45)-C(47) 108.89(17) 
C(48)-C(45)-C(35) 109.04(14) 
C(48)-C(45)-C(46) 108.31(16) 
C(48)-C(45)-C(47) 108.79(15) 
C(45)-C(46)-H(46A) 109.5 
C(45)-C(46)-H(46B) 109.5 
C(45)-C(46)-H(46C) 109.5 
H(46A)-C(46)-H(46B) 109.5 
H(46A)-C(46)-H(46C) 109.5 
H(46B)-C(46)-H(46C) 109.5 
C(45)-C(47)-H(47A) 109.5 
C(45)-C(47)-H(47B) 109.5 
C(45)-C(47)-H(47C) 109.5 
H(47A)-C(47)-H(47B) 109.5 
H(47A)-C(47)-H(47C) 109.5 
H(47B)-C(47)-H(47C) 109.5 
C(45)-C(48)-H(48A) 109.5 
C(45)-C(48)-H(48B) 109.5 
C(45)-C(48)-H(48C) 109.5 
H(48A)-C(48)-H(48B) 109.5 
H(48A)-C(48)-H(48C) 109.5 
H(48B)-C(48)-H(48C) 109.5 
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C(38)-C(49)-H(49A) 109.5 
C(38)-C(49)-H(49B) 109.5 
C(38)-C(49)-H(49C) 109.5 
H(49A)-C(49)-H(49B) 109.5 
H(49A)-C(49)-H(49C) 109.5 
H(49B)-C(49)-H(49C) 109.5 
C(38)-C(50)-H(50A) 109.5 
C(38)-C(50)-H(50B) 109.5 
C(38)-C(50)-H(50C) 109.5 
H(50A)-C(50)-H(50B) 109.5 
H(50A)-C(50)-H(50C) 109.5 
H(50B)-C(50)-H(50C) 109.5 
 
 
 
 
Figure 4.8. X-ray crystal structure of 4.5. 
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